DTASelect v2.0.39
/home/mauraisa/sequest_data/20160416
/home/mauraisa/dbase/UniProt_Human_Cravattlab_nonredundant2_98id_11-05-2012_reversed.fasta
SEQUEST 3.0 in SQT format.
 --trypstat
true	Use criteria
0.0	Minimum peptide probability
0.05	Peptide global false discovery rate
0.0	Minimum protein probability
1.0	Protein false discovery rate
1	Minimum charge state
16	Maximum charge state
0.0	Minimum ion proportion
1000	Maximum Sp rank
-1.0	Minimum Sp score
Include	Modified peptide inclusion
Any	Tryptic status requirement
false	Multiple, ambiguous IDs allowed
Ignore	Peptide validation handling
XCorr	Purge duplicate peptides by protein
false	Include only loci with unique peptide
true	Remove subset proteins
Ignore	Locus validation handling
0	Minimum modified peptides per locus
2	Minimum peptides per locus

Locus	Sequence Count	Spectrum Count	Sequence Coverage	Length	MolWt	pI	Validation Status	Descriptive Name
Unique	FileName	XCorr	DeltCN	Conf%	M+H+	CalcM+H+	TotalIntensity	SpR	ZScore	IonProportion	Redundancy	Sequence
sp|P01834|IGKC_HUMAN	16	176	89.6%	106	11609	5.9	U	IGKC Ig kappa chain C region [REVIEWED] ENSG00000163245;IPI00979250;P01834 
*	20160416_RA_P1_SF_02.17581.17581.2	3.7959	0.5087	100.0	1946.0214	1946.0275	4126.1	1	8.312	70.6	16	-.TVAAPSVFIFPPSDEQLK.S
*	20160416_RA_P1_SF_02.18062.18062.3	3.1374	0.1768	99.6	1947.0267	1946.0275	6833.9	1	4.884	42.6	5	-.TVAAPSVFIFPPSDEQLK.S
*	20160416_RA_P1_SF_05.23167.23167.3	4.3141	0.4736	100.0	3726.9246	3724.9048	6381.8	1	7.25	28.8	3	-.TVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPR.E
*	20160416_RA_P1_SF_05.23158.23158.4	3.546	0.2027	99.8	3725.9236	3724.9048	7500.6	1	4.292	20.7	1	-.TVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPR.E
*	20160416_RA_P1_SF_05.23145.23145.3	2.5919	0.0517	96.3	4055.1064	4053.0796	3973.4	2	3.168	18.8	1	-.TVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAK.V
*	20160416_RA_P1_SF_04.01146.01146.1	1.7754	0.1106	96.9	1797.8881	1797.8958	4066.3	3	4.386	36.7	1	K.SGTASVVCLLNNFYPR.E
*	20160416_RA_P1_SF_04.01038.01038.2	4.6734	0.3247	100.0	1799.8937	1797.8958	7032.6	1	5.697	66.7	40	K.SGTASVVCLLNNFYPR.E
*	20160416_RA_P1_SF_05.00892.00892.3	4.2178	0.359	100.0	1797.8889	1797.8958	8182.9	1	7.297	51.7	8	K.SGTASVVCLLNNFYPR.E
*	20160416_RA_P1_SF_03.12040.12040.2	2.5403	0.2999	100.0	1036.5552	1036.558	5803.0	5	5.304	78.6	1	C.LLNNFYPR.E
*	20160416_RA_P1_SF_04.13544.13544.3	5.5923	0.5218	100.0	3620.694	3619.71	7279.4	1	8.291	31.1	21	K.VDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSK.A
*	20160416_RA_P1_SF_05.05074.05074.4	2.718	0.0155	95.3	3620.7046	3619.71	8171.3	28	3.409	18.2	1	K.VDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSK.A
*	20160416_RA_P1_SF_02.13206.13206.1	2.2037	0.1382	95.7	1502.7566	1502.759	6476.4	1	5.535	57.7	1	K.DSTYSLSSTLTLSK.A
*	20160416_RA_P1_SF_02.13243.13243.2	3.8949	0.399	100.0	1502.7544	1502.759	6390.4	1	7.574	76.9	67	K.DSTYSLSSTLTLSK.A
*	20160416_RA_P1_SF_05.06096.06096.3	3.8319	0.3482	100.0	2748.3352	2747.3462	8175.4	1	6.509	34.8	2	K.ADYEKHKVYACEVTHQGLSSPVTK.S
*	20160416_RA_P1_SF_04.06337.06337.2	4.7146	0.2846	100.0	1876.9265	1875.9275	10231.1	1	7.133	56.2	7	K.VYACEVTHQGLSSPVTK.S
*	20160416_RA_P1_SF_04.06402.06402.3	3.3192	0.3191	100.0	1875.9203	1875.9275	3357.4	1	7.351	45.3	1	K.VYACEVTHQGLSSPVTK.S
sp|P02768|ALBU_HUMAN	127	2149	76.8%	609	69367	6.3	U	ALB Serum albumin [REVIEWED] ENSG00000163631;IPI00745872;P02768;O95574;P04277;Q13140;Q645G4;Q68DN5;Q6UXK4;Q86YG0;Q9P157;Q9P1I7;Q9UHS3;Q9UJZ0 
*	20160416_RA_P1_SF_05.07224.07224.2	2.8972	0.2983	100.0	1149.5729	1149.5765	6594.1	1	5.832	77.8	8	R.DAHKSEVAHR.F
*	20160416_RA_P1_SF_03.09822.09822.1	1.572	0.1657	96.2	1226.6036	1226.6057	4975.5	19	4.007	50.0	2	R.FKDLGEENFK.A
*	20160416_RA_P1_SF_03.09972.09972.2	3.4415	0.2362	100.0	1226.6007	1226.6057	4714.0	1	5.121	88.9	38	R.FKDLGEENFK.A
*	20160416_RA_P1_SF_03.10389.10389.3	3.1601	0.1135	99.7	1226.6018	1226.6057	6812.2	1	4.288	63.9	8	R.FKDLGEENFK.A
*	20160416_RA_P1_SF_05.23103.23103.2	5.4134	0.5497	100.0	2490.3076	2490.2854	10150.0	1	10.186	60.0	4	K.ALVLIAFAQYLQQCPFEDHVK.L
*	20160416_RA_P1_SF_05.23049.23049.3	5.165	0.4829	100.0	2492.3208	2490.2854	6169.8	1	7.631	41.2	1	K.ALVLIAFAQYLQQCPFEDHVK.L
*	20160416_RA_P1_SF_05.22970.22970.4	4.7287	0.3885	100.0	2492.2847	2490.2854	6602.0	1	6.316	37.5	2	K.ALVLIAFAQYLQQCPFEDHVK.L
*	20160416_RA_P1_SF_03.10476.10476.2	4.6201	0.4387	100.0	1763.8174	1762.8223	8213.9	1	7.327	73.1	15	F.AQYLQQCPFEDHVK.L
*	20160416_RA_P1_SF_03.10276.10276.2	3.568	0.3566	100.0	1691.777	1691.7852	5345.7	1	6.803	83.3	3	A.QYLQQCPFEDHVK.L
*	20160416_RA_P1_SF_02.08507.08507.2	3.6293	0.3139	100.0	1149.611	1149.6156	4271.8	1	6.323	88.9	45	K.LVNEVTEFAK.T
*	20160416_RA_P1_SF_02.17911.17911.2	2.4034	0.2349	98.5	1036.5297	1036.5315	6141.9	4	4.718	75.0	2	L.VNEVTEFAK.T
*	20160416_RA_P1_SF_03.16578.16578.3	2.4619	0.0314	95.3	2497.0789	2497.0974	6868.1	46	3.781	26.2	1	K.TCVADESAENCDKSLHTLFGDK.L
*	20160416_RA_P1_SF_05.05124.05124.3	4.7495	0.2835	100.0	3413.5847	3411.5984	8822.5	1	5.51	24.1	1	K.TCVADESAENCDKSLHTLFGDKLCTVATLR.E
*	20160416_RA_P1_SF_05.12647.12647.1	1.6231	0.1762	95.7	1017.5346	1017.5369	6384.4	4	4.129	50.0	1	K.SLHTLFGDK.L
*	20160416_RA_P1_SF_05.13600.13600.2	2.7595	0.2591	100.0	1017.5338	1017.5369	3989.4	1	4.633	87.5	33	K.SLHTLFGDK.L
*	20160416_RA_P1_SF_05.17403.17403.2	2.6626	0.2462	100.0	1933.0194	1932.0377	8730.0	1	5.347	53.1	4	K.SLHTLFGDKLCTVATLR.E
*	20160416_RA_P1_SF_05.21297.21297.3	2.4218	0.2291	99.6	1934.0205	1932.0377	7441.9	50	5.243	34.4	4	K.SLHTLFGDKLCTVATLR.E
*	20160416_RA_P1_SF_05.05243.05243.2	4.3097	0.3773	100.0	1594.8608	1594.8627	6548.6	1	8.207	80.8	1	H.TLFGDKLCTVATLR.E
*	20160416_RA_P1_SF_03.06787.06787.2	2.3368	0.1256	99.9	933.5147	933.51917	2892.5	5	3.571	78.6	3	K.LCTVATLR.E
*	20160416_RA_P1_SF_03.11960.11960.2	4.0774	0.3955	100.0	2350.027	2349.0347	6250.1	1	7.476	52.6	7	K.LCTVATLRETYGEMADCCAK.Q
*	20160416_RA_P1_SF_03.12136.12136.3	4.0386	0.4119	100.0	2349.0251	2349.0347	7611.8	1	6.725	36.8	4	K.LCTVATLRETYGEMADCCAK.Q
*	20160416_RA_P1_SF_05.05154.05154.2	2.8142	0.2272	100.0	2638.2258	2636.2275	5908.5	1	4.706	37.5	2	K.QEPERNECFLQHKDDNPNLPR.L
*	20160416_RA_P1_SF_05.11532.11532.3	3.7439	0.2487	100.0	2637.2234	2636.2275	7139.3	3	5.887	32.5	43	K.QEPERNECFLQHKDDNPNLPR.L
*	20160416_RA_P1_SF_05.21490.21490.4	3.2679	0.2496	99.9	2637.2224	2636.2275	6847.7	3	5.531	28.3	8	K.QEPERNECFLQHKDDNPNLPR.L
*	20160416_RA_P1_SF_04.07819.07819.2	1.6438	0.1611	99.5	1075.4972	1075.4995	3981.0	1	4.345	71.4	1	R.NECFLQHK.D
*	20160416_RA_P1_SF_04.13096.13096.2	5.3143	0.4407	100.0	1997.9257	1996.9299	6316.1	1	7.658	76.7	60	R.NECFLQHKDDNPNLPR.L
*	20160416_RA_P1_SF_04.12960.12960.3	4.7426	0.4393	100.0	1996.92	1996.9299	7595.8	1	6.943	43.3	81	R.NECFLQHKDDNPNLPR.L
*	20160416_RA_P1_SF_05.05104.05104.4	2.3249	0.1997	99.7	1997.9258	1996.9299	6772.2	45	4.663	32.2	5	R.NECFLQHKDDNPNLPR.L
*	20160416_RA_P1_SF_04.06511.06511.2	4.5816	0.4899	100.0	2651.2617	2650.2646	8284.1	1	8.202	54.8	30	R.LVRPEVDVMCTAFHDNEETFLK.K
*	20160416_RA_P1_SF_05.01178.01178.3	6.7932	0.5004	100.0	2651.2568	2650.2646	11238.8	1	8.83	45.2	68	R.LVRPEVDVMCTAFHDNEETFLK.K
*	20160416_RA_P1_SF_05.00852.00852.4	4.2777	0.4025	100.0	2651.261	2650.2646	6499.2	3	6.399	33.3	25	R.LVRPEVDVMCTAFHDNEETFLK.K
*	20160416_RA_P1_SF_05.05449.05449.2	3.4507	0.2482	100.0	2779.3533	2778.3594	7645.5	1	6.243	38.6	7	R.LVRPEVDVMCTAFHDNEETFLKK.Y
*	20160416_RA_P1_SF_05.05655.05655.3	6.6115	0.4458	100.0	2779.3567	2778.3594	7386.7	1	8.21	36.4	47	R.LVRPEVDVMCTAFHDNEETFLKK.Y
*	20160416_RA_P1_SF_05.21410.21410.4	5.1992	0.4514	100.0	2780.3577	2778.3594	5661.3	4	7.357	29.5	14	R.LVRPEVDVMCTAFHDNEETFLKK.Y
*	20160416_RA_P1_SF_05.21701.21701.5	4.1872	0.2327	100.0	2778.3438	2778.3594	5921.4	1	5.389	31.2	6	R.LVRPEVDVMCTAFHDNEETFLKK.Y
*	20160416_RA_P1_SF_03.12539.12539.2	2.9471	0.3163	100.0	1841.8239	1841.8202	7832.5	1	6.714	53.6	1	D.VMCTAFHDNEETFLK.K
*	20160416_RA_P1_SF_03.10622.10622.2	4.1283	0.4709	100.0	1611.7053	1611.7113	6057.5	1	7.414	83.3	2	M.CTAFHDNEETFLK.K
*	20160416_RA_P1_SF_04.12944.12944.2	3.4412	0.3533	100.0	1739.7965	1739.8063	6835.3	1	6.453	61.5	5	M.CTAFHDNEETFLKK.Y
*	20160416_RA_P1_SF_03.10602.10602.2	3.0521	0.3864	100.0	1451.674	1451.6807	7905.5	1	6.883	68.2	1	C.TAFHDNEETFLK.K
*	20160416_RA_P1_SF_04.11225.11225.2	2.6963	0.243	100.0	1055.5848	1055.589	4908.4	1	4.91	92.9	8	K.KYLYEIAR.R
*	20160416_RA_P1_SF_02.09555.09555.2	2.7899	0.0061	99.8	930.49774	927.494	2674.6	1	3.209	91.7	35	K.YLYEIAR.R
*	20160416_RA_P1_SF_05.22388.22388.2	2.506	0.2192	100.0	1743.9001	1742.8947	3825.5	1	4.482	65.4	6	R.HPYFYAPELLFFAK.R
*	20160416_RA_P1_SF_05.22084.22084.3	3.906	0.3471	100.0	1743.8925	1742.8947	4811.1	2	5.712	51.9	5	R.HPYFYAPELLFFAK.R
*	20160416_RA_P1_SF_05.21939.21939.2	2.6402	0.2586	98.7	1605.8232	1605.8357	5357.0	7	4.992	45.8	1	H.PYFYAPELLFFAK.R
*	20160416_RA_P1_SF_04.02110.02110.2	3.7761	0.4761	100.0	1508.7778	1508.783	4352.3	1	7.391	90.9	2	P.YFYAPELLFFAK.R
*	20160416_RA_P1_SF_04.01718.01718.2	3.5364	0.4361	100.0	1345.7153	1345.7196	3624.5	1	6.577	85.0	4	Y.FYAPELLFFAK.R
*	20160416_RA_P1_SF_05.21831.21831.2	2.9965	0.2376	100.0	964.5459	964.5508	3452.2	1	4.705	92.9	4	A.PELLFFAK.R
*	20160416_RA_P1_SF_03.13309.13309.2	5.1944	0.3564	100.0	2125.9849	2124.988	6069.7	1	7.717	66.7	10	K.AAFTECCQAADKAACLLPK.L
*	20160416_RA_P1_SF_03.13798.13798.3	4.016	0.3289	100.0	2125.9807	2124.988	5611.6	1	6.405	38.9	7	K.AAFTECCQAADKAACLLPK.L
*	20160416_RA_P1_SF_04.13468.13468.3	2.9512	0.0522	98.7	1828.96	1827.9639	7499.5	32	4.328	35.0	1	K.AACLLPKLDELRDEGK.A
*	20160416_RA_P1_SF_03.06337.06337.2	2.1995	0.1301	99.8	1074.5364	1074.5431	5679.0	21	3.84	68.8	1	K.LDELRDEGK.A
*	20160416_RA_P1_SF_05.12798.12798.2	2.9725	0.2443	100.0	1019.5737	1019.57904	5277.4	1	4.775	87.5	9	R.AFKAWAVAR.L
*	20160416_RA_P1_SF_04.00546.00546.2	4.8573	0.3802	100.0	1651.8917	1650.8954	7842.2	1	7.267	82.1	3	K.AEFAEVSKLVTDLTK.V
*	20160416_RA_P1_SF_04.00565.00565.3	3.2411	0.1661	99.6	1650.8907	1650.8954	3443.6	3	5.316	44.6	1	K.AEFAEVSKLVTDLTK.V
*	20160416_RA_P1_SF_04.06697.06697.2	4.7038	0.4018	100.0	2586.1143	2585.1182	8705.9	1	7.938	47.6	29	K.VHTECCHGDLLECADDRADLAK.Y
*	20160416_RA_P1_SF_04.13569.13569.3	5.1524	0.4323	100.0	2586.1145	2585.1182	5855.1	1	7.357	45.2	80	K.VHTECCHGDLLECADDRADLAK.Y
*	20160416_RA_P1_SF_05.21380.21380.4	2.7979	0.142	99.5	2587.1245	2585.1182	5800.2	13	4.196	27.0	7	K.VHTECCHGDLLECADDRADLAK.Y
*	20160416_RA_P1_SF_05.05613.05613.2	3.0054	0.1064	100.0	1547.7977	1546.7972	9381.7	2	4.033	59.1	5	K.LKECCEKPLLEK.S
*	20160416_RA_P1_SF_04.01958.01958.2	5.729	0.5955	100.0	2975.3325	2974.345	6246.3	1	10.064	51.9	69	K.SHCIAEVENDEMPADLPSLAADFVESK.D
*	20160416_RA_P1_SF_04.00538.00538.3	5.9842	0.4375	100.0	2974.3364	2974.345	6455.0	1	8.355	40.4	74	K.SHCIAEVENDEMPADLPSLAADFVESK.D
*	20160416_RA_P1_SF_04.06374.06374.3	5.3853	0.2702	100.0	3479.5576	3476.566	10254.8	1	5.404	28.3	2	K.SHCIAEVENDEMPADLPSLAADFVESKDVCK.N
*	20160416_RA_P1_SF_03.01108.01108.2	2.8839	0.4286	100.0	2751.2485	2750.2542	7670.6	1	7.385	41.7	1	H.CIAEVENDEMPADLPSLAADFVESK.D
*	20160416_RA_P1_SF_03.01021.01021.2	2.093	0.4019	99.7	2590.2761	2590.2234	6000.8	5	5.618	30.4	1	C.IAEVENDEMPADLPSLAADFVESK.D
*	20160416_RA_P1_SF_03.00800.00800.2	4.1299	0.4829	100.0	1935.9001	1934.9058	5512.0	1	7.445	61.8	1	N.DEMPADLPSLAADFVESK.D
*	20160416_RA_P1_SF_03.00552.00552.2	4.1085	0.4206	100.0	1820.878	1819.8788	4737.6	1	6.934	65.6	2	D.EMPADLPSLAADFVESK.D
*	20160416_RA_P1_SF_03.00227.00227.2	4.3534	0.4463	100.0	1690.8337	1690.8362	4465.2	1	8.541	70.0	1	E.MPADLPSLAADFVESK.D
*	20160416_RA_P1_SF_02.17869.17869.2	5.0793	0.3867	100.0	1559.793	1559.7957	3768.6	1	8.742	89.3	10	M.PADLPSLAADFVESK.D
*	20160416_RA_P1_SF_03.06508.06508.2	4.0915	0.3381	100.0	1277.6787	1276.6788	7693.4	1	6.744	81.8	3	D.LPSLAADFVESK.D
*	20160416_RA_P1_SF_04.01156.01156.2	2.9719	0.2667	100.0	1163.593	1163.5948	8228.3	1	5.363	80.0	2	L.PSLAADFVESK.D
*	20160416_RA_P1_SF_05.23110.23110.2	3.4945	0.3941	100.0	1623.8003	1623.7881	7736.5	1	7.455	75.0	3	K.DVFLGMFLYEYAR.R
*	20160416_RA_P1_SF_03.16671.16671.2	3.7976	0.2979	100.0	1262.6194	1262.6244	5218.3	1	7.607	83.3	3	F.LGMFLYEYAR.R
*	20160416_RA_P1_SF_03.14072.14072.2	2.618	0.3818	100.0	1149.5364	1149.5403	7886.3	1	6.663	87.5	1	L.GMFLYEYAR.R
*	20160416_RA_P1_SF_05.20940.20940.2	2.4969	0.3671	100.0	1311.7375	1311.7424	3162.8	1	5.918	75.0	42	R.HPDYSVVLLLR.L
*	20160416_RA_P1_SF_05.17219.17219.3	2.5768	0.1044	99.3	1311.7369	1311.7424	3931.7	19	3.71	55.0	1	R.HPDYSVVLLLR.L
*	20160416_RA_P1_SF_03.17920.17920.2	3.3032	0.3593	100.0	1174.6794	1174.6836	7570.8	1	6.605	88.9	3	H.PDYSVVLLLR.L
*	20160416_RA_P1_SF_03.06982.06982.2	2.4412	0.16	99.9	1552.5963	1552.5983	5756.3	1	4.892	58.3	2	K.CCAAADPHECYAK.V
*	20160416_RA_P1_SF_02.11598.11598.2	3.0677	0.2144	98.7	1691.8293	1690.8328	7139.3	6	4.731	50.0	1	K.VFDEFKPLVEEPQN.L
*	20160416_RA_P1_SF_02.17048.17048.2	3.5319	0.2728	100.0	1804.9165	1803.9169	7808.8	1	5.438	64.3	1	K.VFDEFKPLVEEPQNL.I
*	20160416_RA_P1_SF_03.17786.17786.2	5.1817	0.3797	100.0	2046.0885	2045.096	4366.8	1	6.404	68.8	25	K.VFDEFKPLVEEPQNLIK.Q
*	20160416_RA_P1_SF_04.00519.00519.3	4.8167	0.2117	100.0	2046.0956	2045.096	6464.6	1	5.289	56.2	20	K.VFDEFKPLVEEPQNLIK.Q
*	20160416_RA_P1_SF_05.04633.04633.3	4.0469	0.0779	99.5	3687.8176	3683.8308	6107.5	1	3.394	28.4	9	K.VFDEFKPLVEEPQNLIKQNCELFEQLGEYK.F
*	20160416_RA_P1_SF_05.01775.01775.4	3.8649	0.1619	99.6	3685.8228	3683.8308	11137.3	1	4.613	21.8	1	K.VFDEFKPLVEEPQNLIKQNCELFEQLGEYK.F
*	20160416_RA_P1_SF_05.22782.22782.3	3.1845	0.1944	99.6	4627.3735	4625.3755	6134.3	1	4.188	17.6	1	K.VFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVR.Y
*	20160416_RA_P1_SF_05.22638.22638.4	5.7521	0.4838	100.0	4627.3687	4625.3755	7455.9	1	7.835	23.0	1	K.VFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVR.Y
*	20160416_RA_P1_SF_03.17568.17568.2	3.3175	0.3829	100.0	1946.0208	1946.0275	4933.1	1	7.13	63.3	4	V.FDEFKPLVEEPQNLIK.Q
*	20160416_RA_P1_SF_03.17322.17322.2	3.6927	0.3609	100.0	1798.9545	1798.9591	4100.0	1	6.595	64.3	5	F.DEFKPLVEEPQNLIK.Q
*	20160416_RA_P1_SF_03.17141.17141.1	2.0043	0.1467	95.8	1279.7174	1279.7262	6414.9	290	4.393	45.0	2	K.PLVEEPQNLIK.Q
*	20160416_RA_P1_SF_02.15365.15365.2	4.5166	0.3205	100.0	1658.7388	1657.7532	5914.7	1	6.887	83.3	133	K.QNCELFEQLGEYK.F
*	20160416_RA_P1_SF_05.00418.00418.2	3.9895	0.4045	100.0	2600.2925	2599.2979	5817.0	1	6.737	42.5	7	K.QNCELFEQLGEYKFQNALLVR.Y
*	20160416_RA_P1_SF_05.00698.00698.3	5.2688	0.3678	100.0	2600.2754	2599.2979	7996.3	1	6.734	31.2	18	K.QNCELFEQLGEYKFQNALLVR.Y
*	20160416_RA_P1_SF_05.12655.12655.2	3.03	0.1624	98.7	1089.6571	1088.6581	4818.8	1	4.144	93.8	1	Y.KFQNALLVR.Y
*	20160416_RA_P1_SF_03.12408.12408.1	1.8517	0.0958	96.9	960.5602	960.56305	4085.3	132	4.326	64.3	2	K.FQNALLVR.Y
*	20160416_RA_P1_SF_03.10895.10895.2	3.0214	0.0728	100.0	963.5651	960.56305	3675.3	2	3.216	92.9	91	K.FQNALLVR.Y
*	20160416_RA_P1_SF_05.13897.13897.2	2.7305	0.3758	100.0	1352.7701	1352.769	5951.1	1	6.077	70.0	3	K.FQNALLVRYTK.K
*	20160416_RA_P1_SF_05.05647.05647.2	4.0527	0.4807	100.0	1639.9359	1639.9382	4705.1	1	8.648	82.1	60	K.KVPQVSTPTLVEVSR.N
*	20160416_RA_P1_SF_05.12799.12799.3	4.4679	0.433	100.0	1639.9314	1639.9382	5787.3	1	8.385	51.8	22	K.KVPQVSTPTLVEVSR.N
*	20160416_RA_P1_SF_03.06499.06499.2	3.5236	0.5189	100.0	1511.8392	1511.8434	5985.1	1	8.569	80.8	25	K.VPQVSTPTLVEVSR.N
*	20160416_RA_P1_SF_05.22792.22792.2	4.6309	0.4251	100.0	2675.3066	2674.3154	7969.2	1	7.457	50.0	5	K.RMPCAEDYLSVVLNQLCVLHEK.T
*	20160416_RA_P1_SF_05.22747.22747.3	6.031	0.2618	100.0	2675.3052	2674.3154	10918.9	1	6.853	41.7	3	K.RMPCAEDYLSVVLNQLCVLHEK.T
*	20160416_RA_P1_SF_05.23150.23150.2	4.771	0.4548	100.0	2519.2114	2518.2144	7457.7	1	7.855	60.0	7	R.MPCAEDYLSVVLNQLCVLHEK.T
*	20160416_RA_P1_SF_05.22600.22600.3	6.8384	0.4261	100.0	2519.2195	2518.2144	10194.7	1	7.678	47.5	9	R.MPCAEDYLSVVLNQLCVLHEK.T
*	20160416_RA_P1_SF_05.22897.22897.4	2.8069	0.0902	98.8	2519.2485	2518.2144	5590.5	62	3.544	25.8	1	R.MPCAEDYLSVVLNQLCVLHEK.T
*	20160416_RA_P1_SF_05.22417.22417.3	2.9258	0.2529	99.8	3174.5618	3173.5435	8792.6	4	4.801	25.0	1	R.MPCAEDYLSVVLNQLCVLHEKTPVSDR.V
*	20160416_RA_P1_SF_05.22523.22523.4	5.3255	0.3301	100.0	3174.5413	3173.5435	7129.8	1	6.484	31.4	2	R.MPCAEDYLSVVLNQLCVLHEKTPVSDR.V
*	20160416_RA_P1_SF_05.22471.22471.2	3.1496	0.176	95.2	2291.1306	2290.121	7623.8	3	5.217	33.3	1	P.CAEDYLSVVLNQLCVLHEK.T
*	20160416_RA_P1_SF_05.01742.01742.2	3.6334	0.4753	100.0	2131.091	2130.0906	8428.0	1	8.511	61.8	1	C.AEDYLSVVLNQLCVLHEK.T
*	20160416_RA_P1_SF_05.05273.05273.2	3.4002	0.3905	100.0	1451.7983	1451.8044	6496.0	1	6.953	72.7	1	S.VVLNQLCVLHEK.T
*	20160416_RA_P1_SF_04.13408.13408.2	4.384	0.2954	100.0	1911.9265	1910.9323	5514.0	1	7.194	70.0	85	R.RPCFSALEVDETYVPK.E
*	20160416_RA_P1_SF_04.13480.13480.3	4.0222	0.3011	100.0	1910.9225	1910.9323	3625.3	1	5.739	53.3	41	R.RPCFSALEVDETYVPK.E
*	20160416_RA_P1_SF_02.14680.14680.2	5.5585	0.4718	100.0	1754.8239	1754.831	8265.0	1	9.519	82.1	15	R.PCFSALEVDETYVPK.E
*	20160416_RA_P1_SF_02.12364.12364.2	3.5645	0.3521	100.0	1498.7456	1497.7477	9317.5	1	6.538	70.8	10	C.FSALEVDETYVPK.E
*	20160416_RA_P1_SF_05.03656.03656.2	6.0993	0.4458	100.0	2261.0186	2260.0232	8691.2	1	9.012	58.3	195	K.EFNAETFTFHADICTLSEK.E
*	20160416_RA_P1_SF_05.18679.18679.3	3.1085	0.3227	100.0	2261.018	2260.0232	6441.5	1	5.538	40.3	63	K.EFNAETFTFHADICTLSEK.E
*	20160416_RA_P1_SF_05.16848.16848.2	4.3474	0.5403	100.0	2546.1594	2545.167	6492.1	1	8.737	45.0	11	K.EFNAETFTFHADICTLSEKER.Q
*	20160416_RA_P1_SF_04.13638.13638.3	3.4736	0.1336	99.7	2546.1628	2545.167	6873.1	3	4.649	30.0	27	K.EFNAETFTFHADICTLSEKER.Q
*	20160416_RA_P1_SF_04.06398.06398.2	3.1957	0.4028	100.0	1421.6694	1421.6735	4876.8	1	7.19	63.6	2	F.TFHADICTLSEK.E
*	20160416_RA_P1_SF_05.05445.05445.2	3.0645	0.2422	100.0	1128.6959	1128.6992	4815.9	1	5.371	88.9	12	K.KQTALVELVK.H
*	20160416_RA_P1_SF_05.12623.12623.2	2.5265	0.2671	98.7	1266.7576	1265.7582	6502.3	1	5.02	70.0	1	K.KQTALVELVKH.K
*	20160416_RA_P1_SF_02.11899.11899.2	2.1009	0.2068	100.0	1000.599	1000.60425	3308.1	45	4.079	62.5	17	K.QTALVELVK.H
*	20160416_RA_P1_SF_02.18538.18538.1	1.8602	0.1661	95.6	1342.6312	1342.6353	9993.4	7	5.356	50.0	2	K.AVMDDFAAFVEK.C
*	20160416_RA_P1_SF_02.18269.18269.2	3.9789	0.3681	100.0	1342.6292	1342.6353	7503.3	1	7.946	77.3	98	K.AVMDDFAAFVEK.C
*	20160416_RA_P1_SF_02.17282.17282.2	4.1496	0.4513	100.0	1271.5934	1271.5981	4264.0	1	8.413	90.0	2	A.VMDDFAAFVEK.C
*	20160416_RA_P1_SF_02.17839.17839.2	3.145	0.2896	100.0	1172.5269	1172.5298	6479.6	1	7.617	88.9	9	V.MDDFAAFVEK.C
*	20160416_RA_P1_SF_04.12546.12546.1	1.7108	0.0961	97.1	1141.6912	1141.6945	5982.3	23	4.257	45.5	1	K.KLVAASQAALGL.-
*	20160416_RA_P1_SF_04.12714.12714.2	3.2081	0.2669	100.0	1141.6908	1141.6945	7350.9	1	5.53	72.7	8	K.KLVAASQAALGL.-
*	20160416_RA_P1_SF_02.16463.16463.1	1.46	0.1822	96.2	1013.59717	1013.59955	6413.6	16	4.32	50.0	2	K.LVAASQAALGL.-
*	20160416_RA_P1_SF_02.07491.07491.2	3.6944	0.3629	100.0	1013.5957	1013.59955	4454.5	1	6.186	85.0	53	K.LVAASQAALGL.-
sp|P68871|HBB_HUMAN	12	55	69.4%	147	15998	7.3	U	HBB Hemoglobin subunit beta [REVIEWED] ENSG00000244734;ENSG00000188170;IPI00654755;P68871;A4GX73;B2ZUE0;P02023;Q13852;Q14481;Q14510;Q45KT0;Q549N7;Q6FI08;Q6R7N2;Q8IZI1;Q9BX96;Q9UCD6;Q9UCP8;Q9UCP9 
*	20160416_RA_P1_SF_03.12730.12730.1	1.4619	0.1177	97.1	932.51697	932.52057	9881.4	20	3.689	56.2	1	K.SAVTALWGK.V
*	20160416_RA_P1_SF_03.12549.12549.2	3.1216	0.1044	100.0	933.51874	932.52057	5087.1	1	4.576	93.8	3	K.SAVTALWGK.V
*	20160416_RA_P1_SF_02.06654.06654.2	3.3755	0.4099	100.0	1315.6614	1314.6654	6474.7	3	7.063	70.8	2	K.VNVDEVGGEALGR.L
	20160416_RA_P1_SF_03.16424.16424.2	2.7852	0.2958	100.0	1274.7224	1274.7261	4997.1	1	5.456	83.3	3	R.LLVVYPWTQR.F
*	20160416_RA_P1_SF_02.17047.17047.2	4.8317	0.5383	100.0	2059.9463	2058.9482	6329.6	1	9.748	66.7	8	R.FFESFGDLSTPDAVMGNPK.V
	20160416_RA_P1_SF_05.17064.17064.2	4.6237	0.513	100.0	1797.9827	1797.9863	9375.1	1	9.099	65.6	6	K.KVLGAFSDGLAHLDNLK.G
	20160416_RA_P1_SF_05.17232.17232.3	4.0128	0.2561	100.0	1798.9849	1797.9863	6498.5	1	4.902	45.3	6	K.KVLGAFSDGLAHLDNLK.G
	20160416_RA_P1_SF_02.18674.18674.2	3.7588	0.3723	100.0	1542.7933	1541.7964	10880.3	1	6.784	67.9	1	K.VLGAFSDGLAHLDNL.K
	20160416_RA_P1_SF_04.06449.06449.2	4.3591	0.3725	100.0	1670.8894	1669.8914	7834.3	1	6.654	76.7	1	K.VLGAFSDGLAHLDNLK.G
*	20160416_RA_P1_SF_03.12195.12195.2	2.9286	0.265	100.0	1479.6943	1478.695	7832.1	45	5.926	45.8	7	K.GTFATLSELHCDK.L
	20160416_RA_P1_SF_04.09745.09745.2	2.4872	0.1462	100.0	1126.5614	1126.5646	4824.4	11	4.954	75.0	11	K.LHVDPENFR.L
	20160416_RA_P1_SF_05.05847.05847.2	3.3569	0.3324	100.0	1149.6716	1149.6744	6596.4	1	7.193	86.4	6	K.VVAGVANALAHK.Y
sp|P02766|TTHY_HUMAN	12	79	65.3%	147	15887	5.7	U	TTR Transthyretin [REVIEWED] ENSG00000118271;IPI00022432;P02766;Q549C7;Q6IB96;Q9UBZ6;Q9UCM9 
*	20160416_RA_P1_SF_05.15104.15104.2	4.0637	0.4616	100.0	1366.7562	1366.7595	6200.6	1	7.843	75.0	18	R.GSPAINVAVHVFR.K
*	20160416_RA_P1_SF_05.15192.15192.3	1.6076	0.1255	95.8	1366.754	1366.7595	2248.7	15	3.675	41.7	1	R.GSPAINVAVHVFR.K
*	20160416_RA_P1_SF_03.11291.11291.2	4.5408	0.5231	100.0	1522.7123	1522.7178	9313.3	1	9.472	76.9	24	R.KAADDTWEPFASGK.T
*	20160416_RA_P1_SF_03.06479.06479.2	5.2193	0.4796	100.0	2456.15	2455.1516	8056.9	1	9.05	61.9	4	K.TSESGELHGLTTEEEFVEGIYK.V
*	20160416_RA_P1_SF_03.16609.16609.3	4.4698	0.4678	100.0	2456.1426	2455.1516	10349.7	1	7.667	34.5	4	K.TSESGELHGLTTEEEFVEGIYK.V
*	20160416_RA_P1_SF_05.05513.05513.2	3.4541	0.4584	100.0	2452.1929	2451.2058	7924.5	1	7.859	45.5	1	K.ALGISPFHEHAEVVFTANDSGPR.R
*	20160416_RA_P1_SF_05.05495.05495.3	3.734	0.2929	100.0	2452.2021	2451.2058	7971.2	3	5.217	31.8	3	K.ALGISPFHEHAEVVFTANDSGPR.R
*	20160416_RA_P1_SF_05.19826.19826.2	5.8591	0.5883	100.0	2645.3777	2645.3826	9493.1	1	10.957	60.9	10	R.RYTIAALLSPYSYSTTAVVTNPKE.-
*	20160416_RA_P1_SF_05.19618.19618.3	4.2184	0.3931	100.0	2646.381	2645.3826	7414.0	1	7.159	32.6	5	R.RYTIAALLSPYSYSTTAVVTNPKE.-
*	20160416_RA_P1_SF_05.00739.00739.2	4.7389	0.4268	100.0	2361.2283	2360.239	6054.1	1	8.268	57.1	2	R.YTIAALLSPYSYSTTAVVTNPK.E
*	20160416_RA_P1_SF_03.00387.00387.2	5.2062	0.5556	100.0	2490.2795	2489.2815	7051.0	1	10.293	54.5	6	R.YTIAALLSPYSYSTTAVVTNPKE.-
*	20160416_RA_P1_SF_03.00550.00550.3	3.3576	0.2308	99.9	2490.2793	2489.2815	8091.0	92	4.696	26.1	1	R.YTIAALLSPYSYSTTAVVTNPKE.-
sp|P02787|TRFE_HUMAN	65	661	64.2%	698	77064	7.1	U	TF Serotransferrin [REVIEWED] ENSG00000091513;IPI00022463;P02787;O43890;Q1HBA5;Q9NQB8;Q9UHV0 
*	20160416_RA_P1_SF_05.05292.05292.2	3.2322	0.3807	100.0	1543.8112	1543.8154	5032.4	1	6.183	60.7	1	M.KSVIPSDGPSVACVK.K
*	20160416_RA_P1_SF_02.09303.09303.2	3.0394	0.505	100.0	1415.7118	1415.7205	3160.1	1	7.569	69.2	39	K.SVIPSDGPSVACVK.K
*	20160416_RA_P1_SF_04.08618.08618.2	1.3884	0.0904	97.3	1543.8141	1543.8154	3971.6	439	3.799	28.6	1	K.SVIPSDGPSVACVKK.A
*	20160416_RA_P1_SF_02.09688.09688.2	2.0797	0.1355	99.8	997.4752	997.47766	5926.3	55	3.844	64.3	1	K.ASYLDCIR.A
*	20160416_RA_P1_SF_05.01883.01883.3	5.3081	0.4929	100.0	3955.0042	3954.0176	5587.5	1	8.212	27.0	11	R.AIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSK.E
*	20160416_RA_P1_SF_05.01972.01972.4	3.1692	0.1	99.2	3956.013	3954.0176	6764.3	50	4.801	16.2	1	R.AIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSK.E
*	20160416_RA_P1_SF_02.06929.06929.2	4.4438	0.4454	100.0	1630.8175	1629.8164	7708.6	1	8.032	80.8	57	K.EDPQTFYYAVAVVK.K
*	20160416_RA_P1_SF_03.14294.14294.2	2.9714	0.2246	100.0	1758.9106	1757.9114	4190.5	56	5.038	46.4	5	K.EDPQTFYYAVAVVKK.D
*	20160416_RA_P1_SF_04.14294.14294.2	3.9824	0.3397	100.0	1385.7404	1385.747	4390.7	1	7.085	90.9	10	D.PQTFYYAVAVVK.K
*	20160416_RA_P1_SF_04.09704.09704.2	2.7654	0.3008	100.0	1323.6444	1323.648	5268.5	4	5.47	65.0	4	K.KDSGFQMNQLR.G
*	20160416_RA_P1_SF_02.09284.09284.2	2.5301	0.1333	100.0	1195.6051	1195.553	7799.9	4	5.086	72.2	4	K.DSGFQMNQLR.G
*	20160416_RA_P1_SF_04.02023.02023.2	5.2443	0.5017	100.0	2172.0913	2171.096	4179.0	1	8.192	75.0	18	R.SAGWNIPIGLLYCDLPEPR.K
*	20160416_RA_P1_SF_04.01878.01878.3	4.192	0.3756	100.0	2171.0923	2171.096	6462.7	1	7.225	54.2	4	R.SAGWNIPIGLLYCDLPEPR.K
*	20160416_RA_P1_SF_04.01760.01760.2	3.5388	0.4186	100.0	1957.0065	1956.0054	5146.8	1	7.038	63.3	1	G.WNIPIGLLYCDLPEPR.K
*	20160416_RA_P1_SF_04.00038.00038.2	3.5337	0.4747	100.0	1770.9226	1769.926	3972.9	1	7.165	71.4	2	W.NIPIGLLYCDLPEPR.K
*	20160416_RA_P1_SF_03.18038.18038.2	4.1633	0.4728	100.0	1655.882	1655.883	7870.8	1	8.816	73.1	1	N.IPIGLLYCDLPEPR.K
*	20160416_RA_P1_SF_02.15120.15120.2	3.2718	0.2469	100.0	1446.7426	1445.7462	7260.7	1	5.21	63.6	1	P.IGLLYCDLPEPR.K
*	20160416_RA_P1_SF_04.01456.01456.3	3.4471	0.4723	100.0	4991.0825	4988.098	5800.6	1	7.534	17.0	3	K.AVANFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFK.C
*	20160416_RA_P1_SF_04.01462.01462.4	4.4395	0.2785	100.0	4992.091	4988.098	6898.0	5	5.205	14.0	1	K.AVANFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFK.C
*	20160416_RA_P1_SF_03.16018.16018.2	4.6199	0.6	100.0	2113.9114	2113.9111	9030.1	1	10.693	55.6	1	C.PGCGCSTLNQYFGYSGAFK.C
*	20160416_RA_P1_SF_03.15201.15201.2	3.4753	0.3735	100.0	1582.7443	1582.7542	6826.7	1	6.882	61.5	2	C.STLNQYFGYSGAFK.C
*	20160416_RA_P1_SF_03.14895.14895.2	2.6133	0.2554	98.7	1495.7284	1495.7222	9203.2	1	5.866	70.8	1	S.TLNQYFGYSGAFK.C
*	20160416_RA_P1_SF_04.06421.06421.2	3.5954	0.3746	100.0	1379.6963	1379.6993	5627.0	1	6.683	79.2	1	K.CLKDGAGDVAFVK.H
*	20160416_RA_P1_SF_05.13672.13672.2	2.903	0.2977	100.0	1273.65	1273.654	4326.5	1	6.476	70.0	4	K.HSTIFENLANK.A
*	20160416_RA_P1_SF_05.15120.15120.2	4.8523	0.5364	100.0	1615.8137	1615.8192	6212.8	1	9.337	84.6	42	K.HSTIFENLANKADR.D
*	20160416_RA_P1_SF_05.16352.16352.3	4.8321	0.3705	100.0	1615.8162	1615.8192	6462.3	1	7.376	55.8	49	K.HSTIFENLANKADR.D
*	20160416_RA_P1_SF_03.13374.13374.2	4.5113	0.3298	100.0	1882.8704	1881.8765	6098.3	1	7.252	78.6	19	K.ADRDQYELLCLDNTR.K
*	20160416_RA_P1_SF_03.13417.13417.3	4.1578	0.1136	99.6	1882.8728	1881.8765	7246.7	6	4.002	46.4	5	K.ADRDQYELLCLDNTR.K
*	20160416_RA_P1_SF_02.13830.13830.2	3.8137	0.3811	100.0	1540.7501	1539.7113	7358.4	1	7.06	81.8	5	R.DQYELLCLDNTR.K
*	20160416_RA_P1_SF_05.10724.10724.2	3.9686	0.3239	100.0	1689.8451	1689.8495	6710.8	1	6.958	67.9	4	K.DCHLAQVPSHTVVAR.S
*	20160416_RA_P1_SF_05.10611.10611.3	2.0766	0.1246	98.5	1690.8447	1689.8495	5532.9	1	3.951	39.3	1	K.DCHLAQVPSHTVVAR.S
*	20160416_RA_P1_SF_05.05523.05523.2	3.4565	0.2601	100.0	2531.2341	2530.24	7346.9	1	5.522	45.2	1	R.SMGGKEDLIWELLNQAQEHFGK.D
*	20160416_RA_P1_SF_05.05520.05520.3	5.0293	0.305	100.0	2531.2349	2530.24	10471.6	1	6.007	34.5	4	R.SMGGKEDLIWELLNQAQEHFGK.D
*	20160416_RA_P1_SF_05.22449.22449.4	2.84	0.1238	99.3	2531.2556	2530.24	5904.8	9	3.814	32.5	1	R.SMGGKEDLIWELLNQAQEHFGK.D
*	20160416_RA_P1_SF_05.22830.22830.2	4.7405	0.3806	100.0	2072.0352	2070.0295	11995.9	1	6.943	68.8	2	K.EDLIWELLNQAQEHFGK.D
*	20160416_RA_P1_SF_05.15728.15728.2	3.7264	0.4055	100.0	1491.7557	1491.7596	8438.9	1	7.33	75.0	19	K.SKEFQLFSSPHGK.D
*	20160416_RA_P1_SF_05.15626.15626.3	2.9152	0.1479	99.7	1492.7603	1491.7596	7031.3	6	4.509	45.8	5	K.SKEFQLFSSPHGK.D
*	20160416_RA_P1_SF_02.11111.11111.2	2.4561	0.2341	98.7	1091.5117	1091.5162	6292.6	2	5.07	68.8	2	K.EFQLFSSPH.G
*	20160416_RA_P1_SF_04.12808.12808.2	3.6165	0.3088	100.0	1276.6285	1276.6326	4426.3	1	6.19	85.0	5	K.EFQLFSSPHGK.D
*	20160416_RA_P1_SF_02.16231.16231.1	1.8322	0.1905	95.0	1478.7322	1478.7354	4761.4	2	4.71	50.0	2	K.MYLGYEYVTAIR.N
*	20160416_RA_P1_SF_04.15742.15742.2	4.4915	0.5145	100.0	1478.7303	1478.7354	8134.1	1	9.176	86.4	72	K.MYLGYEYVTAIR.N
*	20160416_RA_P1_SF_02.13913.13913.2	2.6825	0.2115	98.0	1348.6953	1347.6948	6630.3	1	4.461	85.0	1	M.YLGYEYVTAIR.N
*	20160416_RA_P1_SF_05.10684.10684.2	2.2323	0.144	99.9	1195.5378	1195.5431	4776.7	1	5.348	75.0	7	K.WCALSHHER.L
*	20160416_RA_P1_SF_04.06370.06370.2	3.9688	0.3797	100.0	1521.7344	1521.7372	9131.5	1	7.043	83.3	3	R.LKCDEWSVNSVGK.I
*	20160416_RA_P1_SF_02.06544.06544.2	4.986	0.475	100.0	1726.7644	1725.7676	7400.7	1	8.496	78.6	2	K.IECVSAETTEDCIAK.I
*	20160416_RA_P1_SF_02.17968.17968.2	5.4262	0.5497	100.0	2161.0159	2159.0154	7290.2	1	10.229	60.0	43	K.IMNGEADAMSLDGGFVYIAGK.C
*	20160416_RA_P1_SF_04.17786.17786.3	3.7989	0.2636	100.0	2160.0078	2159.0154	9014.8	2	5.737	31.2	1	K.IMNGEADAMSLDGGFVYIAGK.C
*	20160416_RA_P1_SF_03.11783.11783.2	3.6512	0.212	100.0	1377.696	1377.7014	7670.4	1	5.554	90.9	14	K.KSASDLTWDNLK.G
*	20160416_RA_P1_SF_03.11855.11855.3	2.7388	0.0539	98.7	1377.6967	1377.7014	6249.1	57	3.29	45.5	2	K.KSASDLTWDNLK.G
*	20160416_RA_P1_SF_02.11445.11445.2	2.9891	0.2547	100.0	1249.599	1249.6064	6661.6	1	5.758	80.0	3	K.SASDLTWDNLK.G
*	20160416_RA_P1_SF_05.00378.00378.2	4.9228	0.3551	100.0	1578.8119	1577.8151	4144.5	1	6.711	76.9	37	R.TAGWNIPMGLLYNK.I
*	20160416_RA_P1_SF_05.00148.00148.3	2.6385	0.1582	99.7	1577.8085	1577.8151	5598.6	8	5.202	44.2	1	R.TAGWNIPMGLLYNK.I
*	20160416_RA_P1_SF_02.11765.11765.2	3.9122	0.3317	100.0	1577.6511	1577.6582	7201.3	1	7.519	69.2	6	R.FDEFFSEGCAPGSK.K
*	20160416_RA_P1_SF_03.09879.09879.2	3.8544	0.3988	100.0	1705.7489	1705.7532	8635.2	1	8.305	64.3	32	R.FDEFFSEGCAPGSKK.D
*	20160416_RA_P1_SF_03.11864.11864.3	2.4311	0.2116	99.6	1705.7472	1705.7532	6968.2	10	5.071	35.7	2	R.FDEFFSEGCAPGSKK.D
*	20160416_RA_P1_SF_03.15808.15808.3	3.3538	0.2008	99.7	2973.2974	2971.3176	5698.7	1	4.26	31.0	4	K.LCMGSGLNLCEPNNKEGYYGYTGAFR.C
*	20160416_RA_P1_SF_02.10519.10519.2	2.331	0.2891	100.0	1283.5668	1283.5697	7082.9	1	5.753	60.0	6	K.EGYYGYTGAFR.C
*	20160416_RA_P1_SF_04.10558.10558.2	1.9338	0.0817	98.9	1364.7218	1364.7247	5688.7	4	3.297	63.6	1	R.CLVEKGDVAFVK.H
*	20160416_RA_P1_SF_03.14253.14253.2	4.5233	0.5094	100.0	1952.931	1952.9387	8558.8	1	9.635	63.3	15	K.NLNEKDYELLCLDGTR.K
*	20160416_RA_P1_SF_03.14151.14151.3	3.9721	0.149	99.8	1953.9371	1952.9387	9275.8	9	4.148	40.0	6	K.NLNEKDYELLCLDGTR.K
*	20160416_RA_P1_SF_02.13960.13960.2	2.4843	0.0297	99.5	1354.63	1354.6312	8196.2	2	4.247	70.0	1	K.DYELLCLDGTR.K
*	20160416_RA_P1_SF_05.06013.06013.2	2.9018	0.2635	100.0	1586.7646	1586.7749	6098.3	1	6.985	70.8	1	R.KPVEEYANCHLAR.A
*	20160416_RA_P1_SF_03.10649.10649.2	1.8934	0.1032	99.4	1108.5977	1108.6002	7462.0	1	3.967	75.0	1	R.SETKDLLFR.D
*	20160416_RA_P1_SF_02.16975.16975.2	3.8956	0.3028	100.0	1565.7955	1565.7998	6312.3	1	7.018	70.8	38	K.DLLFRDDTVCLAK.L
*	20160416_RA_P1_SF_02.12051.12051.2	4.5625	0.5325	100.0	1531.6836	1531.6885	7084.4	1	9.408	83.3	22	K.CSTSSLLEACTFR.R
sp|P01857|IGHG1_HUMAN	33	573	62.4%	330	36106	8.2	U	IGHG1 Ig gamma-1 chain C region [REVIEWED] ENSG00000211896;ENSG00000130076;IPI00423463;P01857 
*	20160416_RA_P1_SF_05.13291.13291.2	1.2218	0.0266	96.0	1574.8634	1573.859	5139.3	229	3.296	26.7	1	-.ASTKGPSVFPLAPSSK.S
*	20160416_RA_P1_SF_04.12579.12579.1	1.4114	0.1487	96.8	1186.6451	1186.6472	7452.3	3	3.788	45.5	2	K.GPSVFPLAPSSK.S
*	20160416_RA_P1_SF_04.12400.12400.2	2.8986	0.1008	100.0	1189.6488	1186.6472	4764.8	2	3.416	68.2	56	K.GPSVFPLAPSSK.S
*	20160416_RA_P1_SF_05.16747.16747.3	3.0872	0.2569	99.9	2492.3044	2489.3074	5187.2	1	4.986	29.0	1	K.GPSVFPLAPSSKSTSGGTAALGCLVK.D
	20160416_RA_P1_SF_03.09224.09224.2	3.8393	0.3293	100.0	1321.6733	1321.6786	7001.6	1	7.327	73.1	25	K.STSGGTAALGCLVK.D
	20160416_RA_P1_SF_02.17888.17888.2	2.9171	0.521	100.0	2263.0576	2263.0671	6482.5	1	8.478	50.0	1	K.DYFPEPVTVSWNSGALTSGVH.T
	20160416_RA_P1_SF_03.00638.00638.2	2.9038	0.2761	99.2	2610.2405	2608.236	7830.9	1	5.5	41.3	1	K.DYFPEPVTVSWNSGALTSGVHTFP.A
	20160416_RA_P1_SF_03.00423.00423.2	3.0628	0.3148	100.0	2680.2673	2679.2732	7064.5	1	6.089	35.4	1	K.DYFPEPVTVSWNSGALTSGVHTFPA.V
	20160416_RA_P1_SF_04.02080.02080.2	2.8571	0.3469	100.0	3528.7102	3526.717	6375.4	2	6.15	23.4	1	K.DYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLY.S
*	20160416_RA_P1_SF_04.12106.12106.2	2.5528	0.2602	98.3	1703.784	1703.7886	7168.5	5	5.837	53.3	1	K.THTCPPCPAPELLGGP.S
*	20160416_RA_P1_SF_04.16822.16822.2	4.2713	0.4768	100.0	2037.9506	2036.9574	5971.5	1	7.697	52.8	5	K.THTCPPCPAPELLGGPSVF.L
*	20160416_RA_P1_SF_05.20632.20632.3	2.7511	0.2464	99.7	2620.3147	2619.3103	6648.9	1	4.891	29.3	1	K.THTCPPCPAPELLGGPSVFLFPPK.P
	20160416_RA_P1_SF_05.19147.19147.2	4.0878	0.3145	100.0	1726.99	1725.9944	6231.3	1	5.438	70.0	5	P.ELLGGPSVFLFPPKPK.D
	20160416_RA_P1_SF_02.12132.12132.2	5.5102	0.5114	100.0	1686.7654	1685.7693	8725.7	1	9.359	78.6	29	R.TPEVTCVVVDVSHED.P
*	20160416_RA_P1_SF_02.12507.12507.3	2.7694	0.0046	95.5	2140.025	2139.028	7243.4	2	3.806	33.3	2	R.TPEVTCVVVDVSHEDPEVK.F
	20160416_RA_P1_SF_02.13764.13764.2	3.8931	0.5031	100.0	1364.622	1364.6276	9227.3	1	8.526	85.0	6	K.FNWYVDGVEVH.N
	20160416_RA_P1_SF_04.13504.13504.2	5.4078	0.5309	100.0	1677.7965	1677.8025	9827.0	1	9.699	80.8	56	K.FNWYVDGVEVHNAK.T
	20160416_RA_P1_SF_03.10846.10846.2	4.1999	0.4656	100.0	1416.6868	1416.6912	7378.9	1	8.112	86.4	26	N.WYVDGVEVHNAK.T
	20160416_RA_P1_SF_03.14977.14977.2	2.512	0.3407	100.0	1094.6515	1094.6573	5691.6	1	5.835	83.3	1	R.VVSVLTVLHQ.D
	20160416_RA_P1_SF_05.19794.19794.2	5.2167	0.5083	100.0	1808.0054	1808.0071	8861.9	1	9.483	60.0	76	R.VVSVLTVLHQDWLNGK.E
	20160416_RA_P1_SF_05.16803.16803.3	3.2261	0.2629	100.0	1810.0107	1808.0071	3183.2	1	4.654	40.0	33	R.VVSVLTVLHQDWLNGK.E
	20160416_RA_P1_SF_05.21530.21530.2	4.1838	0.2713	100.0	2230.209	2228.208	9197.1	1	5.567	47.2	8	R.VVSVLTVLHQDWLNGKEYK.C
	20160416_RA_P1_SF_05.21547.21547.3	3.9401	0.4557	100.0	2229.2004	2228.208	4017.8	1	7.091	43.1	19	R.VVSVLTVLHQDWLNGKEYK.C
	20160416_RA_P1_SF_05.20916.20916.2	3.4242	0.2275	99.4	1609.8644	1609.8702	8544.4	1	6.192	57.7	3	V.SVLTVLHQDWLNGK.E
	20160416_RA_P1_SF_04.11456.11456.2	2.6085	0.2659	98.9	1310.6793	1310.6857	8875.4	2	5.524	60.0	1	L.TVLHQDWLNGK.E
	20160416_RA_P1_SF_02.09606.09606.2	2.4738	0.2907	100.0	1286.6697	1286.6744	4374.4	1	4.952	70.0	16	R.EPQVYTLPPSR.D
*	20160416_RA_P1_SF_03.06395.06395.2	3.7964	0.4534	100.0	1872.9663	1872.9707	5662.9	1	7.782	63.3	20	R.EPQVYTLPPSRDELTK.N
	20160416_RA_P1_SF_03.10388.10388.2	3.0521	0.3025	100.0	1161.6262	1161.6301	5416.0	1	5.939	88.9	36	K.NQVSLTCLVK.G
	20160416_RA_P1_SF_02.16683.16683.2	5.1668	0.4104	100.0	2545.124	2544.1318	7874.4	1	8.026	57.1	65	K.GFYPSDIAVEWESNGQPENNYK.T
	20160416_RA_P1_SF_02.16052.16052.3	4.4503	0.3429	100.0	2545.1277	2544.1318	6626.7	1	6.397	42.9	12	K.GFYPSDIAVEWESNGQPENNYK.T
*	20160416_RA_P1_SF_02.16539.16539.2	3.9826	0.3867	100.0	1874.9185	1873.9224	1771.7	2	6.889	75.0	56	K.TTPPVLDSDGSFFLYSK.L
*	20160416_RA_P1_SF_02.17046.17046.3	2.2763	0.2518	99.6	1874.921	1873.9224	7000.2	1	5.226	37.5	2	K.TTPPVLDSDGSFFLYSK.L
*	20160416_RA_P1_SF_02.18704.18704.2	4.8072	0.3748	100.0	1672.8251	1671.827	10401.0	1	7.561	75.0	5	T.PPVLDSDGSFFLYSK.L
sp|P01859|IGHG2_HUMAN	24	319	60.7%	326	35901	7.6	U	IGHG2 Ig gamma-2 chain C region [REVIEWED] ENSG00000211893;ENSG00000205401;IPI00399007;P01859;A6NE66 
	20160416_RA_P1_SF_04.13064.13064.2	3.0957	0.3772	100.0	1287.6481	1287.652	3862.3	1	6.048	72.7	23	K.GPSVFPLAPCSR.S
	20160416_RA_P1_SF_04.13099.13099.2	3.1185	0.2778	100.0	1231.628	1230.6305	4654.5	4	5.072	65.0	1	G.PSVFPLAPCSR.S
	20160416_RA_P1_SF_02.06948.06948.2	3.8301	0.4046	100.0	1423.703	1423.7102	7096.4	1	7.76	73.1	10	R.STSESTAALGCLVK.D
	20160416_RA_P1_SF_02.17888.17888.2	2.9171	0.521	100.0	2263.0576	2263.0671	6482.5	1	8.478	50.0	1	K.DYFPEPVTVSWNSGALTSGVH.T
	20160416_RA_P1_SF_03.00638.00638.2	2.9038	0.2761	99.2	2610.2405	2608.236	7830.9	1	5.5	41.3	1	K.DYFPEPVTVSWNSGALTSGVHTFP.A
	20160416_RA_P1_SF_03.00423.00423.2	3.0628	0.3148	100.0	2680.2673	2679.2732	7064.5	1	6.089	35.4	1	K.DYFPEPVTVSWNSGALTSGVHTFPA.V
	20160416_RA_P1_SF_04.02080.02080.2	2.8571	0.3469	100.0	3528.7102	3526.717	6375.4	2	6.15	23.4	1	K.DYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLY.S
*	20160416_RA_P1_SF_05.18312.18312.2	1.573	0.17	99.1	2909.3762	2908.402	3999.8	475	4.0	14.0	1	K.CCVECPPCPAPPVAGPSVFLFPPKPK.D
*	20160416_RA_P1_SF_05.18317.18317.3	3.0906	0.1935	99.6	2909.369	2908.402	3658.3	1	5.265	27.0	3	K.CCVECPPCPAPPVAGPSVFLFPPKPK.D
	20160416_RA_P1_SF_02.12132.12132.2	5.5102	0.5114	100.0	1686.7654	1685.7693	8725.7	1	9.359	78.6	29	R.TPEVTCVVVDVSHED.P
	20160416_RA_P1_SF_02.13764.13764.2	3.8931	0.5031	100.0	1364.622	1364.6276	9227.3	1	8.526	85.0	6	Q.FNWYVDGVEVH.N
	20160416_RA_P1_SF_04.13504.13504.2	5.4078	0.5309	100.0	1677.7965	1677.8025	9827.0	1	9.699	80.8	56	Q.FNWYVDGVEVHNAK.T
	20160416_RA_P1_SF_03.10846.10846.2	4.1999	0.4656	100.0	1416.6868	1416.6912	7378.9	1	8.112	86.4	26	N.WYVDGVEVHNAK.T
*	20160416_RA_P1_SF_05.18902.18902.2	5.3767	0.5263	100.0	1793.9868	1793.9913	8041.0	1	9.527	70.0	44	R.VVSVLTVVHQDWLNGK.E
*	20160416_RA_P1_SF_04.17856.17856.3	2.7468	0.1271	99.4	1795.9717	1793.9913	2847.6	1	4.16	41.7	9	R.VVSVLTVVHQDWLNGK.E
*	20160416_RA_P1_SF_05.05532.05532.2	3.2777	0.2483	100.0	2216.2007	2214.1924	11415.3	1	4.907	44.4	3	R.VVSVLTVVHQDWLNGKEYK.C
*	20160416_RA_P1_SF_05.19539.19539.3	2.7633	0.2458	99.8	2215.1875	2214.1924	4785.4	97	4.957	29.2	8	R.VVSVLTVVHQDWLNGKEYK.C
	20160416_RA_P1_SF_02.09606.09606.2	2.4738	0.2907	100.0	1286.6697	1286.6744	4374.4	1	4.952	70.0	16	R.EPQVYTLPPSR.E
	20160416_RA_P1_SF_03.06515.06515.2	3.8186	0.3746	100.0	1905.9425	1904.9427	5605.0	1	7.334	66.7	25	R.EPQVYTLPPSREEMTK.N
	20160416_RA_P1_SF_03.09916.09916.3	1.649	0.1152	95.5	1904.9366	1904.9427	5040.6	3	3.491	35.0	1	R.EPQVYTLPPSREEMTK.N
	20160416_RA_P1_SF_03.10388.10388.2	3.0521	0.3025	100.0	1161.6262	1161.6301	5416.0	1	5.939	88.9	36	K.NQVSLTCLVK.G
*	20160416_RA_P1_SF_02.18299.18299.2	2.2267	0.1	99.5	2561.1226	2560.1267	6531.5	131	3.611	26.2	1	K.GFYPSDISVEWESNGQPENNYK.T
	20160416_RA_P1_SF_02.16925.16925.2	3.3448	0.3182	100.0	1906.8907	1905.8944	1872.1	1	6.065	71.9	16	K.TTPPMLDSDGSFFLYSK.L
	20160416_RA_P1_SF_02.17183.17183.2	4.8394	0.5158	100.0	1704.7727	1703.7991	9740.7	1	9.029	78.6	1	T.PPMLDSDGSFFLYSK.L
sp|P0CG05|LAC2_HUMAN	10	94	55.7%	106	11294	7.2	U	IGLC2 Ig lambda-2 chain C regions [REVIEWED] ENSG00000100208;IPI00154742;P0CG05;A0M8Q4;P80423 
*	20160416_RA_P1_SF_02.14371.14371.2	3.9708	0.4326	100.0	1986.0148	1986.0184	3658.3	1	7.707	66.7	22	K.AAPSVTLFPPSSEELQANK.A
*	20160416_RA_P1_SF_02.13380.13380.3	3.3433	0.3828	100.0	1987.0134	1986.0184	5387.1	2	5.893	37.5	7	K.AAPSVTLFPPSSEELQANK.A
	20160416_RA_P1_SF_05.23166.23166.2	4.7057	0.4888	100.0	2212.1648	2211.1523	5080.7	1	8.767	73.7	3	K.ATLVCLISDFYPGAVTVAWK.A
	20160416_RA_P1_SF_05.23036.23036.3	3.5161	0.2543	100.0	2213.1394	2211.1523	6444.0	1	5.357	39.5	1	K.ATLVCLISDFYPGAVTVAWK.A
	20160416_RA_P1_SF_02.18354.18354.2	3.4472	0.428	100.0	1666.8789	1666.8844	5109.7	1	7.101	67.9	1	C.LISDFYPGAVTVAWK.A
	20160416_RA_P1_SF_04.15263.15263.2	4.7792	0.3631	100.0	2316.1243	2315.1309	6180.1	1	7.721	52.6	12	K.QSNNKYAASSYLSLTPEQWK.S
	20160416_RA_P1_SF_04.15239.15239.3	3.0668	0.4046	100.0	2315.123	2315.1309	6179.1	1	6.507	35.5	5	K.QSNNKYAASSYLSLTPEQWK.S
	20160416_RA_P1_SF_02.15403.15403.2	5.225	0.4512	100.0	1743.8549	1743.8594	5488.8	1	8.968	82.1	41	K.YAASSYLSLTPEQWK.S
	20160416_RA_P1_SF_02.14656.14656.2	2.9829	0.2556	99.2	1580.7943	1580.796	6291.5	17	5.013	50.0	1	Y.AASSYLSLTPEQWK.S
	20160416_RA_P1_SF_02.14404.14404.2	2.775	0.1926	97.4	1351.6844	1351.6898	6769.2	2	4.593	75.0	1	S.SYLSLTPEQWK.S
sp|P01009|A1AT_HUMAN	35	329	52.9%	418	46737	5.6	U	SERPINA1 Alpha-1-antitrypsin [REVIEWED] ENSG00000197249;IPI00869004;P01009;A6PX14;B2RDQ8;Q0PVP5;Q13672;Q53XB8;Q5U0M1;Q7M4R2;Q86U18;Q86U19;Q96BF9;Q96ES1;Q9P1P0;Q9UCE6;Q9UCM3 
*	20160416_RA_P1_SF_04.01926.01926.2	4.2536	0.4325	100.0	1642.8623	1641.864	4362.1	1	7.109	80.8	24	K.ITPNLAEFAFSLYR.Q
*	20160416_RA_P1_SF_05.01690.01690.3	3.1298	0.2694	100.0	1641.8584	1641.864	9271.7	1	5.099	50.0	2	K.ITPNLAEFAFSLYR.Q
*	20160416_RA_P1_SF_05.01713.01713.2	3.6043	0.4381	100.0	1528.7769	1528.78	7853.4	1	7.489	66.7	1	I.TPNLAEFAFSLYR.Q
*	20160416_RA_P1_SF_05.01715.01715.2	4.4615	0.3579	100.0	1429.7329	1427.7323	7574.1	1	6.132	90.9	1	T.PNLAEFAFSLYR.Q
*	20160416_RA_P1_SF_04.16672.16672.2	3.3216	0.2797	100.0	1216.6306	1216.6366	8237.3	1	6.62	94.4	3	N.LAEFAFSLYR.Q
*	20160416_RA_P1_SF_02.17147.17147.2	5.2988	0.5491	100.0	2574.3325	2574.3416	9145.7	1	11.281	54.3	18	R.TLNQPDSQLQLTTGNGLFLSEGLK.L
*	20160416_RA_P1_SF_02.17268.17268.3	5.2486	0.4137	100.0	2576.3337	2574.3416	9941.1	1	8.045	41.3	3	R.TLNQPDSQLQLTTGNGLFLSEGLK.L
*	20160416_RA_P1_SF_03.12461.12461.2	2.8871	0.2022	100.0	1205.6735	1205.6781	5805.2	50	5.308	72.2	6	K.LVDKFLEDVK.K
*	20160416_RA_P1_SF_04.13321.13321.2	3.5056	0.1981	100.0	1334.7706	1333.7731	7716.8	1	5.192	80.0	16	K.LVDKFLEDVKK.L
*	20160416_RA_P1_SF_04.13489.13489.3	3.6939	0.2207	100.0	1333.7667	1333.7731	3940.3	25	5.598	57.5	11	K.LVDKFLEDVKK.L
*	20160416_RA_P1_SF_05.22596.22596.4	2.9745	0.1587	99.7	2314.1292	2314.1355	7288.8	1	4.787	30.7	1	K.KLYHSEAFTVNFGDTEEAKK.Q
*	20160416_RA_P1_SF_03.13326.13326.2	5.5279	0.5473	100.0	2058.9434	2057.9456	5869.2	1	9.483	79.4	12	K.LYHSEAFTVNFGDTEEAK.K
*	20160416_RA_P1_SF_04.13372.13372.3	2.7571	0.147	99.5	2058.9392	2057.9456	10049.8	23	3.49	32.4	1	K.LYHSEAFTVNFGDTEEAK.K
*	20160416_RA_P1_SF_04.13041.13041.2	6.083	0.5718	100.0	2186.0354	2186.0405	10986.8	1	10.244	72.2	41	K.LYHSEAFTVNFGDTEEAKK.Q
*	20160416_RA_P1_SF_04.13257.13257.3	4.4652	0.3807	100.0	2187.0334	2186.0405	6325.8	1	6.445	43.1	11	K.LYHSEAFTVNFGDTEEAKK.Q
*	20160416_RA_P1_SF_04.13201.13201.4	2.8502	0.1704	99.7	2186.0325	2186.0405	5695.1	4	4.359	30.6	5	K.LYHSEAFTVNFGDTEEAKK.Q
*	20160416_RA_P1_SF_04.00019.00019.2	2.7627	0.1677	96.7	1114.6241	1114.6301	4621.1	4	5.145	75.0	1	F.ALVNYIFFK.G
*	20160416_RA_P1_SF_05.17462.17462.2	2.7483	0.0833	99.9	1276.6849	1275.6849	5999.4	5	3.6	77.8	16	K.GKWERPFEVK.D
*	20160416_RA_P1_SF_05.22527.22527.3	2.5836	0.0911	99.2	1275.678	1275.6849	4666.4	18	3.449	55.6	2	K.GKWERPFEVK.D
*	20160416_RA_P1_SF_04.10369.10369.2	2.2248	0.1722	100.0	1090.5641	1090.5686	4067.3	122	4.35	64.3	2	K.WERPFEVK.D
*	20160416_RA_P1_SF_03.06254.06254.2	5.2389	0.5061	100.0	1891.8529	1891.8561	9098.4	1	9.112	73.3	26	K.DTEEEDFHVDQVTTVK.V
*	20160416_RA_P1_SF_03.12941.12941.2	2.8584	0.2411	100.0	959.47406	959.4773	5302.7	1	5.217	92.9	1	R.LGMFNIQH.C
*	20160416_RA_P1_SF_05.14744.14744.2	2.9859	0.2068	100.0	1247.599	1247.6029	8384.2	1	6.355	72.2	16	R.LGMFNIQHCK.K
*	20160416_RA_P1_SF_05.13368.13368.3	1.8593	0.2214	99.7	1247.5984	1247.6029	3124.8	9	4.107	44.4	1	R.LGMFNIQHCK.K
*	20160416_RA_P1_SF_04.17363.17363.2	2.7447	0.2461	100.0	1076.614	1076.6178	6041.9	1	5.151	81.2	13	K.LSSWVLLMK.Y
*	20160416_RA_P1_SF_03.00484.00484.2	3.2104	0.1114	100.0	1757.8812	1755.8958	7356.4	1	4.306	56.7	1	K.YLGNATAIFFLPDEGK.L
*	20160416_RA_P1_SF_04.13465.13465.2	5.0534	0.4329	100.0	1803.9564	1803.9604	9276.8	1	7.59	75.0	19	K.LQHLENELTHDIITK.F
*	20160416_RA_P1_SF_04.13328.13328.3	4.5359	0.3031	100.0	1803.9554	1803.9604	4606.4	1	6.792	51.8	21	K.LQHLENELTHDIITK.F
*	20160416_RA_P1_SF_04.13475.13475.4	3.4622	0.2276	100.0	1803.9548	1803.9604	6165.7	1	5.08	40.5	4	K.LQHLENELTHDIITK.F
*	20160416_RA_P1_SF_05.10409.10409.2	2.5508	0.1374	100.0	852.4915	852.4943	6982.7	19	3.906	78.6	10	R.SASLHLPK.L
*	20160416_RA_P1_SF_02.07739.07739.2	2.9474	0.0835	100.0	1110.6002	1110.6046	5380.0	1	4.67	77.8	35	K.LSITGTYDLK.S
*	20160416_RA_P1_SF_03.13557.13557.2	3.3004	0.2886	100.0	1015.6117	1015.6152	4241.5	1	5.517	88.9	2	K.SVLGQLGITK.V
*	20160416_RA_P1_SF_05.00469.00469.3	3.1591	0.1714	99.7	2832.519	2830.5203	8316.9	1	3.993	25.0	1	K.SVLGQLGITKVFSNGADLSGVTEEAPLK.L
*	20160416_RA_P1_SF_02.06588.06588.2	4.7473	0.4288	100.0	1833.9187	1833.9235	7821.3	1	8.167	73.5	1	K.VFSNGADLSGVTEEAPLK.L
*	20160416_RA_P1_SF_03.01158.01158.2	2.8287	0.2723	100.0	2260.1392	2259.1404	6094.9	1	4.848	40.5	1	K.GTEAAGAMFLEAIPMSIPPEVK.F
sp|P02790|HEMO_HUMAN	32	341	52.6%	462	51676	7.0	U	HPX Hemopexin [REVIEWED] ENSG00000110169;IPI00022488;P02790;B2R957 
*	20160416_RA_P1_SF_05.16160.16160.2	3.6352	0.401	100.0	1534.7784	1534.7806	5073.5	1	7.313	83.3	11	R.WKNFPSPVDAAFR.Q
*	20160416_RA_P1_SF_05.16193.16193.3	4.1529	0.4328	100.0	1534.7758	1534.7806	6686.2	1	7.308	58.3	7	R.WKNFPSPVDAAFR.Q
*	20160416_RA_P1_SF_03.13559.13559.2	2.2354	0.0905	99.7	1220.6011	1220.6064	3230.0	2	4.473	85.0	10	K.NFPSPVDAAFR.Q
*	20160416_RA_P1_SF_05.14009.14009.2	2.119	0.2348	100.0	1142.6292	1142.6322	2522.3	5	4.926	77.8	10	R.QGHNSVFLIK.G
*	20160416_RA_P1_SF_04.10048.10048.2	2.2745	0.1233	99.8	1145.6333	1145.6359	4877.7	3	4.34	68.8	4	K.VWVYPPEKK.E
*	20160416_RA_P1_SF_02.18991.18991.2	3.3404	0.3299	100.0	2208.0027	2208.0647	5948.1	1	6.136	47.4	1	K.LLQDEFPGIPSPLDAAVECH.R
*	20160416_RA_P1_SF_03.18232.18232.2	5.3062	0.3681	100.0	2365.1626	2364.1658	4337.2	1	7.294	65.0	12	K.LLQDEFPGIPSPLDAAVECHR.G
*	20160416_RA_P1_SF_04.00173.00173.3	3.4837	0.0904	99.4	2365.1624	2364.1658	6163.7	1	3.574	41.2	6	K.LLQDEFPGIPSPLDAAVECHR.G
*	20160416_RA_P1_SF_05.01769.01769.4	2.8704	0.1344	99.3	4060.9165	4057.9177	4957.3	29	3.719	16.7	1	K.LLQDEFPGIPSPLDAAVECHRGECQAEGVLFFQGDR.E
*	20160416_RA_P1_SF_03.18124.18124.2	3.4847	0.4443	100.0	1618.8085	1618.8011	6348.7	1	8.32	60.7	2	F.PGIPSPLDAAVECHR.G
*	20160416_RA_P1_SF_02.12989.12989.2	4.1321	0.4097	100.0	1712.7631	1712.7703	8983.7	1	7.472	75.0	19	R.GECQAEGVLFFQGDR.E
*	20160416_RA_P1_SF_05.22795.22795.3	4.9465	0.4785	100.0	3178.429	3178.4402	7803.3	1	7.189	33.7	6	R.GECQAEGVLFFQGDREWFWDLATGTMK.E
*	20160416_RA_P1_SF_04.01323.01323.2	3.4643	0.4832	100.0	1484.6816	1484.6884	6583.5	1	8.61	81.8	9	R.EWFWDLATGTMK.E
*	20160416_RA_P1_SF_03.12157.12157.2	3.5761	0.4136	100.0	1495.6737	1495.6792	6965.2	1	7.938	85.0	45	R.YYCFQGNQFLR.F
*	20160416_RA_P1_SF_05.13720.13720.2	1.2778	0.0049	95.9	1684.8898	1684.8923	3443.3	148	2.815	50.0	1	R.FDPVRGEVPPRYPR.D
*	20160416_RA_P1_SF_05.21533.21533.3	4.1549	0.3488	100.0	3221.477	3219.4712	10726.7	1	5.844	26.9	4	R.DGWHSWPIAHQWPQGPSAVDAAFSWEEK.L
*	20160416_RA_P1_SF_05.20613.20613.2	4.9381	0.4426	100.0	1773.0017	1771.9999	7968.1	1	7.607	75.0	4	K.LYLVQGTQVYVFLTK.G
*	20160416_RA_P1_SF_03.06449.06449.2	2.1844	0.2867	100.0	1141.5853	1141.5894	6655.7	1	6.157	70.0	1	K.GGYTLVSGYPK.R
*	20160416_RA_P1_SF_04.00015.00015.2	5.6565	0.4824	100.0	2499.2285	2498.2349	10108.2	1	9.892	56.5	42	K.EVGTPHGIILDSVDAAFICPGSSR.L
*	20160416_RA_P1_SF_03.18224.18224.3	5.0499	0.4468	100.0	2499.2336	2498.2349	6896.5	1	6.953	37.0	26	K.EVGTPHGIILDSVDAAFICPGSSR.L
*	20160416_RA_P1_SF_03.18178.18178.2	3.3534	0.3625	100.0	1877.9415	1877.9431	8568.8	9	6.278	41.2	4	H.GIILDSVDAAFICPGSSR.L
*	20160416_RA_P1_SF_02.17426.17426.2	3.519	0.4311	100.0	1581.7471	1580.7498	7586.7	1	6.894	53.8	1	K.SGAQATWTELPWPH.E
*	20160416_RA_P1_SF_04.12986.12986.2	4.9143	0.4504	100.0	1838.8821	1837.8873	7162.3	1	7.994	76.7	67	K.SGAQATWTELPWPHEK.V
*	20160416_RA_P1_SF_04.14686.14686.3	4.5744	0.4804	100.0	1837.8787	1837.8873	5958.3	1	8.012	53.3	20	K.SGAQATWTELPWPHEK.V
*	20160416_RA_P1_SF_05.00132.00132.3	3.8936	0.3235	100.0	2843.302	2841.334	9431.9	1	6.318	28.1	7	K.SGAQATWTELPWPHEKVDGALCMEK.S
*	20160416_RA_P1_SF_03.14339.14339.2	3.1452	0.326	100.0	1856.8861	1856.8965	8428.4	1	6.125	50.0	1	K.SLGPNSCSANGPGLYLIH.G
*	20160416_RA_P1_SF_04.15614.15614.2	3.8524	0.4243	100.0	2010.9613	2010.9707	7220.2	1	8.555	55.3	2	K.SLGPNSCSANGPGLYLIHGP.N
*	20160416_RA_P1_SF_04.14718.14718.2	4.5719	0.5349	100.0	2126.0107	2125.0137	6650.4	1	10.315	50.0	2	K.SLGPNSCSANGPGLYLIHGPN.L
*	20160416_RA_P1_SF_04.17667.17667.2	2.9922	0.282	99.4	2401.1511	2401.1611	6754.6	1	6.413	34.1	1	K.SLGPNSCSANGPGLYLIHGPNLY.C
*	20160416_RA_P1_SF_05.05348.05348.2	2.1639	0.1385	99.7	3284.5173	3282.52	7925.3	7	3.768	20.7	1	K.SLGPNSCSANGPGLYLIHGPNLYCYSDVEK.L
*	20160416_RA_P1_SF_05.05217.05217.3	3.7921	0.359	100.0	3284.5051	3282.52	6308.8	1	5.978	20.7	9	K.SLGPNSCSANGPGLYLIHGPNLYCYSDVEK.L
*	20160416_RA_P1_SF_05.18158.18158.3	4.333	0.3987	100.0	3781.805	3779.8162	8868.7	1	6.905	24.3	5	K.SLGPNSCSANGPGLYLIHGPNLYCYSDVEKLNAAK.A
sp|P02652|APOA2_HUMAN	5	19	52.0%	100	11175	6.6	U	APOA2 Apolipoprotein A-II [REVIEWED] ENSG00000158874;IPI00021854;P02652;B2R524 
*	20160416_RA_P1_SF_03.02010.02010.2	5.4205	0.4788	100.0	2351.0906	2350.0913	6974.2	1	9.784	71.1	9	K.EPCVESLVSQYFQTVTDYGK.D
*	20160416_RA_P1_SF_03.02029.02029.3	2.8746	0.1989	99.6	2351.0923	2350.0913	7211.8	233	4.666	27.6	2	K.EPCVESLVSQYFQTVTDYGK.D
*	20160416_RA_P1_SF_05.05265.05265.2	2.8376	0.3051	100.0	1156.6895	1156.6941	6719.5	68	5.261	61.1	1	K.SKEQLTPLIK.K
*	20160416_RA_P1_SF_03.04200.04200.2	3.365	0.1493	100.0	2386.1943	2385.1978	6531.9	1	5.994	42.9	4	K.AGTELVNFLSYFVELGTQPATQ.-
*	20160416_RA_P1_SF_05.03481.03481.3	3.3837	0.274	100.0	2386.1926	2385.1978	6561.4	42	4.608	27.4	3	K.AGTELVNFLSYFVELGTQPATQ.-
sp|P00738|HPT_HUMAN	19	169	51.7%	406	45205	6.6	U	HP Haptoglobin [REVIEWED] ENSG00000197711;ENSG00000257017;IPI00641737;P00738;B0AZL5;P00737;Q0VAC4;Q2PP15;Q3B7J0;Q6LBY9;Q9UC67 
	20160416_RA_P1_SF_04.13110.13110.3	4.6269	0.0566	99.7	2378.2034	2378.2468	12338.1	1	5.473	35.5	3	K.LRTEGDGVYTLNDKKQWINK.A
*	20160416_RA_P1_SF_05.05341.05341.3	2.3693	0.0755	96.6	3435.5845	3432.5952	7372.8	1	4.305	22.5	1	K.AVGDKLPECEADDGCPKPPEIAHGYVEHSVR.Y
	20160416_RA_P1_SF_03.12061.12061.2	2.7442	0.1727	100.0	922.46484	920.463	2951.2	1	4.733	85.7	3	K.GSFPWQAK.M
	20160416_RA_P1_SF_02.14334.14334.2	2.7117	0.2099	100.0	1290.7268	1290.731	5010.9	1	5.602	81.8	10	K.DIAPTLTLYVGK.K
	20160416_RA_P1_SF_04.13024.13024.2	3.1705	0.1918	100.0	1418.8169	1418.8259	4498.2	1	5.497	79.2	16	K.DIAPTLTLYVGKK.Q
	20160416_RA_P1_SF_04.13530.13530.2	2.4988	0.3208	99.7	1190.7094	1190.7148	8590.6	4	6.257	60.0	1	I.APTLTLYVGKK.Q
*	20160416_RA_P1_SF_05.05300.05300.2	3.4486	0.3213	100.0	1796.0164	1795.0118	6888.9	1	5.88	56.7	1	K.VVLHPNYSQVDIGLIK.L
	20160416_RA_P1_SF_03.11352.11352.2	1.4839	0.1831	99.3	1044.5547	1044.5586	2490.8	1	3.919	81.2	2	R.VMPICLPSK.D
*	20160416_RA_P1_SF_04.13156.13156.2	3.3886	0.3605	100.0	1834.9128	1834.9196	3829.2	1	7.315	63.3	6	R.VMPICLPSKDYAEVGR.V
*	20160416_RA_P1_SF_05.12822.12822.2	2.1454	0.2632	100.0	1334.6826	1334.6857	5148.2	188	5.558	50.0	5	R.NANFKFTDHLK.Y
*	20160416_RA_P1_SF_02.11819.11819.2	4.5586	0.3993	100.0	1708.8163	1707.8198	3890.7	1	7.737	88.5	36	K.YVMLPVADQDQCIR.H
*	20160416_RA_P1_SF_03.15774.15774.2	2.7955	0.2153	95.6	1956.9309	1956.9312	6367.7	2	5.326	47.1	1	K.SPVGVQPILNEHTFCAGM.S
*	20160416_RA_P1_SF_04.14164.14164.2	2.6986	0.2351	100.0	2174.0332	2172.058	6336.3	1	4.593	47.4	4	K.SPVGVQPILNEHTFCAGMSK.Y
*	20160416_RA_P1_SF_05.05346.05346.3	3.0112	0.2124	99.7	2172.05	2172.058	5454.4	6	4.405	34.2	3	K.SPVGVQPILNEHTFCAGMSK.Y
*	20160416_RA_P1_SF_05.01852.01852.3	4.8514	0.4222	100.0	3876.6675	3874.6707	12411.9	1	7.871	27.3	2	K.YQEDTCYGDAGSAFAVHDLEEDTWYATGILSFDK.S
	20160416_RA_P1_SF_02.09759.09759.1	1.689	0.1476	96.5	1345.6398	1345.6462	10607.7	74	4.328	50.0	3	K.SCAVAEYGVYVK.V
	20160416_RA_P1_SF_02.09388.09388.2	4.6265	0.4611	100.0	1345.6383	1345.6462	6326.1	1	9.271	86.4	46	K.SCAVAEYGVYVK.V
*	20160416_RA_P1_SF_02.09076.09076.2	3.6149	0.3549	100.0	1203.6316	1203.6373	6963.1	1	6.594	88.9	25	K.VTSIQDWVQK.T
*	20160416_RA_P1_SF_02.18718.18718.2	2.9057	0.1054	99.9	1731.8873	1731.8917	6492.8	10	4.816	53.6	1	K.VTSIQDWVQKTIAEN.-
sp|P01024|CO3_HUMAN	74	498	50.0%	1663	187147	6.4	U	C3 Complement C3 [REVIEWED] ENSG00000125730;IPI00783987;P01024;A7E236 
*	20160416_RA_P1_SF_04.06761.06761.2	3.2743	0.3694	100.0	1504.8138	1504.8197	6448.1	1	6.47	66.7	2	G.SPMYSIITPNILR.L
*	20160416_RA_P1_SF_04.06214.06214.3	3.6091	0.2279	99.9	3252.567	3250.5579	7872.7	1	4.923	24.1	1	R.LESEETMVLEAHDAQGDVPVTVTVHDFPGK.K
*	20160416_RA_P1_SF_04.13867.13867.2	2.2267	0.2656	100.0	1653.8328	1653.8851	9440.9	2	4.885	50.0	1	K.FVTVQATFGTQVVEK.V
*	20160416_RA_P1_SF_03.06529.06529.2	2.4852	0.2111	100.0	1370.7274	1370.7319	5276.4	1	5.494	77.3	1	K.TIYTPGSTVLYR.I
*	20160416_RA_P1_SF_02.11916.11916.2	3.7612	0.3328	100.0	1639.8665	1639.8729	5831.1	1	6.674	67.9	15	R.TVMVNIENPEGIPVK.Q
*	20160416_RA_P1_SF_04.02897.02897.3	2.666	0.119	99.1	3284.655	3282.647	6881.1	120	3.404	21.4	1	K.QDSLSSQNQLGVLPLSWDIPELVNMGQWK.I
*	20160416_RA_P1_SF_02.15556.15556.2	2.8834	0.1512	100.0	2168.0105	2166.0032	7725.6	24	5.014	35.3	3	R.AYYENSPQQVFSTEFEVK.E
*	20160416_RA_P1_SF_02.18685.18685.2	5.421	0.3903	100.0	1880.9758	1878.9741	4514.8	1	7.758	80.0	6	K.EYVLPSFEVIVEPTEK.F
*	20160416_RA_P1_SF_02.10976.10976.1	1.7519	0.1296	96.7	1139.5367	1139.5414	7173.0	3	3.737	71.4	1	K.FYYIYNEK.G
*	20160416_RA_P1_SF_02.10419.10419.2	2.5516	0.1797	100.0	1139.5372	1139.5414	2789.7	1	4.571	85.7	6	K.FYYIYNEK.G
*	20160416_RA_P1_SF_02.09298.09298.2	2.7984	0.2086	100.0	959.5465	959.55255	5903.3	1	5.357	81.2	6	K.GLEVTITAR.F
*	20160416_RA_P1_SF_05.17846.17846.2	4.867	0.3516	100.0	1995.036	1994.0347	9885.0	1	7.074	52.9	5	K.KVEGTAFVIFGIQDGEQR.I
*	20160416_RA_P1_SF_05.17923.17923.3	3.8126	0.3105	100.0	1995.0286	1994.0347	10218.0	1	5.713	42.6	3	K.KVEGTAFVIFGIQDGEQR.I
*	20160416_RA_P1_SF_04.17928.17928.2	5.2576	0.4877	100.0	1865.9362	1865.9397	9092.1	1	8.691	68.8	5	K.VEGTAFVIFGIQDGEQR.I
*	20160416_RA_P1_SF_05.05308.05308.2	1.8591	0.0935	99.2	1042.6234	1042.6261	2973.3	28	3.962	56.2	1	R.ISLPESLKR.I
*	20160416_RA_P1_SF_05.05504.05504.2	4.033	0.4218	100.0	1788.9708	1787.9696	6559.2	1	6.997	60.0	6	R.SGIPIVTSPYQIHFTK.T
*	20160416_RA_P1_SF_05.22348.22348.2	4.5771	0.5425	100.0	2750.307	2749.316	7050.8	1	9.356	50.0	3	K.YFKPGMPFDLMVFVTNPDGSPAYR.V
*	20160416_RA_P1_SF_05.22287.22287.3	4.6691	0.3189	100.0	2750.307	2749.316	5342.5	1	5.551	32.6	2	K.YFKPGMPFDLMVFVTNPDGSPAYR.V
*	20160416_RA_P1_SF_04.02315.02315.2	3.7176	0.4215	100.0	2312.0818	2311.089	6979.8	1	8.074	47.5	1	K.PGMPFDLMVFVTNPDGSPAYR.V
*	20160416_RA_P1_SF_03.06302.06302.2	5.9927	0.5885	100.0	2199.1199	2198.1304	6368.3	1	11.12	64.3	6	R.VPVAVQGEDTVQSLTQGDGVAK.L
*	20160416_RA_P1_SF_04.17081.17081.2	1.9577	0.072	98.8	2580.2888	2578.3088	7730.2	2	3.761	31.8	2	R.TMQALPYSTVGNSNNYLHLSVLR.T
*	20160416_RA_P1_SF_04.16855.16855.2	3.6681	0.3554	100.0	1872.0271	1872.0343	3749.9	1	6.344	63.3	18	R.TELRPGETLNVNFLLR.M
*	20160416_RA_P1_SF_04.17182.17182.3	5.1297	0.3281	100.0	1873.028	1872.0343	7299.8	1	5.939	56.7	19	R.TELRPGETLNVNFLLR.M
*	20160416_RA_P1_SF_02.12747.12747.2	3.2169	0.3737	100.0	1208.596	1208.6025	4426.9	1	6.646	81.2	6	R.YYTYLIMNK.G
*	20160416_RA_P1_SF_04.03300.03300.2	4.7529	0.4794	100.0	2445.3115	2444.3076	5387.6	1	9.006	57.1	23	R.EPGQDLVVLPLSITTDFIPSFR.L
*	20160416_RA_P1_SF_02.16655.16655.2	2.8421	0.3156	100.0	1283.6593	1283.6636	4661.6	1	6.208	75.0	1	L.SITTDFIPSFR.L
*	20160416_RA_P1_SF_03.14941.14941.2	4.3509	0.3571	100.0	1511.8168	1511.8221	6816.9	1	7.38	88.5	18	R.LVAYYTLIGASGQR.E
*	20160416_RA_P1_SF_03.14943.14943.3	3.9392	0.3042	100.0	1511.8143	1511.8221	8323.0	1	6.097	57.7	4	R.LVAYYTLIGASGQR.E
*	20160416_RA_P1_SF_02.13165.13165.2	4.1372	0.3741	100.0	1345.6964	1345.7003	8807.3	1	7.662	72.7	12	R.EVVADSVWVDVK.D
*	20160416_RA_P1_SF_02.08382.08382.1	1.7642	0.0893	97.0	842.5319	842.53516	7008.0	1	4.729	71.4	2	R.VVLVAVDK.G
*	20160416_RA_P1_SF_05.11420.11420.2	2.6316	0.1171	100.0	904.55835	904.562	4196.1	7	4.418	78.6	1	K.GVFVLNKK.N
*	20160416_RA_P1_SF_02.15781.15781.3	6.8692	0.5699	100.0	3539.5945	3537.6191	8453.3	1	9.602	27.9	9	K.ADIGCTPGSGKDYAGVFSDAGLTFTSSSGQQTAQR.A
*	20160416_RA_P1_SF_02.13813.13813.2	2.5385	0.2333	100.0	1702.7092	1702.7933	5073.1	1	4.815	58.3	4	K.VFLDCCNYITELR.R
*	20160416_RA_P1_SF_02.15912.15912.2	4.7883	0.3928	100.0	1816.8883	1816.8928	9858.7	1	7.405	76.7	4	R.SNLDEDIIAEENIVSR.S
*	20160416_RA_P1_SF_04.00643.00643.2	3.6503	0.4084	100.0	2331.1267	2330.1345	10224.0	1	7.293	52.8	2	R.SEFPESWLWNVEDLKEPPK.N
*	20160416_RA_P1_SF_04.00587.00587.3	2.2742	0.2696	99.6	2332.1309	2330.1345	3095.8	1	4.901	38.9	1	R.SEFPESWLWNVEDLKEPPK.N
*	20160416_RA_P1_SF_04.18051.18051.3	3.4111	0.4029	100.0	2931.4534	2930.4575	5918.3	259	5.987	22.9	3	R.SEFPESWLWNVEDLKEPPKNGISTK.L
*	20160416_RA_P1_SF_03.15735.15735.1	2.1292	0.0365	97.3	878.51447	878.5174	8677.8	23	2.815	83.3	1	K.LMNIFLK.D
*	20160416_RA_P1_SF_03.15961.15961.2	1.9729	0.0974	99.7	878.5135	878.5174	3044.4	26	3.771	91.7	1	K.LMNIFLK.D
*	20160416_RA_P1_SF_05.00544.00544.2	3.395	0.3423	100.0	1924.9716	1923.9738	11196.3	1	6.408	46.9	1	K.DSITTWEILAVSMSDKK.G
*	20160416_RA_P1_SF_04.14143.14143.2	3.5426	0.3622	100.0	1800.9258	1800.9318	5539.8	1	6.654	66.7	5	R.VELLHNPAFCSLATTK.R
*	20160416_RA_P1_SF_04.14174.14174.3	4.0285	0.419	100.0	1800.9241	1800.9318	8131.2	1	8.208	46.7	2	R.VELLHNPAFCSLATTK.R
*	20160416_RA_P1_SF_03.16685.16685.2	2.7078	0.0479	99.7	1404.8412	1401.8357	3531.9	1	3.948	66.7	2	K.SSLSVPYVIVPLK.T
*	20160416_RA_P1_SF_05.14841.14841.2	3.9939	0.4088	100.0	1471.7384	1471.7446	9898.8	1	8.189	75.0	52	K.AAVYHHFISDGVR.K
*	20160416_RA_P1_SF_05.15778.15778.3	3.318	0.3407	100.0	1472.7424	1471.7446	6271.2	1	6.354	50.0	42	K.AAVYHHFISDGVR.K
*	20160416_RA_P1_SF_03.06244.06244.3	4.9745	0.3513	100.0	2757.2844	2755.291	5317.4	1	6.604	31.2	1	R.EGVQKEDIPPADLSDQVPDTESETR.I
*	20160416_RA_P1_SF_02.06543.06543.2	5.1646	0.5192	100.0	2215.0002	2214.005	4708.7	1	9.196	57.9	1	K.EDIPPADLSDQVPDTESETR.I
*	20160416_RA_P1_SF_02.06937.06937.2	4.5528	0.4796	100.0	2158.0793	2157.0862	7336.4	1	9.429	57.9	3	R.ILLQGTPVAQMTEDAVDAER.L
*	20160416_RA_P1_SF_05.11494.11494.2	3.2273	0.3549	100.0	1211.649	1211.6537	5203.1	1	5.926	83.3	4	K.KGYTQQLAFR.Q
*	20160416_RA_P1_SF_03.10316.10316.2	2.5693	0.1747	100.0	1083.5548	1083.5587	3444.6	1	4.188	81.2	4	K.GYTQQLAFR.Q
*	20160416_RA_P1_SF_02.13200.13200.2	1.825	0.1778	99.8	1154.5826	1152.6053	6909.7	23	4.285	50.0	4	R.QPSSAFAAFVK.R
*	20160416_RA_P1_SF_03.16430.16430.2	3.4013	0.4002	100.0	1336.7303	1335.7312	6327.2	1	6.995	77.3	2	R.APSTWLTAYVVK.V
*	20160416_RA_P1_SF_04.17143.17143.3	3.8725	0.3413	100.0	2565.287	2564.2932	8036.2	1	6.068	28.4	29	K.QKPDGVFQEDAPVIHQEMIGGLR.N
*	20160416_RA_P1_SF_05.05097.05097.4	2.7373	0.0071	95.0	2565.296	2564.2932	7651.5	17	3.274	25.8	3	K.QKPDGVFQEDAPVIHQEMIGGLR.N
*	20160416_RA_P1_SF_02.06565.06565.2	4.0196	0.4698	100.0	1789.8553	1789.8643	5609.7	1	7.89	73.3	2	K.DICEEQVNSLPGSITK.A
*	20160416_RA_P1_SF_02.15021.15021.2	3.8859	0.2485	100.0	1642.7745	1641.7695	8008.5	2	5.458	57.7	3	K.AGDFLEANYMNLQR.S
*	20160416_RA_P1_SF_05.19322.19322.2	4.4211	0.5279	100.0	1671.8488	1671.8529	9256.6	1	8.985	70.0	15	R.SYTVAIAGYALAQMGR.L
*	20160416_RA_P1_SF_05.00077.00077.2	3.4143	0.1974	100.0	982.6628	982.66644	6088.5	1	4.639	87.5	1	Y.ALLALLQLK.D
*	20160416_RA_P1_SF_02.13665.13665.1	1.2834	0.239	95.1	1190.6165	1190.621	4071.9	143	4.333	38.9	1	K.DFDFVPPVVR.W
*	20160416_RA_P1_SF_02.13412.13412.2	2.9389	0.4082	100.0	1190.6161	1190.621	3484.9	1	6.484	77.8	45	K.DFDFVPPVVR.W
*	20160416_RA_P1_SF_05.01647.01647.2	5.2482	0.5698	100.0	2680.254	2679.2554	9353.8	1	10.902	50.0	16	R.YYGGGYGSTQATFMVFQALAQYQK.D
*	20160416_RA_P1_SF_05.01654.01654.3	4.3164	0.3567	100.0	2681.2576	2679.2554	7958.2	1	6.109	31.5	5	R.YYGGGYGSTQATFMVFQALAQYQK.D
*	20160416_RA_P1_SF_03.13815.13815.2	4.0709	0.2998	100.0	1326.6859	1326.688	12184.3	1	7.645	85.0	1	F.MVFQALAQYQK.D
*	20160416_RA_P1_SF_05.13090.13090.2	2.1692	0.1006	99.5	1491.7577	1491.763	7874.4	246	3.878	38.5	1	K.GQGTLSVVTMYHAK.A
*	20160416_RA_P1_SF_03.13055.13055.2	3.3932	0.3329	100.0	1250.6182	1250.6237	8471.7	1	5.911	88.9	9	K.NTMILEICTR.Y
*	20160416_RA_P1_SF_03.14263.14263.2	2.6812	0.1767	100.0	1092.6238	1092.6305	4837.0	12	3.992	75.0	4	R.NTLIIYLDK.V
*	20160416_RA_P1_SF_05.05529.05529.2	3.6324	0.4202	100.0	1841.9897	1841.9913	8555.8	1	7.127	53.3	13	K.VHQYFNVELIQPGAVK.V
*	20160416_RA_P1_SF_02.10334.10334.2	3.8203	0.3813	100.0	1667.7294	1667.7375	10257.3	1	7.449	75.0	7	K.VYAYYNLEESCTR.F
*	20160416_RA_P1_SF_04.02761.02761.2	6.1925	0.4997	100.0	2258.0989	2257.1062	8633.6	1	9.081	69.4	7	K.VQLSNDFDEYIMAIEQTIK.S
*	20160416_RA_P1_SF_04.02617.02617.3	4.3545	0.1327	99.7	2259.1157	2257.1062	6732.8	5	4.487	36.1	1	K.VQLSNDFDEYIMAIEQTIK.S
*	20160416_RA_P1_SF_03.13056.13056.2	3.4174	0.3937	100.0	2604.02	2603.0269	5703.8	1	7.766	44.7	2	K.DTWVEHWPEEDECQDEENQK.Q
*	20160416_RA_P1_SF_03.13126.13126.3	3.5921	0.3375	100.0	2604.0156	2603.0269	8227.8	1	6.012	44.7	2	K.DTWVEHWPEEDECQDEENQK.Q
*	20160416_RA_P1_SF_05.01125.01125.3	2.1612	0.2696	99.6	4745.9165	4743.9287	7698.6	5	4.568	15.8	1	K.DTWVEHWPEEDECQDEENQKQCQDLGAFTESMVVFGCPN.-
*	20160416_RA_P1_SF_03.00562.00562.2	2.7706	0.1989	100.0	2160.9185	2159.92	10096.0	1	5.503	44.4	1	K.QCQDLGAFTESMVVFGCPN.-
sp|P01876|IGHA1_HUMAN	16	150	48.4%	353	37655	6.5	U	IGHA1 Ig alpha-1 chain C region [REVIEWED] ENSG00000211895;ENSG00000130076;IPI00449920;P01876 
*	20160416_RA_P1_SF_04.00130.00130.2	4.3858	0.4989	100.0	2721.3608	2720.3684	7417.4	1	9.343	41.7	1	C.LVQGFFPQEPLSVTWSESGQGVTAR.N
*	20160416_RA_P1_SF_02.12468.12468.2	3.716	0.3846	100.0	1540.7212	1540.7284	6235.8	1	7.997	67.9	15	R.DASGVTFTWTPSSGK.S
*	20160416_RA_P1_SF_03.15686.15686.2	4.4568	0.0835	100.0	2594.121	2593.1274	4429.2	1	7.551	40.9	9	R.DLCGCYSVSSVLPGCAEPWNHGK.T
*	20160416_RA_P1_SF_03.15637.15637.3	3.5885	0.0626	99.2	2594.1216	2593.1274	5236.9	1	5.62	34.1	5	R.DLCGCYSVSSVLPGCAEPWNHGK.T
*	20160416_RA_P1_SF_03.08724.08724.2	2.5071	0.251	100.0	931.54364	931.54645	5273.0	1	4.941	75.0	2	K.TPLTATLSK.S
	20160416_RA_P1_SF_05.22917.22917.3	5.0985	0.399	100.0	3575.8696	3573.874	4832.0	1	7.89	29.8	4	K.SGNTFRPEVHLLPPPSEELALNELVTLTCLAR.G
	20160416_RA_P1_SF_05.05297.05297.2	2.6811	0.3748	100.0	1117.6342	1117.637	5651.0	1	6.562	72.2	1	R.GFSPKDVLVR.W
	20160416_RA_P1_SF_03.06557.06557.2	2.8794	0.3199	100.0	1213.6283	1213.6329	7305.3	1	5.356	88.9	5	R.WLQGSQELPR.E
	20160416_RA_P1_SF_04.10800.10800.2	2.2904	0.2805	100.0	1153.5996	1153.6006	4329.1	12	4.576	75.0	4	R.EKYLTWASR.Q
	20160416_RA_P1_SF_03.10669.10669.2	1.9681	0.0754	99.5	896.4602	896.463	3859.4	8	3.605	91.7	1	K.YLTWASR.Q
	20160416_RA_P1_SF_02.14660.14660.2	4.4303	0.4489	100.0	1835.9456	1835.9503	6526.8	1	9.528	65.6	45	R.QEPSQGTTTFAVTSILR.V
	20160416_RA_P1_SF_02.13824.13824.3	2.5362	0.1213	99.2	1836.9525	1835.9503	8011.3	9	3.81	34.4	5	R.QEPSQGTTTFAVTSILR.V
	20160416_RA_P1_SF_05.17121.17121.2	5.0129	0.4692	100.0	2337.1206	2337.1372	7780.9	1	9.665	62.5	24	K.KGDTFSCMVGHEALPLAFTQK.T
	20160416_RA_P1_SF_05.17208.17208.3	4.7908	0.2291	100.0	2338.1338	2337.1372	6505.0	1	5.797	42.5	27	K.KGDTFSCMVGHEALPLAFTQK.T
	20160416_RA_P1_SF_05.17145.17145.4	1.9781	0.121	97.3	2338.131	2337.1372	4095.6	1	3.913	30.8	1	K.KGDTFSCMVGHEALPLAFTQK.T
	20160416_RA_P1_SF_03.16997.16997.2	2.886	0.1891	100.0	2211.1516	2209.0422	7316.6	1	4.598	44.7	1	K.GDTFSCMVGHEALPLAFTQK.T
sp|P02042|HBD_HUMAN	8	35	45.6%	147	16055	8.0	U	HBD Hemoglobin subunit delta [REVIEWED] ENSG00000223609;ENSG00000188170;IPI00473011;P02042;Q3Y5H3;Q8WXT7 
	20160416_RA_P1_SF_03.16424.16424.2	2.7852	0.2958	100.0	1274.7224	1274.7261	4997.1	1	5.456	83.3	3	R.LLVVYPWTQR.F
*	20160416_RA_P1_SF_02.16980.16980.2	3.3555	0.3268	100.0	2045.9314	2044.9326	6924.8	1	6.004	55.6	1	R.FFESFGDLSSPDAVMGNPK.V
	20160416_RA_P1_SF_05.17064.17064.2	4.6237	0.513	100.0	1797.9827	1797.9863	9375.1	1	9.099	65.6	6	K.KVLGAFSDGLAHLDNLK.G
	20160416_RA_P1_SF_05.17232.17232.3	4.0128	0.2561	100.0	1798.9849	1797.9863	6498.5	1	4.902	45.3	6	K.KVLGAFSDGLAHLDNLK.G
	20160416_RA_P1_SF_02.18674.18674.2	3.7588	0.3723	100.0	1542.7933	1541.7964	10880.3	1	6.784	67.9	1	K.VLGAFSDGLAHLDNL.K
	20160416_RA_P1_SF_04.06449.06449.2	4.3591	0.3725	100.0	1670.8894	1669.8914	7834.3	1	6.654	76.7	1	K.VLGAFSDGLAHLDNLK.G
	20160416_RA_P1_SF_04.09745.09745.2	2.4872	0.1462	100.0	1126.5614	1126.5646	4824.4	11	4.954	75.0	11	K.LHVDPENFR.L
	20160416_RA_P1_SF_05.05847.05847.2	3.3569	0.3324	100.0	1149.6716	1149.6744	6596.4	1	7.193	86.4	6	K.VVAGVANALAHK.Y
sp|P01860|IGHG3_HUMAN	25	355	45.1%	377	41287	7.9	U	IGHG3 Ig gamma-3 chain C region [REVIEWED] ENSG00000130076;IPI00973474;P01860;A2NU35 
	20160416_RA_P1_SF_04.13064.13064.2	3.0957	0.3772	100.0	1287.6481	1287.652	3862.3	1	6.048	72.7	23	K.GPSVFPLAPCSR.S
	20160416_RA_P1_SF_04.13099.13099.2	3.1185	0.2778	100.0	1231.628	1230.6305	4654.5	4	5.072	65.0	1	G.PSVFPLAPCSR.S
	20160416_RA_P1_SF_03.09224.09224.2	3.8393	0.3293	100.0	1321.6733	1321.6786	7001.6	1	7.327	73.1	25	R.STSGGTAALGCLVK.D
	20160416_RA_P1_SF_02.17888.17888.2	2.9171	0.521	100.0	2263.0576	2263.0671	6482.5	1	8.478	50.0	1	K.DYFPEPVTVSWNSGALTSGVH.T
	20160416_RA_P1_SF_03.00638.00638.2	2.9038	0.2761	99.2	2610.2405	2608.236	7830.9	1	5.5	41.3	1	K.DYFPEPVTVSWNSGALTSGVHTFP.A
	20160416_RA_P1_SF_03.00423.00423.2	3.0628	0.3148	100.0	2680.2673	2679.2732	7064.5	1	6.089	35.4	1	K.DYFPEPVTVSWNSGALTSGVHTFPA.V
	20160416_RA_P1_SF_04.02080.02080.2	2.8571	0.3469	100.0	3528.7102	3526.717	6375.4	2	6.15	23.4	1	K.DYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLY.S
	20160416_RA_P1_SF_05.19147.19147.2	4.0878	0.3145	100.0	1726.99	1725.9944	6231.3	1	5.438	70.0	5	P.ELLGGPSVFLFPPKPK.D
	20160416_RA_P1_SF_02.12132.12132.2	5.5102	0.5114	100.0	1686.7654	1685.7693	8725.7	1	9.359	78.6	29	R.TPEVTCVVVDVSHED.P
*	20160416_RA_P1_SF_03.15811.15811.2	2.6688	0.3274	100.0	2415.1504	2414.155	7245.7	1	6.143	45.0	2	R.TPEVTCVVVDVSHEDPEVQFK.W
*	20160416_RA_P1_SF_05.05087.05087.3	4.3185	0.3668	100.0	2415.1548	2414.155	6575.2	1	6.529	40.0	4	R.TPEVTCVVVDVSHEDPEVQFK.W
	20160416_RA_P1_SF_03.10846.10846.2	4.1999	0.4656	100.0	1416.6868	1416.6912	7378.9	1	8.112	86.4	26	K.WYVDGVEVHNAK.T
	20160416_RA_P1_SF_03.14977.14977.2	2.512	0.3407	100.0	1094.6515	1094.6573	5691.6	1	5.835	83.3	1	R.VVSVLTVLHQ.D
	20160416_RA_P1_SF_05.19794.19794.2	5.2167	0.5083	100.0	1808.0054	1808.0071	8861.9	1	9.483	60.0	76	R.VVSVLTVLHQDWLNGK.E
	20160416_RA_P1_SF_05.16803.16803.3	3.2261	0.2629	100.0	1810.0107	1808.0071	3183.2	1	4.654	40.0	33	R.VVSVLTVLHQDWLNGK.E
	20160416_RA_P1_SF_05.21530.21530.2	4.1838	0.2713	100.0	2230.209	2228.208	9197.1	1	5.567	47.2	8	R.VVSVLTVLHQDWLNGKEYK.C
	20160416_RA_P1_SF_05.21547.21547.3	3.9401	0.4557	100.0	2229.2004	2228.208	4017.8	1	7.091	43.1	19	R.VVSVLTVLHQDWLNGKEYK.C
	20160416_RA_P1_SF_05.20916.20916.2	3.4242	0.2275	99.4	1609.8644	1609.8702	8544.4	1	6.192	57.7	3	V.SVLTVLHQDWLNGK.E
	20160416_RA_P1_SF_04.11456.11456.2	2.6085	0.2659	98.9	1310.6793	1310.6857	8875.4	2	5.524	60.0	1	L.TVLHQDWLNGK.E
	20160416_RA_P1_SF_02.09606.09606.2	2.4738	0.2907	100.0	1286.6697	1286.6744	4374.4	1	4.952	70.0	16	R.EPQVYTLPPSR.E
	20160416_RA_P1_SF_03.06515.06515.2	3.8186	0.3746	100.0	1905.9425	1904.9427	5605.0	1	7.334	66.7	25	R.EPQVYTLPPSREEMTK.N
	20160416_RA_P1_SF_03.09916.09916.3	1.649	0.1152	95.5	1904.9366	1904.9427	5040.6	3	3.491	35.0	1	R.EPQVYTLPPSREEMTK.N
	20160416_RA_P1_SF_03.10388.10388.2	3.0521	0.3025	100.0	1161.6262	1161.6301	5416.0	1	5.939	88.9	36	K.NQVSLTCLVK.G
	20160416_RA_P1_SF_02.16925.16925.2	3.3448	0.3182	100.0	1906.8907	1905.8944	1872.1	1	6.065	71.9	16	N.TTPPMLDSDGSFFLYSK.L
	20160416_RA_P1_SF_02.17183.17183.2	4.8394	0.5158	100.0	1704.7727	1703.7991	9740.7	1	9.029	78.6	1	T.PPMLDSDGSFFLYSK.L
sp|P01602|KV110_HUMAN	3	9	44.4%	117	12768	6.3	U	IGKV1-5 Ig kappa chain V-I region HK102 [REVIEWED] ENSG00000163245;IPI00829912;P01602 
*	20160416_RA_P1_SF_02.06571.06571.2	4.2182	0.1637	99.4	1894.8414	1892.9023	9898.5	1	4.655	58.8	1	C.DIQMTQSPSTLSASVGDR.V
*	20160416_RA_P1_SF_05.18783.18783.2	3.3888	0.2343	100.0	2066.048	2065.0508	7593.4	1	5.869	47.1	7	R.ASQSISSWLAWYQQKPGK.A
*	20160416_RA_P1_SF_03.02486.02486.2	2.3746	0.1393	99.8	1707.9413	1706.8965	2700.1	16	3.879	53.3	1	K.LLIYDASSLESGVPSR.F
sp|P01861|IGHG4_HUMAN	22	388	43.1%	327	35941	7.4	U	IGHG4 Ig gamma-4 chain C region [REVIEWED] ENSG00000211892;ENSG00000205402;IPI00930442;P01861 
	20160416_RA_P1_SF_04.13064.13064.2	3.0957	0.3772	100.0	1287.6481	1287.652	3862.3	1	6.048	72.7	23	K.GPSVFPLAPCSR.S
	20160416_RA_P1_SF_04.13099.13099.2	3.1185	0.2778	100.0	1231.628	1230.6305	4654.5	4	5.072	65.0	1	G.PSVFPLAPCSR.S
	20160416_RA_P1_SF_02.06948.06948.2	3.8301	0.4046	100.0	1423.703	1423.7102	7096.4	1	7.76	73.1	10	R.STSESTAALGCLVK.D
	20160416_RA_P1_SF_02.17888.17888.2	2.9171	0.521	100.0	2263.0576	2263.0671	6482.5	1	8.478	50.0	1	K.DYFPEPVTVSWNSGALTSGVH.T
	20160416_RA_P1_SF_03.00638.00638.2	2.9038	0.2761	99.2	2610.2405	2608.236	7830.9	1	5.5	41.3	1	K.DYFPEPVTVSWNSGALTSGVHTFP.A
	20160416_RA_P1_SF_03.00423.00423.2	3.0628	0.3148	100.0	2680.2673	2679.2732	7064.5	1	6.089	35.4	1	K.DYFPEPVTVSWNSGALTSGVHTFPA.V
	20160416_RA_P1_SF_04.02080.02080.2	2.8571	0.3469	100.0	3528.7102	3526.717	6375.4	2	6.15	23.4	1	K.DYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLY.S
	20160416_RA_P1_SF_02.13764.13764.2	3.8931	0.5031	100.0	1364.622	1364.6276	9227.3	1	8.526	85.0	6	Q.FNWYVDGVEVH.N
	20160416_RA_P1_SF_04.13504.13504.2	5.4078	0.5309	100.0	1677.7965	1677.8025	9827.0	1	9.699	80.8	56	Q.FNWYVDGVEVHNAK.T
	20160416_RA_P1_SF_03.10846.10846.2	4.1999	0.4656	100.0	1416.6868	1416.6912	7378.9	1	8.112	86.4	26	N.WYVDGVEVHNAK.T
	20160416_RA_P1_SF_03.14977.14977.2	2.512	0.3407	100.0	1094.6515	1094.6573	5691.6	1	5.835	83.3	1	R.VVSVLTVLHQ.D
	20160416_RA_P1_SF_05.19794.19794.2	5.2167	0.5083	100.0	1808.0054	1808.0071	8861.9	1	9.483	60.0	76	R.VVSVLTVLHQDWLNGK.E
	20160416_RA_P1_SF_05.16803.16803.3	3.2261	0.2629	100.0	1810.0107	1808.0071	3183.2	1	4.654	40.0	33	R.VVSVLTVLHQDWLNGK.E
	20160416_RA_P1_SF_05.21530.21530.2	4.1838	0.2713	100.0	2230.209	2228.208	9197.1	1	5.567	47.2	8	R.VVSVLTVLHQDWLNGKEYK.C
	20160416_RA_P1_SF_05.21547.21547.3	3.9401	0.4557	100.0	2229.2004	2228.208	4017.8	1	7.091	43.1	19	R.VVSVLTVLHQDWLNGKEYK.C
	20160416_RA_P1_SF_05.20916.20916.2	3.4242	0.2275	99.4	1609.8644	1609.8702	8544.4	1	6.192	57.7	3	V.SVLTVLHQDWLNGK.E
	20160416_RA_P1_SF_04.11456.11456.2	2.6085	0.2659	98.9	1310.6793	1310.6857	8875.4	2	5.524	60.0	1	L.TVLHQDWLNGK.E
	20160416_RA_P1_SF_03.10388.10388.2	3.0521	0.3025	100.0	1161.6262	1161.6301	5416.0	1	5.939	88.9	36	K.NQVSLTCLVK.G
	20160416_RA_P1_SF_02.16683.16683.2	5.1668	0.4104	100.0	2545.124	2544.1318	7874.4	1	8.026	57.1	65	K.GFYPSDIAVEWESNGQPENNYK.T
	20160416_RA_P1_SF_02.16052.16052.3	4.4503	0.3429	100.0	2545.1277	2544.1318	6626.7	1	6.397	42.9	12	K.GFYPSDIAVEWESNGQPENNYK.T
*	20160416_RA_P1_SF_02.17020.17020.2	3.6704	0.512	100.0	1901.9247	1901.9285	2297.9	1	8.675	75.0	7	K.TTPPVLDSDGSFFLYSR.L
*	20160416_RA_P1_SF_02.16855.16855.2	2.944	0.2682	99.2	1700.7559	1699.8331	6501.1	1	5.405	64.3	1	T.PPVLDSDGSFFLYSR.L
sp|P02647|APOA1_HUMAN	15	150	41.2%	267	30778	5.8	U	APOA1 Apolipoprotein A-I [REVIEWED] ENSG00000118137;IPI00021841;P02647;A8K866;Q6LDN9;Q6Q785;Q9UCS8;Q9UCT8 
*	20160416_RA_P1_SF_04.06338.06338.2	4.3164	0.4137	100.0	1462.8473	1462.852	7453.9	1	7.398	75.0	12	R.VKDLATVYVDVLK.D
*	20160416_RA_P1_SF_04.15786.15786.3	2.2934	0.0684	97.3	1462.8477	1462.852	6428.7	128	4.265	35.4	1	R.VKDLATVYVDVLK.D
*	20160416_RA_P1_SF_02.17695.17695.1	1.7565	0.0749	96.3	1235.6819	1235.6887	5301.3	68	3.241	55.0	2	K.DLATVYVDVLK.D
*	20160416_RA_P1_SF_02.17016.17016.2	3.4601	0.3006	100.0	1236.6865	1235.6887	5059.0	1	5.562	85.0	23	K.DLATVYVDVLK.D
*	20160416_RA_P1_SF_03.06373.06373.2	5.0083	0.4295	100.0	1816.8472	1815.8513	5986.8	1	7.832	75.0	12	K.DSGRDYVSQFEGSALGK.Q
*	20160416_RA_P1_SF_02.13613.13613.3	3.0578	0.156	99.7	1816.8431	1815.8513	7808.6	2	4.379	39.1	1	K.DSGRDYVSQFEGSALGK.Q
*	20160416_RA_P1_SF_02.15349.15349.2	4.5799	0.5233	100.0	1612.7809	1612.7859	7699.9	1	8.95	76.9	29	K.LLDNWDSVTSTFSK.L
*	20160416_RA_P1_SF_04.17921.17921.2	5.5585	0.5134	100.0	2203.1145	2202.1194	7145.1	1	8.88	67.6	15	K.LREQLGPVTQEFWDNLEK.E
*	20160416_RA_P1_SF_04.17903.17903.3	6.0251	0.3767	100.0	2203.111	2202.1194	10775.4	1	7.459	50.0	19	K.LREQLGPVTQEFWDNLEK.E
*	20160416_RA_P1_SF_02.18797.18797.2	3.7636	0.472	100.0	1932.9274	1932.9343	7148.6	1	8.282	60.0	5	R.EQLGPVTQEFWDNLEK.E
*	20160416_RA_P1_SF_03.10478.10478.2	3.3098	0.2269	100.0	1380.7095	1380.7163	3081.2	1	4.615	80.0	15	K.VQPYLDDFQKK.W
*	20160416_RA_P1_SF_04.09746.09746.2	1.3319	0.0717	97.1	1467.7885	1467.792	6033.7	40	2.847	41.7	2	K.VEPLRAELQEGAR.Q
*	20160416_RA_P1_SF_05.00087.00087.2	2.4676	0.0884	99.8	1230.7042	1230.7098	3929.6	1	3.594	65.0	3	R.QGLLPVLESFK.V
*	20160416_RA_P1_SF_05.00650.00650.2	4.2672	0.4633	100.0	1386.7104	1386.7157	6884.5	1	9.073	86.4	7	K.VSFLSALEEYTK.K
*	20160416_RA_P1_SF_04.18191.18191.2	3.4823	0.3221	100.0	1514.8086	1514.8107	5874.9	1	7.279	66.7	4	K.VSFLSALEEYTKK.L
sp|P01023|A2MG_HUMAN	49	210	41.0%	1474	163290	6.5	U	A2M Alpha-2-macroglobulin [REVIEWED] ENSG00000175899;IPI00478003;P01023;Q13677;Q59F47;Q5QTS0;Q68DN2;Q6PIY3;Q6PN97 
*	20160416_RA_P1_SF_05.17837.17837.2	3.1814	0.4349	100.0	2544.3306	2544.3384	5622.8	1	7.868	43.2	3	A.SVSGKPQYMVLVPSLLHTETTEK.G
*	20160416_RA_P1_SF_04.17346.17346.2	3.2653	0.1522	100.0	2087.0837	2086.0894	4507.4	3	4.828	44.1	1	K.PQYMVLVPSLLHTETTEK.G
*	20160416_RA_P1_SF_03.01946.01946.2	3.3303	0.484	100.0	2080.9712	2079.9697	4444.7	1	7.19	55.9	1	R.SLFTDLEAENDVLHCVAF.A
*	20160416_RA_P1_SF_05.01554.01554.2	4.9072	0.4034	100.0	2476.2185	2475.223	9576.9	1	8.423	50.0	2	R.SLFTDLEAENDVLHCVAFAVPK.S
*	20160416_RA_P1_SF_05.01638.01638.3	3.9102	0.4553	100.0	2476.2146	2475.223	5807.7	1	7.728	39.3	3	R.SLFTDLEAENDVLHCVAFAVPK.S
*	20160416_RA_P1_SF_02.10376.10376.2	3.4684	0.4038	100.0	1394.6747	1394.6803	7051.4	1	7.596	81.8	2	K.NEDSLVFVQTDK.S
*	20160416_RA_P1_SF_05.21896.21896.3	3.0802	0.1232	99.4	3114.611	3113.6133	8331.3	103	3.894	20.0	1	K.FRVVSMDENFHPLNELIPLVYIQDPK.G
*	20160416_RA_P1_SF_05.01479.01479.2	2.6953	0.1023	99.8	2812.4531	2810.4438	4882.6	22	3.427	30.4	2	R.VVSMDENFHPLNELIPLVYIQDPK.G
*	20160416_RA_P1_SF_05.01555.01555.3	3.0046	0.2756	99.9	2810.4368	2810.4438	5017.3	1	5.162	37.0	1	R.VVSMDENFHPLNELIPLVYIQDPK.G
*	20160416_RA_P1_SF_03.14694.14694.2	4.4011	0.2712	100.0	1605.8406	1604.8436	7689.1	1	6.929	73.1	15	R.IAQWQSFQLEGGLK.Q
*	20160416_RA_P1_SF_03.16666.16666.2	3.8085	0.4886	100.0	1848.8754	1848.8809	6401.4	1	7.448	73.3	1	K.QFSFPLSSEPFQGSYK.V
*	20160416_RA_P1_SF_03.16655.16655.2	3.7258	0.3038	100.0	1672.8533	1672.8586	7594.0	1	6.31	69.2	3	R.TEHPFTVEEFVLPK.F
*	20160416_RA_P1_SF_03.16505.16505.3	4.0331	0.2661	100.0	1672.8513	1672.8586	8465.3	1	5.774	55.8	2	R.TEHPFTVEEFVLPK.F
*	20160416_RA_P1_SF_02.10243.10243.2	3.3817	0.194	100.0	1046.5845	1046.5886	5033.1	1	5.086	87.5	11	K.FEVQVTVPK.I
*	20160416_RA_P1_SF_04.13234.13234.2	2.2989	0.2636	100.0	1148.6173	1148.6217	4253.0	27	4.929	61.1	20	R.QGIPFFGQVR.L
*	20160416_RA_P1_SF_05.14032.14032.2	3.0337	0.2636	100.0	1084.6124	1084.6155	3506.2	2	5.767	72.2	10	K.GHFSISIPVK.S
*	20160416_RA_P1_SF_02.19060.19060.2	4.0414	0.3163	100.0	1846.0336	1845.0374	3822.8	1	6.192	76.5	5	R.LLIYAVLPTGDVIGDSAK.Y
*	20160416_RA_P1_SF_05.21645.21645.3	3.7962	0.2634	100.0	3256.5757	3255.5857	6955.2	4	5.381	23.2	4	K.YDVENCLANKVDLSFSPSQSLPASHAHLR.V
*	20160416_RA_P1_SF_05.22153.22153.4	2.86	0.0763	98.5	3257.5837	3255.5857	7176.5	344	4.052	20.8	1	K.YDVENCLANKVDLSFSPSQSLPASHAHLR.V
*	20160416_RA_P1_SF_03.18410.18410.2	3.3764	0.3941	100.0	2918.5166	2917.5232	9498.9	1	6.974	40.4	3	R.AVDQSVLLMKPDAELSASSVYNLLPEK.D
*	20160416_RA_P1_SF_04.00199.00199.3	2.6725	0.0358	95.8	2918.5198	2917.5232	6974.5	152	3.416	20.2	1	R.AVDQSVLLMKPDAELSASSVYNLLPEK.D
*	20160416_RA_P1_SF_05.01262.01262.4	2.7425	0.0164	95.3	5191.476	5188.5093	6334.6	1	3.317	16.7	1	R.AVDQSVLLMKPDAELSASSVYNLLPEKDLTGFPGPLNDQDNEDCINR.H
*	20160416_RA_P1_SF_04.11754.11754.2	6.061	0.5827	100.0	2138.0544	2137.0566	9101.0	1	10.476	63.9	9	R.HNVYINGITYTPVSSTNEK.D
*	20160416_RA_P1_SF_04.11352.11352.3	4.0067	0.2293	100.0	2138.0496	2137.0566	7709.3	1	5.647	38.9	4	R.HNVYINGITYTPVSSTNEK.D
*	20160416_RA_P1_SF_03.02026.02026.2	4.5895	0.3917	100.0	1449.6443	1448.6442	8159.7	1	8.393	86.4	2	K.DMYSFLEDMGLK.A
*	20160416_RA_P1_SF_04.12153.12153.2	4.8531	0.5187	100.0	2073.925	2073.931	7889.1	1	8.759	68.8	10	K.MCPQLQQYEMHGPEGLR.V
*	20160416_RA_P1_SF_04.12208.12208.3	1.6466	0.1171	95.5	2075.9294	2073.931	2336.2	1	3.656	37.5	1	K.MCPQLQQYEMHGPEGLR.V
	20160416_RA_P1_SF_03.06833.06833.2	2.3772	0.0972	99.8	1018.5892	1018.5937	4802.8	4	4.919	75.0	2	K.ATVLNYLPK.C
*	20160416_RA_P1_SF_02.16740.16740.2	4.7671	0.4339	100.0	1885.0479	1884.0482	8740.5	1	7.448	61.8	2	R.VSVQLEASPAFLAVPVEK.E
*	20160416_RA_P1_SF_03.09965.09965.2	2.0646	0.2705	100.0	1116.6018	1116.6053	5637.8	138	5.083	61.1	2	R.QTVSWAVTPK.S
*	20160416_RA_P1_SF_03.14589.14589.2	4.4838	0.1822	100.0	1781.0061	1780.0107	3988.1	1	5.768	70.0	7	K.DTVIKPLLVEPEGLEK.E
*	20160416_RA_P1_SF_03.14791.14791.3	4.1131	0.2644	100.0	1781.0072	1780.0107	6880.8	6	5.178	38.3	3	K.DTVIKPLLVEPEGLEK.E
*	20160416_RA_P1_SF_02.17659.17659.2	3.8705	0.3895	100.0	2398.1416	2397.1497	5651.1	1	7.172	50.0	9	K.ETTFNSLLCPSGGEVSEELSLK.L
	20160416_RA_P1_SF_05.00778.00778.2	4.1577	0.3845	100.0	1491.7922	1491.796	7232.8	1	7.949	87.5	4	R.NQGNTWLTAFVLK.T
	20160416_RA_P1_SF_03.09863.09863.2	2.6395	0.27	100.0	1103.603	1103.6061	4534.1	1	5.181	70.0	2	R.SSGSLLNNAIK.G
*	20160416_RA_P1_SF_03.18056.18056.2	3.4764	0.3404	100.0	1338.6488	1338.6516	5172.5	1	7.241	80.0	5	R.NALFCLESAWK.T
*	20160416_RA_P1_SF_05.00341.00341.2	4.5594	0.435	100.0	1565.8291	1565.8328	6616.9	1	7.293	75.0	9	K.ALLAYAFALAGNQDK.R
*	20160416_RA_P1_SF_05.00060.00060.3	3.3987	0.2674	100.0	1565.8246	1565.8328	5445.2	4	5.114	46.4	4	K.ALLAYAFALAGNQDK.R
*	20160416_RA_P1_SF_05.18938.18938.2	2.2984	0.2401	100.0	1722.9354	1721.9338	11121.2	4	4.704	50.0	1	K.ALLAYAFALAGNQDKR.K
*	20160416_RA_P1_SF_02.18041.18041.2	3.1157	0.3692	100.0	2617.4136	2616.4136	6492.4	1	6.936	37.5	1	Y.VLLAYLTAQPAPTSEDLTSATNIVK.W
*	20160416_RA_P1_SF_04.13570.13570.3	3.0871	0.303	100.0	2390.198	2387.1956	5593.2	19	5.223	26.1	2	K.QQNAQGGFSSTQDTVVALHALSK.Y
*	20160416_RA_P1_SF_03.09225.09225.2	3.2864	0.3882	100.0	1511.7676	1511.7705	7929.9	1	7.617	67.9	3	K.AAQVTIQSSGTFSSK.F
*	20160416_RA_P1_SF_04.00346.00346.2	4.6923	0.307	100.0	2046.0953	2045.0992	4481.5	1	6.097	61.8	1	R.LLLQQVSLPELPGEYSMK.V
*	20160416_RA_P1_SF_02.10324.10324.2	3.5134	0.3704	100.0	1555.7819	1554.7838	8074.9	1	6.79	61.5	8	K.VTGEGCVYLQTSLK.Y
*	20160416_RA_P1_SF_04.00427.00427.3	3.6008	0.2556	100.0	3163.5513	3163.5662	5823.2	7	4.97	26.0	1	K.YNILPEKEEFPFALGVQTLPQTCDEPK.A
*	20160416_RA_P1_SF_02.08573.08573.2	2.9178	0.1836	100.0	1134.5797	1134.5829	7077.6	4	4.968	75.0	7	R.SASNMAIVDVK.M
	20160416_RA_P1_SF_05.14768.14768.2	3.6628	0.4822	100.0	1416.8251	1416.8289	4473.9	1	7.453	79.2	6	K.MVSGFIPLKPTVK.M
*	20160416_RA_P1_SF_03.12231.12231.2	5.0301	0.4678	100.0	1617.8429	1617.8488	7898.2	1	8.485	76.9	8	R.TEVSSNHVLIYLDK.V
*	20160416_RA_P1_SF_03.16033.16033.2	3.7997	0.3973	100.0	2550.0798	2548.0867	6317.3	1	6.962	50.0	4	K.VYDYYETDEFAIAEYNAPCSK.D
sp|P02749|APOH_HUMAN	12	37	39.7%	345	38298	8.0	U	APOH Beta-2-glycoprotein 1 [REVIEWED] ENSG00000091583;IPI00298828;P02749;B2R9M3;Q9UCN7 
*	20160416_RA_P1_SF_03.12192.12192.2	4.4813	0.4411	100.0	2384.0862	2383.0916	6309.6	1	8.367	65.8	15	K.TFYEPGEEITYSCKPGYVSR.G
*	20160416_RA_P1_SF_05.01946.01946.2	4.2296	0.3925	100.0	1773.974	1772.9773	6315.2	1	6.676	82.1	3	K.FICPLTGLWPINTLK.C
*	20160416_RA_P1_SF_03.16133.16133.2	4.3099	0.3921	100.0	1503.7769	1502.7789	5074.2	1	7.879	84.6	4	R.VCPFAGILENGAVR.Y
*	20160416_RA_P1_SF_03.16263.16263.3	4.0426	0.3011	100.0	1502.7725	1502.7789	6744.9	78	5.804	51.9	2	R.VCPFAGILENGAVR.Y
*	20160416_RA_P1_SF_03.16258.16258.2	2.8375	0.249	98.7	1403.7054	1403.7106	6804.9	1	5.494	66.7	1	V.CPFAGILENGAVR.Y
*	20160416_RA_P1_SF_03.16202.16202.2	3.8988	0.2425	100.0	1243.6729	1243.6799	7363.7	1	6.121	86.4	1	C.PFAGILENGAVR.Y
*	20160416_RA_P1_SF_02.18551.18551.2	4.0964	0.4501	100.0	3070.3591	3068.3623	5500.0	1	7.833	38.5	3	R.YTTFEYPNTISFSCNTGFYLNGADSAK.C
*	20160416_RA_P1_SF_05.00938.00938.3	6.0747	0.5069	100.0	3525.739	3523.7427	6961.7	1	8.081	35.0	2	K.CTEEGKWSPELPVCAPIICPPPSIPTFATLR.V
*	20160416_RA_P1_SF_05.01452.01452.2	3.555	0.4614	100.0	2820.445	2819.463	5035.9	1	7.348	37.5	1	K.WSPELPVCAPIICPPPSIPTFATLR.V
*	20160416_RA_P1_SF_05.01522.01522.3	3.6809	0.3582	100.0	2820.4617	2819.463	6989.9	1	5.814	30.2	1	K.WSPELPVCAPIICPPPSIPTFATLR.V
*	20160416_RA_P1_SF_03.06342.06342.2	3.6687	0.4264	100.0	2385.9897	2385.9968	5341.7	1	7.687	57.5	1	K.ATFGCHDGYSLDGPEEIECTK.L
*	20160416_RA_P1_SF_04.13411.13411.2	1.8238	0.2019	99.8	1104.5452	1104.5479	3842.0	21	4.872	62.5	3	K.EHSSLAFWK.T
sp|P01877|IGHA2_HUMAN	13	135	39.4%	340	36526	6.1	U	IGHA2 Ig alpha-2 chain C region [REVIEWED] ENSG00000177199;IPI00641229;P01877 
*	20160416_RA_P1_SF_04.16663.16663.3	4.6868	0.2174	100.0	3952.73	3949.7405	6012.5	1	5.856	28.7	11	R.DLCGCYSVSSVLPGCAQPWNHGETFTCTAAHPELK.T
*	20160416_RA_P1_SF_04.17151.17151.4	3.9678	0.1443	99.6	3951.7388	3949.7405	8324.3	1	5.357	20.6	6	R.DLCGCYSVSSVLPGCAQPWNHGETFTCTAAHPELK.T
	20160416_RA_P1_SF_05.22917.22917.3	5.0985	0.399	100.0	3575.8696	3573.874	4832.0	1	7.89	29.8	4	K.SGNTFRPEVHLLPPPSEELALNELVTLTCLAR.G
	20160416_RA_P1_SF_05.05297.05297.2	2.6811	0.3748	100.0	1117.6342	1117.637	5651.0	1	6.562	72.2	1	R.GFSPKDVLVR.W
	20160416_RA_P1_SF_03.06557.06557.2	2.8794	0.3199	100.0	1213.6283	1213.6329	7305.3	1	5.356	88.9	5	R.WLQGSQELPR.E
	20160416_RA_P1_SF_04.10800.10800.2	2.2904	0.2805	100.0	1153.5996	1153.6006	4329.1	12	4.576	75.0	4	R.EKYLTWASR.Q
	20160416_RA_P1_SF_03.10669.10669.2	1.9681	0.0754	99.5	896.4602	896.463	3859.4	8	3.605	91.7	1	K.YLTWASR.Q
	20160416_RA_P1_SF_02.14660.14660.2	4.4303	0.4489	100.0	1835.9456	1835.9503	6526.8	1	9.528	65.6	45	R.QEPSQGTTTFAVTSILR.V
	20160416_RA_P1_SF_02.13824.13824.3	2.5362	0.1213	99.2	1836.9525	1835.9503	8011.3	9	3.81	34.4	5	R.QEPSQGTTTFAVTSILR.V
	20160416_RA_P1_SF_05.17121.17121.2	5.0129	0.4692	100.0	2337.1206	2337.1372	7780.9	1	9.665	62.5	24	K.KGDTFSCMVGHEALPLAFTQK.T
	20160416_RA_P1_SF_05.17208.17208.3	4.7908	0.2291	100.0	2338.1338	2337.1372	6505.0	1	5.797	42.5	27	K.KGDTFSCMVGHEALPLAFTQK.T
	20160416_RA_P1_SF_05.17145.17145.4	1.9781	0.121	97.3	2338.131	2337.1372	4095.6	1	3.913	30.8	1	K.KGDTFSCMVGHEALPLAFTQK.T
	20160416_RA_P1_SF_03.16997.16997.2	2.886	0.1891	100.0	2211.1516	2209.0422	7316.6	1	4.598	44.7	1	K.GDTFSCMVGHEALPLAFTQK.T
sp|P02679|FIBG_HUMAN	10	40	37.7%	453	51512	5.6	U	FGG Fibrinogen gamma chain [REVIEWED] ENSG00000171557;IPI00219713;P02679;A8K057;P04469;P04470;Q53Y18;Q96A14;Q96KJ3;Q9UC62;Q9UC63;Q9UCF3 
*	20160416_RA_P1_SF_03.00259.00259.2	4.8539	0.3961	100.0	2417.0728	2417.0793	7166.3	1	10.259	50.0	3	R.FGSYCPTTCGIADFLSTYQTK.V
*	20160416_RA_P1_SF_03.06454.06454.2	4.0335	0.4211	100.0	1491.741	1491.7444	6348.4	1	7.916	75.0	1	K.YEASILTHDSSIR.Y
*	20160416_RA_P1_SF_03.06872.06872.3	4.5568	0.3248	100.0	2770.328	2768.3347	8862.9	1	6.181	32.6	7	K.VAQLEAQCQEPCKDTVQIHDITGK.D
*	20160416_RA_P1_SF_05.14176.14176.2	2.7594	0.3428	100.0	1293.7532	1293.7571	2400.8	272	6.081	60.0	10	K.QSGLYFIKPLK.A
*	20160416_RA_P1_SF_04.00226.00226.2	5.3325	0.5287	100.0	2662.2383	2661.2407	7746.5	1	9.357	59.1	3	K.ANQQFLVYCEIDGSGNGWTVFQK.R
*	20160416_RA_P1_SF_04.00099.00099.3	3.0003	0.1701	99.7	2662.2278	2661.2407	10770.7	2	4.682	27.3	1	K.ANQQFLVYCEIDGSGNGWTVFQK.R
*	20160416_RA_P1_SF_03.16575.16575.2	3.9424	0.4157	100.0	2208.0364	2207.041	8444.3	1	7.404	47.4	1	K.EGFGHLSPTGTTEFWLGNEK.I
*	20160416_RA_P1_SF_05.15808.15808.2	4.7813	0.4184	100.0	1682.9552	1682.9594	5013.4	1	9.065	89.3	9	K.IHLISTQSAIPYALR.V
*	20160416_RA_P1_SF_03.00504.00504.2	4.5939	0.6289	100.0	2835.1772	2834.1746	9183.6	1	11.302	44.2	1	R.LTYAYFAGGDAGDAFDGFDFGDDPSDK.F
*	20160416_RA_P1_SF_02.16781.16781.2	4.3333	0.3162	100.0	1894.914	1893.9136	8537.6	1	6.852	68.8	4	K.ASTPNGYDNGIIWATWK.T
sp|P02675|FIBB_HUMAN	14	72	36.3%	491	55928	8.3	U	FGB Fibrinogen beta chain [REVIEWED] ENSG00000171564;IPI00298497;P02675;B2R7G3;Q3KPF2 
*	20160416_RA_P1_SF_04.10421.10421.3	2.3826	0.2636	99.7	1951.001	1951.0038	6544.7	1	5.656	34.7	2	R.EEAPSLRPAPPPISGGGYR.A
*	20160416_RA_P1_SF_03.00263.00263.2	3.3063	0.3113	100.0	3169.483	3167.4844	5910.2	1	5.998	31.5	2	R.NSVDELNNNVEAVSQTSSSSFQYMYLLK.D
*	20160416_RA_P1_SF_02.06622.06622.2	2.4711	0.1564	99.9	1768.7832	1768.7877	6362.5	1	5.383	53.6	2	K.DNENVVNEYSSELEK.H
*	20160416_RA_P1_SF_04.13124.13124.2	2.7465	0.3426	100.0	2128.0784	2127.0835	9147.4	1	5.815	41.2	1	K.HQLYIDETVNSNIPTNLR.V
*	20160416_RA_P1_SF_03.06507.06507.2	3.9596	0.4729	100.0	1618.792	1618.7933	7100.8	1	8.985	71.4	4	R.TPCTVSCNIPVVSGK.E
*	20160416_RA_P1_SF_03.12505.12505.3	3.2485	0.1206	99.5	2550.2192	2548.221	5418.6	1	4.536	36.9	3	R.TPCTVSCNIPVVSGKECEEIIR.K
*	20160416_RA_P1_SF_04.13265.13265.2	5.523	0.4587	100.0	2386.169	2385.176	8299.7	1	8.246	55.0	11	R.KGGETSEMYLIQPDSSVKPYR.V
*	20160416_RA_P1_SF_04.13147.13147.3	5.1329	0.2893	100.0	2387.1746	2385.176	6957.0	1	6.311	37.5	9	R.KGGETSEMYLIQPDSSVKPYR.V
*	20160416_RA_P1_SF_04.13025.13025.4	3.3109	0.1349	99.7	2386.1624	2385.176	5684.3	72	4.153	26.7	2	R.KGGETSEMYLIQPDSSVKPYR.V
*	20160416_RA_P1_SF_02.14532.14532.2	4.0252	0.4313	100.0	1785.7839	1785.7906	3482.4	1	8.3	67.9	14	K.NYCGLPGEYWLGNDK.I
*	20160416_RA_P1_SF_04.02018.02018.2	4.6383	0.3754	100.0	1691.7961	1691.8025	7369.4	1	7.744	80.8	5	R.MGPTELLIEMEDWK.G
*	20160416_RA_P1_SF_02.15827.15827.2	4.5499	0.5114	100.0	1669.7152	1668.7157	7468.7	1	8.874	87.5	11	R.YYWGGQYTWDMAK.H
*	20160416_RA_P1_SF_03.16416.16416.2	4.6261	0.5225	100.0	1545.6934	1544.6957	5213.0	1	9.112	75.0	5	K.HGTDDGVVWMNWK.G
*	20160416_RA_P1_SF_04.00446.00446.3	2.1681	0.1096	98.5	1544.69	1544.6957	9586.7	47	3.937	39.6	1	K.HGTDDGVVWMNWK.G
sp|P02774|VTDB_HUMAN	15	81	35.0%	474	52964	5.5	U	GC Vitamin D-binding protein [REVIEWED] ENSG00000145321;IPI00968027;P02774;B4DPP2;Q16309;Q16310;Q53F31;Q6GTG1 
*	20160416_RA_P1_SF_05.00251.00251.2	3.8174	0.4017	100.0	1529.781	1529.7852	8591.7	1	7.408	70.8	5	K.EDFTSLSLVLYSR.K
*	20160416_RA_P1_SF_05.05497.05497.2	2.5994	0.3185	100.0	1694.9084	1694.9117	8306.1	22	5.58	57.1	1	R.KFPSGTFEQVSQLVK.E
*	20160416_RA_P1_SF_02.10137.10137.2	2.8756	0.3157	100.0	2519.0059	2518.017	7012.2	1	5.569	38.1	4	K.EVVSLTEACCAEGADPDCYDTR.T
*	20160416_RA_P1_SF_05.11215.11215.2	2.4086	0.1496	100.0	934.5182	934.5218	4062.7	1	4.064	92.9	1	R.KLCMAALK.H
*	20160416_RA_P1_SF_03.15695.15695.2	3.515	0.4167	100.0	2708.2007	2707.21	7785.2	1	7.129	35.7	5	K.HQPQEFPTYVEPTNDEICEAFR.K
*	20160416_RA_P1_SF_03.15959.15959.3	5.2136	0.4786	100.0	2708.1987	2707.21	7779.5	1	7.768	40.5	6	K.HQPQEFPTYVEPTNDEICEAFR.K
*	20160416_RA_P1_SF_03.16327.16327.2	5.2426	0.5312	100.0	2356.0444	2355.0493	7136.4	1	9.771	52.5	10	K.SYLSMVGSCCTSASPTVCFLK.E
*	20160416_RA_P1_SF_05.03141.03141.3	5.2504	0.3979	100.0	2807.5383	2806.5454	5501.7	1	7.085	33.0	5	K.LAQKVPTADLEDVLPLAEDITNILSK.C
*	20160416_RA_P1_SF_04.03830.03830.2	5.2239	0.3566	100.0	2367.2668	2366.2708	4535.8	1	7.319	64.3	16	K.VPTADLEDVLPLAEDITNILSK.C
*	20160416_RA_P1_SF_04.03766.03766.3	3.9027	0.314	100.0	2367.2764	2366.2708	6387.0	1	5.674	35.7	2	K.VPTADLEDVLPLAEDITNILSK.C
*	20160416_RA_P1_SF_03.12376.12376.2	3.2322	0.2604	100.0	1389.6909	1388.6884	6698.1	1	5.443	85.0	9	K.VMDKYTFELSR.R
*	20160416_RA_P1_SF_03.12779.12779.3	1.9116	0.1598	99.2	1388.6837	1388.6884	4320.5	12	4.349	47.5	1	K.VMDKYTFELSR.R
*	20160416_RA_P1_SF_02.09239.09239.2	2.0864	0.0879	99.8	915.4537	915.4576	3421.6	1	5.273	83.3	14	K.YTFELSR.R
*	20160416_RA_P1_SF_04.12507.12507.2	1.9613	0.0646	98.9	1170.6484	1170.6522	5249.0	10	4.029	61.1	1	R.THLPEVFLSK.V
*	20160416_RA_P1_SF_02.06556.06556.2	4.8111	0.6283	100.0	2092.8196	2092.8262	8473.0	1	11.623	64.7	1	K.SLGECCDVEDSTTCFNAK.G
sp|P00450|CERU_HUMAN	34	144	34.9%	1065	122205	5.7	U	CP Ceruloplasmin [REVIEWED] ENSG00000047457;IPI00017601;P00450;Q14063;Q2PP18;Q9UKS4 
*	20160416_RA_P1_SF_04.13418.13418.2	4.2842	0.4828	100.0	1648.8354	1647.8383	10201.3	1	7.392	66.7	4	K.KALYLQYTDETFR.T
*	20160416_RA_P1_SF_02.13479.13479.2	3.7665	0.3961	100.0	1520.7408	1519.7433	7096.9	1	6.404	72.7	22	K.ALYLQYTDETFR.T
*	20160416_RA_P1_SF_05.22183.22183.2	3.9928	0.4336	100.0	1913.1299	1912.1312	3555.7	1	7.391	62.5	2	R.TTIEKPVWLGFLGPIIK.A
*	20160416_RA_P1_SF_05.22199.22199.3	2.2949	0.0636	96.6	1913.1285	1912.1312	6514.9	165	3.326	31.2	1	R.TTIEKPVWLGFLGPIIK.A
*	20160416_RA_P1_SF_02.17061.17061.3	2.5976	0.0734	97.5	3694.7703	3693.6326	10174.1	2	3.98	18.8	1	R.ADDKVYPGEQYTYMLLATEEQSPGEGDGNCVTR.I
*	20160416_RA_P1_SF_02.18352.18352.2	3.4377	0.3482	100.0	3265.4358	3264.4465	7782.2	1	8.341	37.5	2	K.VYPGEQYTYMLLATEEQSPGEGDGNCVTR.I
*	20160416_RA_P1_SF_02.19059.19059.2	3.8586	0.2707	100.0	1472.8414	1469.8402	5041.1	1	5.618	80.8	8	K.DIASGLIGPLIICK.K
*	20160416_RA_P1_SF_02.19018.19018.3	3.9507	0.3292	100.0	1469.8337	1469.8402	6938.2	4	6.415	55.8	1	K.DIASGLIGPLIICK.K
*	20160416_RA_P1_SF_04.00045.00045.2	4.0869	0.4382	100.0	2457.0703	2455.0732	4841.6	1	7.251	40.5	4	R.MYSVNGYTFGSLPGLSMCAEDR.V
*	20160416_RA_P1_SF_03.15943.15943.2	4.9576	0.5053	100.0	1639.7858	1639.7903	8730.2	1	8.975	69.2	5	K.AGLQAFFQVQECNK.S
*	20160416_RA_P1_SF_05.01456.01456.2	5.349	0.5326	100.0	2487.272	2487.2883	7805.0	1	9.739	56.8	5	R.GPEEEHLGILGPVIWAEVGDTIR.V
*	20160416_RA_P1_SF_05.01850.01850.3	5.6425	0.4649	100.0	2488.287	2487.2883	7814.3	1	7.853	45.5	4	R.GPEEEHLGILGPVIWAEVGDTIR.V
*	20160416_RA_P1_SF_03.12935.12935.2	3.1514	0.2765	100.0	1371.7599	1371.7637	4566.7	1	5.633	66.7	31	K.GAYPLSIEPIGVR.F
*	20160416_RA_P1_SF_04.15198.15198.2	2.839	0.2766	100.0	2532.242	2531.2458	5262.4	10	5.661	31.8	4	R.SVPPSASHVAPTETFTYEWTVPK.E
*	20160416_RA_P1_SF_04.14566.14566.3	2.7477	0.1626	99.5	2531.2473	2531.2458	6618.9	4	4.019	29.5	4	R.SVPPSASHVAPTETFTYEWTVPK.E
*	20160416_RA_P1_SF_02.06582.06582.2	2.7633	0.3447	100.0	1470.7196	1470.7262	8342.3	27	6.909	46.2	1	K.EVGPTNADPVCLAK.M
*	20160416_RA_P1_SF_04.00595.00595.2	4.7933	0.3525	100.0	2348.1704	2347.1719	4906.7	1	7.922	70.0	3	K.MYYSAVDPTKDIFTGLIGPMK.I
*	20160416_RA_P1_SF_04.00714.00714.3	2.6241	0.232	99.6	2348.1675	2347.1719	8132.0	1	4.421	35.0	1	K.MYYSAVDPTKDIFTGLIGPMK.I
*	20160416_RA_P1_SF_02.18417.18417.1	2.2686	0.0923	96.7	1191.6387	1191.6448	5504.5	1	4.934	60.0	1	K.DIFTGLIGPMK.I
*	20160416_RA_P1_SF_02.18573.18573.2	2.7431	0.2206	100.0	1192.6154	1191.6448	8598.3	2	4.226	75.0	1	K.DIFTGLIGPMK.I
*	20160416_RA_P1_SF_04.04899.04899.3	4.0045	0.3328	100.0	3162.5354	3160.5366	8208.5	1	6.435	28.0	4	K.DVDKEFYLFPTVFDENESLLLEDNIR.M
*	20160416_RA_P1_SF_04.02671.02671.2	3.8188	0.4615	100.0	2704.3352	2703.3193	6997.6	1	8.067	50.0	1	K.EFYLFPTVFDENESLLLEDNIR.M
*	20160416_RA_P1_SF_04.02705.02705.3	4.6126	0.2448	100.0	2705.325	2703.3193	6151.1	1	5.821	34.5	1	K.EFYLFPTVFDENESLLLEDNIR.M
*	20160416_RA_P1_SF_03.10407.10407.2	2.3882	0.2536	100.0	2474.0564	2474.067	8023.4	3	5.616	35.0	2	R.MFTTAPDQVDKEDEDFQESNK.M
*	20160416_RA_P1_SF_03.06279.06279.3	3.1559	0.4172	100.0	2476.062	2474.067	5622.4	1	6.297	36.2	2	R.MFTTAPDQVDKEDEDFQESNK.M
*	20160416_RA_P1_SF_05.14721.14721.2	3.6659	0.361	100.0	2204.9192	2203.9219	6967.7	1	7.543	58.3	13	K.MHSMNGFMYGNQPGLTMCK.G
*	20160416_RA_P1_SF_03.13641.13641.2	2.9204	0.2005	95.4	1936.8262	1935.8225	7165.4	6	5.852	37.5	1	H.SMNGFMYGNQPGLTMCK.G
*	20160416_RA_P1_SF_04.13725.13725.2	2.6655	0.26	98.7	1713.8887	1713.8925	6048.8	1	5.761	57.1	1	R.RDTANLFPQTSLTLH.M
*	20160416_RA_P1_SF_05.01259.01259.3	4.1021	0.4397	100.0	4329.9473	4328.958	6118.9	1	7.143	22.3	3	R.DTANLFPQTSLTLHMWPDTEGTFNVECLTTDHYTGGMK.Q
*	20160416_RA_P1_SF_02.17129.17129.2	3.6576	0.4228	100.0	2495.2678	2494.2717	5378.6	1	6.865	45.5	1	H.GVQTESSTVTPTLPGETLTYVWK.I
*	20160416_RA_P1_SF_03.00709.00709.2	3.6138	0.3668	100.0	1575.8531	1575.8568	4685.7	1	7.558	69.2	3	K.DLYSGLIGPLIVCR.R
*	20160416_RA_P1_SF_03.00813.00813.3	4.3319	0.3218	100.0	1576.8552	1575.8568	6930.5	1	7.428	53.8	1	K.DLYSGLIGPLIVCR.R
*	20160416_RA_P1_SF_04.02494.02494.2	4.3108	0.4483	100.0	2670.25	2669.2598	4643.9	1	7.824	45.5	4	R.GVYSSDVFDIFPGTYQTLEMFPR.T
*	20160416_RA_P1_SF_04.02670.02670.3	2.8603	0.3849	100.0	2670.2786	2669.2598	4537.8	1	6.256	30.7	2	R.GVYSSDVFDIFPGTYQTLEMFPR.T
sp|P04217|A1BG_HUMAN	11	57	33.7%	495	54254	5.9	U	A1BG Alpha-1B-glycoprotein [REVIEWED] ENSG00000121410;IPI00644018;P04217;A8K052;Q68CK0;Q8IYJ6;Q96P39 
*	20160416_RA_P1_SF_04.06383.06383.2	4.1291	0.4779	100.0	1674.8788	1674.8815	7595.6	1	7.95	56.7	2	K.NGVAQEPVHLDSPAIK.H
*	20160416_RA_P1_SF_03.06536.06536.2	3.3222	0.3175	100.0	1264.6501	1264.6537	5934.2	1	6.144	81.8	1	R.SGLSTGWTQLSK.L
*	20160416_RA_P1_SF_03.17843.17843.2	4.5513	0.5127	100.0	1876.9952	1876.0002	5863.1	1	7.494	71.9	5	K.VTLTCVAPLSGVDFQLR.R
*	20160416_RA_P1_SF_02.18397.18397.3	3.9022	0.3948	100.0	1876.9967	1876.0002	6434.8	1	6.294	43.8	1	K.VTLTCVAPLSGVDFQLR.R
*	20160416_RA_P1_SF_05.17722.17722.2	4.0119	0.5047	100.0	1730.8622	1730.8655	7776.6	1	8.457	66.7	2	R.IFFHLNAVALGDGGHY.T
*	20160416_RA_P1_SF_04.00773.00773.3	3.6828	0.2435	100.0	3993.8447	3990.8633	6112.9	2	5.08	19.4	1	R.LHDNQNGWSGDSAPVELILSDETLPAPEFSPEPESGR.A
*	20160416_RA_P1_SF_03.06700.06700.2	3.1769	0.242	100.0	1088.5797	1088.5852	6690.7	3	5.734	80.0	9	R.ATWSGAVLAGR.D
*	20160416_RA_P1_SF_03.00251.00251.2	4.2332	0.4191	100.0	1645.8207	1645.8259	3336.9	1	7.956	88.5	4	R.CEGPIPDVTFELLR.E
*	20160416_RA_P1_SF_05.18685.18685.2	4.8353	0.4449	100.0	2297.1785	2296.1838	6709.0	1	7.769	50.0	11	R.TPGAAANLELIFVGPQHAGNYR.C
*	20160416_RA_P1_SF_05.18605.18605.3	6.005	0.5549	100.0	2297.179	2296.1838	8253.2	1	9.018	46.4	16	R.TPGAAANLELIFVGPQHAGNYR.C
*	20160416_RA_P1_SF_04.02406.02406.2	3.4145	0.3928	100.0	2472.1904	2471.1982	7452.6	1	6.837	42.9	5	R.SWVPHTFESELSDPVELLVAES.-
sp|P02763|A1AG1_HUMAN	7	65	32.3%	201	23512	5.0	U	ORM1 Alpha-1-acid glycoprotein 1 [REVIEWED] ENSG00000229314;ENSG00000187681;IPI00022429;P02763;B7ZKQ5;Q5T539;Q5U067;Q8TC16 
	20160416_RA_P1_SF_05.17669.17669.2	3.5456	0.2835	100.0	1160.5857	1160.5892	5836.8	1	7.229	100.0	30	K.WFYIASAFR.N
*	20160416_RA_P1_SF_05.21577.21577.2	1.6839	0.0195	97.2	1753.9299	1752.955	9254.9	1	3.08	53.6	1	R.YVGGQEHFAHLLILR.D
*	20160416_RA_P1_SF_02.13644.13644.2	3.98	0.4786	100.0	1445.6552	1445.6622	7140.6	1	8.791	77.3	14	K.TYMLAFDVNDEK.N
*	20160416_RA_P1_SF_04.17991.17991.3	5.0795	0.4296	100.0	3137.486	3135.4985	8388.6	1	8.065	27.9	4	K.TYMLAFDVNDEKNWGLSVYADKPETTK.E
*	20160416_RA_P1_SF_03.12960.12960.2	3.2928	0.2013	100.0	1709.7766	1708.8546	10722.2	1	5.505	57.1	2	K.NWGLSVYADKPETTK.E
*	20160416_RA_P1_SF_02.18687.18687.1	1.8041	0.0793	97.3	1743.8043	1742.8059	2147.3	5	3.577	42.3	1	K.EQLGEFYEALDCLR.I
*	20160416_RA_P1_SF_03.00014.00014.2	4.0045	0.4999	100.0	1742.8009	1742.8059	8712.2	1	9.451	73.1	13	K.EQLGEFYEALDCLR.I
sp|P01008|ANT3_HUMAN	14	58	31.0%	464	52602	6.7	U	SERPINC1 Antithrombin-III [REVIEWED] ENSG00000117601;IPI00032179;P01008;B2R6P0;P78439;P78447;Q13815;Q5TC78;Q7KZ43;Q7KZ97;Q9UC78 
*	20160416_RA_P1_SF_02.07057.07057.2	2.2981	0.0459	99.4	1409.6333	1409.638	3288.7	122	4.411	55.0	1	R.DIPMNPMCIYR.S
*	20160416_RA_P1_SF_04.12776.12776.2	4.1211	0.3594	100.0	1528.7367	1528.7437	7704.8	1	6.411	79.2	5	R.FATTFYQHLADSK.N
*	20160416_RA_P1_SF_05.22436.22436.4	4.3693	0.272	100.0	3810.8696	3808.8533	10208.8	2	5.5	20.7	1	R.FATTFYQHLADSKNDNDNIFLSPLSISTAFAMTK.L
*	20160416_RA_P1_SF_04.02383.02383.2	4.7672	0.4634	100.0	2300.1172	2299.128	6516.5	1	7.872	52.5	2	K.NDNDNIFLSPLSISTAFAMTK.L
*	20160416_RA_P1_SF_04.15142.15142.2	3.7569	0.3863	100.0	1340.6592	1340.664	6765.4	1	6.789	80.0	10	K.TSDQIHFFFAK.L
*	20160416_RA_P1_SF_04.15182.15182.3	2.1752	0.1401	99.2	1340.6589	1340.664	4116.6	188	3.996	40.0	2	K.TSDQIHFFFAK.L
*	20160416_RA_P1_SF_03.10482.10482.2	2.0039	0.0722	98.9	1674.8359	1674.8451	5291.1	36	4.581	38.5	1	K.LQPLDFKENAEQSR.A
*	20160416_RA_P1_SF_02.14926.14926.2	3.6	0.2387	100.0	1431.8502	1430.7896	9693.8	1	5.483	70.8	3	R.VAEGTQVLELPFK.G
*	20160416_RA_P1_SF_04.12674.12674.2	3.04	0.3687	100.0	1211.6387	1211.6425	5934.7	1	6.418	88.9	22	R.FRIEDGFSLK.E
*	20160416_RA_P1_SF_03.00650.00650.2	4.5377	0.4611	100.0	1848.8981	1848.9054	9303.5	1	8.689	73.3	3	K.EQLQDMGLVDLFSPEK.S
*	20160416_RA_P1_SF_03.00560.00560.3	3.4556	0.2084	99.9	1849.903	1848.9054	7153.8	3	5.473	41.7	1	K.EQLQDMGLVDLFSPEK.S
*	20160416_RA_P1_SF_04.16347.16347.2	3.409	0.3434	100.0	2293.1477	2291.1519	9299.4	1	7.076	50.0	1	K.AFLEVNEEGSEAAASTAVVIAGR.S
*	20160416_RA_P1_SF_03.18213.18213.2	3.1494	0.2253	100.0	1390.7534	1389.7565	4115.2	3	5.463	68.2	5	R.EVPLNTIIFMGR.V
*	20160416_RA_P1_SF_02.18435.18435.2	3.1946	0.2132	99.4	1161.6415	1161.6454	5595.2	1	5.199	77.8	1	V.PLNTIIFMGR.V
sp|P18135|KV312_HUMAN	4	16	31.0%	129	14073	7.9	U	Ig kappa chain V-III region HAH [REVIEWED] ENSG00000169769;IPI00030205;P18135 
	20160416_RA_P1_SF_05.13458.13458.2	2.4659	0.3658	100.0	1792.9095	1792.9135	7163.4	1	6.88	53.6	1	S.SYLAWYQQKPGQAPR.L
	20160416_RA_P1_SF_05.13193.13193.2	4.3523	0.4295	100.0	1706.8807	1705.8815	4672.4	1	6.877	69.2	3	S.YLAWYQQKPGQAPR.L
*	20160416_RA_P1_SF_03.09398.09398.2	2.8344	0.1988	100.0	979.55383	979.5577	4975.2	1	5.388	81.2	7	R.LLIYGASSR.A
*	20160416_RA_P1_SF_02.12519.12519.2	4.0739	0.4469	100.0	1633.7854	1632.787	8071.4	1	8.57	63.3	5	R.FSGSGSGTDFTLTISR.L
sp|P25311|ZA2G_HUMAN	8	39	30.5%	298	34259	6.1	U	AZGP1 Zinc-alpha-2-glycoprotein [REVIEWED] ENSG00000160862;IPI00166729;P25311;D6W5T8;O60386;Q5XKQ4;Q8N4N0 
*	20160416_RA_P1_SF_03.15480.15480.2	4.3991	0.492	100.0	1409.7355	1408.7365	7693.8	1	8.18	90.9	11	R.YSLTYIYTGLSK.H
*	20160416_RA_P1_SF_05.01813.01813.2	5.9725	0.4771	100.0	2404.2134	2403.2097	4881.1	1	8.898	67.5	3	K.HVEDVPAFQALGSLNDLQFFR.Y
*	20160416_RA_P1_SF_05.01821.01821.3	3.4401	0.247	100.0	2404.2078	2403.2097	4759.6	1	5.718	35.0	2	K.HVEDVPAFQALGSLNDLQFFR.Y
*	20160416_RA_P1_SF_03.11869.11869.2	1.0813	0.027	95.8	974.4839	974.4882	2015.9	272	3.011	64.3	1	K.SQPMGLWR.Q
*	20160416_RA_P1_SF_03.13903.13903.2	3.3984	0.2145	100.0	1352.6846	1352.6884	7433.6	7	5.537	70.0	5	K.AREDIFMETLK.D
*	20160416_RA_P1_SF_02.12359.12359.2	2.7439	0.3935	100.0	1718.7689	1717.775	4962.2	1	6.205	66.7	1	K.YYYDGKDYIEFNK.E
*	20160416_RA_P1_SF_02.18861.18861.2	3.7265	0.3308	100.0	1783.939	1782.943	3743.0	1	7.197	66.7	2	K.EIPAWVPFDPAAQITK.Q
*	20160416_RA_P1_SF_02.12156.12156.2	3.0372	0.4521	100.0	1233.557	1233.5614	6778.5	1	6.724	66.7	14	K.CLAYDFYPGK.I
sp|P08603|CFAH_HUMAN	26	121	28.8%	1231	139096	6.6	U	CFH Complement factor H [REVIEWED] ENSG00000000971;IPI00942414;P08603;A5PL14;P78435;Q14570;Q2TAZ5;Q38G77;Q5TFM3;Q8N708;Q9NU86 
*	20160416_RA_P1_SF_03.11853.11853.2	3.3602	0.4426	100.0	1148.5873	1148.592	4961.4	1	7.148	83.3	3	R.SLGNVIMVCR.K
*	20160416_RA_P1_SF_02.16574.16574.2	5.1533	0.4418	100.0	2164.0168	2163.018	7338.4	1	8.513	70.6	9	K.AVYTCNEGYQLLGEINYR.E
*	20160416_RA_P1_SF_04.13019.13019.2	1.9421	0.0514	98.5	2194.055	2192.056	6788.3	20	3.113	33.3	2	K.IVSSAMEPDREYHFGQAVR.F
*	20160416_RA_P1_SF_04.12922.12922.3	2.3684	0.0843	97.6	2193.05	2192.056	4786.8	5	3.426	31.9	3	K.IVSSAMEPDREYHFGQAVR.F
*	20160416_RA_P1_SF_03.06289.06289.2	3.0786	0.1756	100.0	2179.9575	2177.9595	6899.6	1	4.71	41.7	1	R.GDAVCTESGWRPLPSCEEK.S
*	20160416_RA_P1_SF_03.06278.06278.3	2.4011	0.2135	99.7	2177.954	2177.9595	4688.6	21	5.041	30.6	1	R.GDAVCTESGWRPLPSCEEK.S
*	20160416_RA_P1_SF_03.10801.10801.2	3.335	0.347	100.0	1245.6005	1245.605	4843.6	1	6.946	85.0	4	K.CTSTGWIPAPR.C
	20160416_RA_P1_SF_02.14885.14885.2	3.7186	0.3594	100.0	2058.8752	2057.8816	7545.9	1	7.044	60.0	3	K.CYFPYLENGYNQNYGR.K
	20160416_RA_P1_SF_04.14248.14248.2	2.7786	0.2242	100.0	2186.9727	2185.9766	8075.1	7	4.667	43.8	3	K.CYFPYLENGYNQNYGRK.F
*	20160416_RA_P1_SF_04.06808.06808.2	3.4615	0.3061	100.0	1527.7588	1527.763	6858.9	1	6.958	76.9	12	K.SIDVACHPGYALPK.A
*	20160416_RA_P1_SF_03.17582.17582.2	1.7188	0.0727	98.2	2265.065	2265.0928	8420.0	8	3.481	31.6	1	K.SSIDIENGFISESQYTYALK.E
*	20160416_RA_P1_SF_02.06625.06625.2	2.8859	0.2948	100.0	1815.8365	1815.8435	7818.5	2	5.386	47.1	1	K.LGYVTADGETSGSITCGK.D
*	20160416_RA_P1_SF_02.12149.12149.2	3.513	0.3554	100.0	1309.5994	1309.6033	3569.2	1	6.563	85.0	14	K.SCDIPVFMNAR.T
*	20160416_RA_P1_SF_02.13671.13671.2	1.9945	0.2068	100.0	957.44415	957.447	4982.3	21	4.424	75.0	3	K.NDFTWFK.L
*	20160416_RA_P1_SF_04.06250.06250.2	2.7484	0.2696	100.0	1063.5867	1063.59	6115.4	1	5.838	81.2	4	K.IDVHLVPDR.K
*	20160416_RA_P1_SF_04.14775.14775.2	3.0001	0.3787	100.0	2060.9514	2060.9573	7269.6	1	7.057	50.0	1	K.FSCKPGFTIVGPNSVQCY.H
*	20160416_RA_P1_SF_04.13959.13959.2	3.8871	0.1921	100.0	1395.7783	1395.7848	5673.1	1	5.103	81.8	10	K.SSNLIILEEHLK.N
*	20160416_RA_P1_SF_04.12176.12176.2	3.2729	0.1704	100.0	1443.7012	1441.701	3423.9	2	5.282	59.1	6	K.EGWIHTVCINGR.W
*	20160416_RA_P1_SF_02.18525.18525.2	4.9524	0.4025	100.0	2413.1396	2412.1426	8151.9	1	7.765	57.9	4	K.VSVLCQENYLIQEGEEITCK.D
*	20160416_RA_P1_SF_02.18464.18464.3	3.6251	0.1539	99.6	2413.1404	2412.1426	8903.7	1	4.658	39.5	1	K.VSVLCQENYLIQEGEEITCK.D
*	20160416_RA_P1_SF_03.06527.06527.2	2.4367	0.0832	99.8	1259.6407	1259.6458	4512.1	61	3.625	66.7	1	R.WQSIPLCVEK.I
*	20160416_RA_P1_SF_02.08823.08823.2	2.1049	0.2216	100.0	1189.5287	1189.5311	7053.8	2	4.779	77.8	2	K.LSYTCEGGFR.I
*	20160416_RA_P1_SF_04.13364.13364.3	3.8205	0.472	100.0	2911.3179	2910.3257	9716.9	1	7.325	33.0	3	K.SPPEISHGVVAHMSDSYQYGEEVTYK.C
*	20160416_RA_P1_SF_02.12573.12573.2	4.6495	0.5124	100.0	1482.7101	1481.7098	8537.2	1	8.608	73.1	24	K.CFEGFGIDGPAIAK.C
*	20160416_RA_P1_SF_02.16247.16247.2	2.1351	0.1643	99.8	2009.9927	2008.936	4418.1	6	4.717	41.2	1	K.TDCLSLPSFENAIPMGEK.K
	20160416_RA_P1_SF_05.00090.00090.3	4.1098	0.4526	100.0	4584.167	4582.166	6472.2	1	8.191	23.8	4	K.CGPPPPIDNGDITSFPLSVYAPASSVEYQCQNLYQLEGNKR.I
sp|P60709|ACTB_HUMAN	6	28	28.5%	375	41737	5.5	U	ACTB Actin, cytoplasmic 1 [REVIEWED] ENSG00000075624;IPI00021439;P60709;P02570;P70514;P99021;Q11211;Q64316;Q75MN2;Q96B34;Q96HG5 
*	20160416_RA_P1_SF_03.13053.13053.2	3.8226	0.2782	100.0	1955.0564	1954.065	7325.5	2	6.451	47.1	6	R.VAPEEHPVLLTEAPLNPK.A
*	20160416_RA_P1_SF_04.17695.17695.3	6.1139	0.4513	100.0	3185.6096	3183.6147	8403.3	1	7.877	34.5	12	R.TTGIVMDSGDGVTHTVPIYEGYALPHAILR.L
	20160416_RA_P1_SF_02.09886.09886.1	1.832	0.1693	95.3	998.4814	998.4869	6622.6	1	4.624	64.3	3	R.DLTDYLMK.I
	20160416_RA_P1_SF_03.00751.00751.2	6.142	0.4978	100.0	2551.172	2550.1743	9563.9	1	9.886	59.1	4	K.LCYVALDFEQEMATAASSSSLEK.S
	20160416_RA_P1_SF_04.00902.00902.3	3.036	0.067	98.7	2552.1792	2550.1743	7824.0	3	3.744	28.4	1	K.LCYVALDFEQEMATAASSSSLEK.S
*	20160416_RA_P1_SF_05.00746.00746.3	4.0204	0.3422	100.0	3233.4568	3231.4624	4808.9	1	5.707	31.5	2	R.CPEALFQPSFLGMESCGIHETTFNSIMK.C
sp|B9A064|IGLL5_HUMAN	9	95	27.6%	214	23063	8.8	U	IGLL5 Immunoglobulin lambda-like polypeptide 5 [REVIEWED] ENSG00000254709;IPI00977041;B9A064 
*	20160416_RA_P1_SF_02.13772.13772.2	4.7568	0.4905	100.0	2044.0363	2043.0398	3747.1	1	7.5	55.6	30	K.ANPTVTLFPPSSEELQANK.A
	20160416_RA_P1_SF_05.23166.23166.2	4.7057	0.4888	100.0	2212.1648	2211.1523	5080.7	1	8.767	73.7	3	K.ATLVCLISDFYPGAVTVAWK.A
	20160416_RA_P1_SF_05.23036.23036.3	3.5161	0.2543	100.0	2213.1394	2211.1523	6444.0	1	5.357	39.5	1	K.ATLVCLISDFYPGAVTVAWK.A
	20160416_RA_P1_SF_02.18354.18354.2	3.4472	0.428	100.0	1666.8789	1666.8844	5109.7	1	7.101	67.9	1	C.LISDFYPGAVTVAWK.A
	20160416_RA_P1_SF_04.15263.15263.2	4.7792	0.3631	100.0	2316.1243	2315.1309	6180.1	1	7.721	52.6	12	K.QSNNKYAASSYLSLTPEQWK.S
	20160416_RA_P1_SF_04.15239.15239.3	3.0668	0.4046	100.0	2315.123	2315.1309	6179.1	1	6.507	35.5	5	K.QSNNKYAASSYLSLTPEQWK.S
	20160416_RA_P1_SF_02.15403.15403.2	5.225	0.4512	100.0	1743.8549	1743.8594	5488.8	1	8.968	82.1	41	K.YAASSYLSLTPEQWK.S
	20160416_RA_P1_SF_02.14656.14656.2	2.9829	0.2556	99.2	1580.7943	1580.796	6291.5	17	5.013	50.0	1	Y.AASSYLSLTPEQWK.S
	20160416_RA_P1_SF_02.14404.14404.2	2.775	0.1926	97.4	1351.6844	1351.6898	6769.2	2	4.593	75.0	1	S.SYLSLTPEQWK.S
sp|P36955|PEDF_HUMAN	6	32	26.6%	418	46312	6.4	U	SERPINF1 Pigment epithelium-derived factor [REVIEWED] ENSG00000132386;IPI00006114;P36955;F1T092;Q13236;Q2TU83;Q96CT1;Q96R01;Q9BWA4 
*	20160416_RA_P1_SF_02.14649.14649.2	4.2814	0.4662	100.0	1559.78	1559.7858	5947.2	1	9.235	76.9	5	K.LAAAVSNFGYDLYR.V
*	20160416_RA_P1_SF_03.13714.13714.2	3.811	0.2924	100.0	1956.975	1955.9755	8304.9	1	5.92	59.4	5	R.ALYYDLISSPDIHGTYK.E
*	20160416_RA_P1_SF_03.01224.01224.2	4.1549	0.3814	100.0	1829.9115	1829.922	8914.3	1	7.456	71.4	1	R.LDLQEINNWVQAQMK.G
*	20160416_RA_P1_SF_03.14200.14200.2	3.2459	0.3113	100.0	1644.7701	1644.7758	8725.7	1	6.889	66.7	3	R.KTSLEDFYLDEER.T
*	20160416_RA_P1_SF_02.11325.11325.2	2.7633	0.2772	100.0	1383.6764	1383.6796	5891.3	1	6.592	54.5	17	K.LQSLFDSPDFSK.I
*	20160416_RA_P1_SF_05.22500.22500.4	3.53	0.2054	99.8	4456.2476	4453.2046	6956.8	6	4.299	15.8	1	R.AGFEWNEDGAGTTPSPGLQPAHLTFPLDYHLNQPFIFVLR.D
sp|P19652|A1AG2_HUMAN	4	39	26.4%	201	23603	5.1	U	ORM2 Alpha-1-acid glycoprotein 2 [REVIEWED] ENSG00000228278;ENSG00000204154;IPI00020091;P19652;B2R5L2;Q16571;Q5T538;Q6IB74 
	20160416_RA_P1_SF_05.17669.17669.2	3.5456	0.2835	100.0	1160.5857	1160.5892	5836.8	1	7.229	100.0	30	K.WFYIASAFR.N
*	20160416_RA_P1_SF_05.00616.00616.3	3.114	0.2454	99.8	3157.4788	3156.4875	11587.1	1	4.596	24.0	1	K.TLMFGSYLDDEKNWGLSFYADKPETTK.E
*	20160416_RA_P1_SF_05.01168.01168.2	4.5737	0.4243	100.0	2113.9622	2112.9734	8710.1	1	8.43	59.4	6	K.EQLGEFYEALDCLCIPR.S
*	20160416_RA_P1_SF_03.00834.00834.3	4.3324	0.2809	100.0	2113.9675	2112.9734	8408.3	1	6.324	46.9	2	K.EQLGEFYEALDCLCIPR.S
sp|P69905|HBA_HUMAN	4	43	26.1%	142	15258	8.7	U	HBA2 Hemoglobin subunit alpha [REVIEWED] ENSG00000188536;ENSG00000206172;IPI00410714;P69905;P01922;Q1HDT5;Q3MIF5;Q53F97;Q96KF1;Q9NYR7;Q9UCM0 
*	20160416_RA_P1_SF_03.15389.15389.2	2.6696	0.1598	100.0	1071.5525	1071.5549	3636.7	4	4.271	81.2	2	R.MFLSFPTTK.T
*	20160416_RA_P1_SF_05.16256.16256.2	4.4568	0.5446	100.0	1833.8876	1833.8925	6019.8	1	10.329	73.3	24	K.TYFPHFDLSHGSAQVK.G
*	20160416_RA_P1_SF_05.14946.14946.3	2.878	0.385	100.0	1833.8896	1833.8925	5768.5	1	5.815	48.3	14	K.TYFPHFDLSHGSAQVK.G
*	20160416_RA_P1_SF_03.13760.13760.2	2.7122	0.2137	100.0	1252.7102	1252.7152	6714.4	2	4.943	63.6	3	K.FLASVSTVLTSK.Y
sp|P06396|GELS_HUMAN	11	51	25.6%	782	85697	6.3	U	GSN Gelsolin [REVIEWED] ENSG00000148180;IPI00647556;P06396;A2A418;A8MUD1;A8MYN7;B7Z373;Q5T0I2;Q8WVV7 
*	20160416_RA_P1_SF_05.00397.00397.2	4.3814	0.5199	100.0	1722.833	1722.8379	11674.6	1	9.189	67.9	9	R.EVQGFESATFLGYFK.S
*	20160416_RA_P1_SF_05.01392.01392.3	3.6213	0.1315	99.7	4041.789	4037.7935	5670.1	1	4.442	21.3	1	R.ATEVPVSWESFNNGDCFILDLGNNIHQWCGSNSNR.Y
*	20160416_RA_P1_SF_02.17993.17993.2	3.2208	0.3745	100.0	2463.2131	2463.219	6905.6	1	7.595	43.8	2	K.VSNGAGTMSVSLVADENPFAQGALK.S
*	20160416_RA_P1_SF_02.13563.13563.2	3.5998	0.4282	100.0	1830.9626	1829.9648	5634.7	2	6.245	46.9	11	K.QTQVSVLPEGGETPLFK.Q
*	20160416_RA_P1_SF_05.05203.05203.3	3.5311	0.1598	99.6	2844.3518	2843.3713	6126.8	32	4.161	22.9	1	K.NWRDPDQTDGLGLSYLSSHIANVER.V
*	20160416_RA_P1_SF_04.00464.00464.3	3.8675	0.2912	100.0	3401.6404	3399.6538	8385.0	1	6.123	26.7	1	R.IEGSNKVPVDPATYGQFYGGDSYIILYNYR.H
*	20160416_RA_P1_SF_04.00541.00541.2	4.6917	0.4565	100.0	2773.3315	2771.3357	8703.6	1	8.169	45.7	2	K.VPVDPATYGQFYGGDSYIILYNYR.H
*	20160416_RA_P1_SF_04.00568.00568.3	3.4438	0.3253	100.0	2772.332	2771.3357	8335.7	1	5.346	28.3	1	K.VPVDPATYGQFYGGDSYIILYNYR.H
*	20160416_RA_P1_SF_02.10971.10971.2	3.8555	0.3941	100.0	1319.691	1319.6959	6462.8	1	6.941	75.0	10	K.AGALNSNDAFVLK.T
*	20160416_RA_P1_SF_02.13595.13595.2	5.6172	0.5307	100.0	1837.8882	1837.8972	8995.5	1	9.025	73.5	4	K.TPSAAYLWVGTGASEAEK.T
*	20160416_RA_P1_SF_02.17152.17152.2	6.0003	0.5632	100.0	2273.0796	2272.0886	5994.8	1	8.966	61.9	9	R.AQPVQVAEGSEPDGFWEALGGK.A
sp|P01011|AACT_HUMAN	9	76	25.3%	423	47651	5.5	U	SERPINA3 Alpha-1-antichymotrypsin [REVIEWED] ENSG00000196136;IPI00847635;P01011;B3KVQ7;Q13703;Q2TU87;Q2TU88;Q59GP9;Q6LBY8;Q6LDT7;Q6NSC9;Q8N177;Q96DW8;Q9UC47;Q9UNU9 
*	20160416_RA_P1_SF_03.13170.13170.2	4.0542	0.4079	100.0	2047.9626	2047.9725	8826.1	1	7.99	52.8	3	K.RLYGSEAFATDFQDSAAAK.K
*	20160416_RA_P1_SF_04.13205.13205.3	4.2818	0.2131	100.0	2176.0667	2176.0674	12818.2	1	5.639	39.5	2	K.RLYGSEAFATDFQDSAAAKK.L
*	20160416_RA_P1_SF_03.06558.06558.2	2.417	0.3114	100.0	1773.762	1773.7655	5267.5	1	5.526	61.5	2	K.WEMPFDPQDTHQSR.F
*	20160416_RA_P1_SF_03.16382.16382.2	3.6228	0.3064	100.0	1789.9238	1788.924	5763.9	1	5.812	64.3	5	K.MEEVEAMLLPETLKR.W
*	20160416_RA_P1_SF_03.16186.16186.3	2.2507	0.1479	99.2	1788.9175	1788.924	6087.3	102	3.254	37.5	1	K.MEEVEAMLLPETLKR.W
*	20160416_RA_P1_SF_04.10120.10120.2	2.5056	0.0382	99.8	1108.5502	1108.554	6191.6	4	4.095	78.6	10	R.WRDSLEFR.E
*	20160416_RA_P1_SF_04.03109.03109.2	5.0249	0.3308	100.0	2298.1824	2296.1711	8708.5	1	6.525	60.5	3	R.DYNLNDILLQLGIEEAFTSK.A
*	20160416_RA_P1_SF_02.13323.13323.2	6.4835	0.5137	100.0	1908.9575	1907.9602	10098.6	1	10.274	75.0	37	K.AVLDVFEEGTEASAATAVK.I
*	20160416_RA_P1_SF_04.17655.17655.2	3.9082	0.3013	100.0	1215.7278	1215.7312	8715.6	1	6.85	90.0	13	K.ITLLSALVETR.T
sp|P27169|PON1_HUMAN	8	30	24.8%	355	39731	5.2	U	PON1 Serum paraoxonase/arylesterase 1 [REVIEWED] ENSG00000005421;IPI00218732;P27169;B2RA40;Q16052;Q6B0J6;Q9UCB1 
*	20160416_RA_P1_SF_03.01907.01907.2	4.8325	0.4886	100.0	2461.2837	2460.2874	4403.1	1	8.874	47.8	3	K.GIETGSEDLEILPNGLAFISSGLK.Y
*	20160416_RA_P1_SF_03.01760.01760.3	4.3756	0.2639	100.0	2462.2888	2460.2874	5408.8	1	5.142	31.5	1	K.GIETGSEDLEILPNGLAFISSGLK.Y
*	20160416_RA_P1_SF_05.01836.01836.3	2.2991	0.0877	97.0	3019.609	3018.604	5777.9	99	3.697	20.5	1	K.GIETGSEDLEILPNGLAFISSGLKYPGIK.S
*	20160416_RA_P1_SF_04.01311.01311.2	5.2732	0.3857	100.0	2401.255	2400.2583	9224.8	1	7.765	57.1	2	K.ILLMDLNEEDPTVLELGITGSK.F
*	20160416_RA_P1_SF_04.17103.17103.2	3.1855	0.2871	100.0	1320.7352	1319.7363	9035.5	1	6.108	80.0	3	K.YVYIAELLAHK.I
*	20160416_RA_P1_SF_04.16975.16975.3	2.24	0.243	99.6	1320.7345	1319.7363	2790.8	7	4.756	52.5	2	K.YVYIAELLAHK.I
*	20160416_RA_P1_SF_02.15165.15165.2	5.311	0.5031	100.0	1884.9124	1883.918	4517.9	1	8.93	73.3	9	K.IFFYDSENPPASEVLR.I
*	20160416_RA_P1_SF_02.09531.09531.2	3.5668	0.1717	100.0	1184.6464	1184.6527	5250.6	2	4.296	83.3	9	R.IQNILTEEPK.V
sp|P0C0L5|CO4B_HUMAN	39	177	24.1%	1744	192792	7.2	U	C4B Complement C4-B [REVIEWED] ENSG00000204319;ENSG00000236625;IPI00654875;P0C0L5;P01028;P78445;Q13160;Q13906;Q14033;Q14835;Q9NPK5;Q9UIP5 
*	20160416_RA_P1_SF_05.22235.22235.2	4.528	0.4587	100.0	2770.5896	2769.603	7297.8	1	7.634	44.0	1	R.LLLFSPSVVHLGVPLSVGVQLQDVPR.G
*	20160416_RA_P1_SF_05.22209.22209.3	4.7087	0.3934	100.0	2770.5972	2769.603	5575.2	1	7.42	36.0	2	R.LLLFSPSVVHLGVPLSVGVQLQDVPR.G
*	20160416_RA_P1_SF_04.18022.18022.2	4.4153	0.3488	100.0	1657.9479	1657.9529	7979.2	1	7.432	71.4	15	R.DFALLSLQVPLKDAK.S
*	20160416_RA_P1_SF_04.17961.17961.3	3.0439	0.2234	99.8	1657.9446	1657.9529	3859.0	1	5.52	46.4	2	R.DFALLSLQVPLKDAK.S
*	20160416_RA_P1_SF_05.12085.12085.2	3.4408	0.2819	100.0	1083.5706	1083.5734	6047.0	1	5.442	87.5	9	K.SCGLHQLLR.G
*	20160416_RA_P1_SF_05.05514.05514.2	4.8702	0.5087	100.0	1560.8511	1560.8539	7893.7	1	8.506	73.1	1	R.GPEVQLVAHSPWLK.D
*	20160416_RA_P1_SF_03.17544.17544.2	4.651	0.3849	100.0	1564.8462	1563.8495	8054.9	1	8.202	84.6	23	R.TTNIQGINLLFSSR.R
*	20160416_RA_P1_SF_04.13522.13522.2	3.0488	0.3981	100.0	1984.9808	1984.004	5636.9	1	6.765	59.4	1	R.GHLFLQTDQPIYNPGQR.V
*	20160416_RA_P1_SF_03.01970.01970.2	3.1315	0.3327	100.0	2901.3616	2900.3704	5738.0	1	5.716	35.4	2	K.EVYMPSSIFQDDFVIPDISEPGTWK.I
*	20160416_RA_P1_SF_03.06619.06619.2	1.9501	0.1207	99.7	1108.601	1108.6042	4403.3	17	3.82	75.0	1	K.YVLPNFEVK.I
*	20160416_RA_P1_SF_05.05620.05620.2	2.6373	0.386	100.0	1612.8813	1612.8851	3784.1	1	6.094	61.5	1	R.YIYGKPVQGVAYVR.F
*	20160416_RA_P1_SF_02.14788.14788.2	3.8012	0.2694	100.0	1330.7107	1330.7153	6057.5	1	7.179	90.9	4	K.LNMGITDLQGLR.L
*	20160416_RA_P1_SF_02.07238.07238.2	3.5705	0.2064	100.0	1114.6168	1114.6221	6866.7	1	5.903	94.4	23	R.VGDTLNLNLR.A
*	20160416_RA_P1_SF_05.19028.19028.2	4.5117	0.4167	100.0	2023.9725	2022.9747	8379.0	1	7.82	61.8	4	R.AVGSGATFSHYYYMILSR.G
*	20160416_RA_P1_SF_05.19053.19053.3	3.2537	0.3834	100.0	2022.9756	2022.9747	4395.3	2	6.392	39.7	3	R.AVGSGATFSHYYYMILSR.G
*	20160416_RA_P1_SF_03.10549.10549.2	2.4908	0.169	100.0	964.50024	964.50385	4277.7	1	5.377	85.7	1	R.GQIVFMNR.E
*	20160416_RA_P1_SF_02.13904.13904.2	1.8911	0.1365	99.4	1743.7814	1743.7834	5462.4	1	4.468	46.2	1	R.EPFLSCCQFAESLR.K
*	20160416_RA_P1_SF_02.18561.18561.2	3.3254	0.2752	100.0	2226.1162	2225.119	6316.4	2	6.334	44.4	1	R.ALEILQEEDLIDEDDIPVR.S
*	20160416_RA_P1_SF_04.01952.01952.2	2.857	0.409	100.0	1381.6649	1381.6693	4783.0	1	6.332	77.8	6	R.SFFPENWLWR.V
*	20160416_RA_P1_SF_03.11744.11744.2	2.6694	0.1418	100.0	1213.6678	1213.6727	5004.6	5	4.384	70.0	2	K.GLCVATPVQLR.V
*	20160416_RA_P1_SF_03.00770.00770.2	6.092	0.5239	100.0	2484.2952	2483.2993	5834.1	1	9.44	58.0	2	R.VTASDPLDTLGSEGALSPGGVASLLR.L
*	20160416_RA_P1_SF_03.00752.00752.3	4.1957	0.0886	99.7	2484.3025	2483.2993	7074.0	2	4.41	36.0	2	R.VTASDPLDTLGSEGALSPGGVASLLR.L
*	20160416_RA_P1_SF_05.01475.01475.3	2.8952	0.2786	99.9	2850.5278	2849.5374	6016.5	1	4.97	25.0	1	R.VTASDPLDTLGSEGALSPGGVASLLRLPR.G
*	20160416_RA_P1_SF_03.00659.00659.2	5.5574	0.3815	100.0	2214.1462	2212.146	6042.2	1	7.313	63.6	1	A.SDPLDTLGSEGALSPGGVASLLR.L
*	20160416_RA_P1_SF_02.19010.19010.2	3.2611	0.3142	100.0	2010.0764	2010.0872	6204.5	1	7.182	50.0	1	D.PLDTLGSEGALSPGGVASLLR.L
*	20160416_RA_P1_SF_03.16693.16693.2	4.1427	0.3633	100.0	1684.9187	1684.9233	5074.9	1	6.494	73.5	1	D.TLGSEGALSPGGVASLLR.L
*	20160416_RA_P1_SF_03.06360.06360.2	2.7537	0.078	99.8	1936.9684	1935.9703	5832.7	3	3.924	46.7	1	R.YLDKTEQWSTLPPETK.D
*	20160416_RA_P1_SF_04.12537.12537.2	3.9203	0.4644	100.0	1324.6594	1324.6649	6271.4	1	8.145	86.4	6	R.KADGSYAAWLSR.D
*	20160416_RA_P1_SF_04.12328.12328.3	3.7517	0.2317	100.0	1324.6606	1324.6649	7496.7	1	5.277	70.5	4	R.KADGSYAAWLSR.D
*	20160416_RA_P1_SF_04.01508.01508.2	3.1171	0.3097	100.0	1367.7186	1367.7211	6693.1	1	6.009	72.7	3	R.DSSTWLTAFVLK.V
*	20160416_RA_P1_SF_02.08883.08883.2	5.0501	0.4554	100.0	1541.8112	1541.8175	10621.3	1	8.438	75.0	15	K.VLSLAQEQVGGSPEK.L
*	20160416_RA_P1_SF_05.01576.01576.2	4.6681	0.3929	100.0	2780.3682	2778.3586	8123.7	1	6.6	52.1	4	R.STQDTVIALDALSAYWIASHTTEER.G
*	20160416_RA_P1_SF_05.01671.01671.3	4.0087	0.3629	100.0	2779.3516	2778.3586	5297.9	1	6.115	37.5	2	R.STQDTVIALDALSAYWIASHTTEER.G
*	20160416_RA_P1_SF_05.14504.14504.2	2.6377	0.2437	100.0	1233.6161	1233.6202	5576.1	1	5.378	75.0	10	R.VHYTVCIWR.N
*	20160416_RA_P1_SF_03.00816.00816.2	4.2592	0.4743	100.0	3502.6685	3500.6685	6510.3	1	8.016	36.7	1	R.ECVGFEAVQEVPVGLVQPASATLYDYYNPER.R
*	20160416_RA_P1_SF_03.00818.00818.3	4.1411	0.2609	100.0	3502.6677	3500.6685	8552.4	1	5.686	25.0	1	R.ECVGFEAVQEVPVGLVQPASATLYDYYNPER.R
*	20160416_RA_P1_SF_04.00589.00589.3	2.9636	0.0344	97.0	3660.7676	3656.7695	6061.4	3	2.999	21.0	2	R.ECVGFEAVQEVPVGLVQPASATLYDYYNPERR.C
*	20160416_RA_P1_SF_02.09588.09588.2	4.874	0.5235	100.0	1910.878	1909.8822	7427.5	1	8.953	59.4	16	R.LLATLCSAEVCQCAEGK.C
*	20160416_RA_P1_SF_05.05841.05841.2	2.2367	0.1569	99.9	1086.627	1086.6311	4500.1	1	4.897	81.2	1	K.ITQVLHFTK.D
sp|P02765|FETUA_HUMAN	5	18	24.0%	367	39325	5.7	U	AHSG Alpha-2-HS-glycoprotein [REVIEWED] ENSG00000145192;IPI00953689;P02765;A8K9N6;B2R7G1;O14961;O14962;Q9P152 
*	20160416_RA_P1_SF_04.02822.02822.3	4.2154	0.4679	100.0	3364.5469	3363.5479	5892.7	1	6.834	32.1	2	R.QPNCDDPETEEAALVAIDYINQNLPWGYK.H
*	20160416_RA_P1_SF_03.12310.12310.2	4.0954	0.4822	100.0	1661.7566	1660.764	7367.8	1	8.257	73.1	4	K.EHAVEGDCDFQLLK.L
*	20160416_RA_P1_SF_05.00039.00039.2	3.641	0.4738	100.0	2580.2979	2579.3066	4945.8	1	7.385	52.2	10	R.AQLVPLPPSTYVEFTVSGTDCVAK.E
*	20160416_RA_P1_SF_03.18382.18382.3	3.2885	0.1326	99.7	2581.3003	2579.3066	7922.5	4	4.433	30.4	1	R.AQLVPLPPSTYVEFTVSGTDCVAK.E
*	20160416_RA_P1_SF_04.10488.10488.2	2.4119	0.2869	100.0	2017.0687	2016.0701	4168.9	1	5.002	45.0	1	R.TVVQPSVGAAAGPVVPPCPGR.I
sp|P13645|K1C10_HUMAN	8	27	22.8%	584	58827	5.2	U	KRT10 Keratin, type I cytoskeletal 10 [REVIEWED] ENSG00000186395;IPI00009865;P13645;Q14664;Q8N175 
*	20160416_RA_P1_SF_03.12606.12606.2	4.7653	0.4206	100.0	1708.7708	1707.7727	9285.9	1	7.948	52.8	7	K.GSLGGGFSSGGFSGGSFSR.G
*	20160416_RA_P1_SF_03.14269.14269.2	5.0888	0.3508	100.0	2342.9685	2342.9849	9605.7	1	10.594	46.2	11	R.GSSGGGCFGGSSGGYGGLGGFGGGSFR.G
*	20160416_RA_P1_SF_03.00415.00415.2	4.7488	0.5058	100.0	2368.257	2367.2632	9712.5	1	9.141	57.5	2	K.NQILNLTTDNANILLQIDNAR.L
	20160416_RA_P1_SF_03.09597.09597.2	1.5015	0.0086	96.8	1357.7162	1357.7188	2548.0	278	2.992	59.1	1	R.QSVEADINGLRR.V
*	20160416_RA_P1_SF_03.01175.01175.2	4.9957	0.4555	100.0	2873.3875	2872.3933	5779.2	1	8.324	40.4	2	R.NVSTGDVNVEMNAAPGVDLTQLLNNMR.S
*	20160416_RA_P1_SF_03.01191.01191.3	4.5578	0.4198	100.0	2873.3792	2872.3933	9039.3	1	7.095	26.9	2	R.NVSTGDVNVEMNAAPGVDLTQLLNNMR.S
*	20160416_RA_P1_SF_05.00396.00396.2	3.66	0.2957	100.0	1798.0074	1797.0122	9158.1	1	5.175	53.3	1	R.NVQALEIELQSQLALK.Q
*	20160416_RA_P1_SF_04.06798.06798.2	2.189	0.2644	100.0	1435.7527	1434.7705	8049.3	1	4.866	65.0	1	K.IRLENEIQTYR.S
sp|Q14624|ITIH4_HUMAN	17	48	22.0%	930	103357	7.0	U	ITIH4 Inter-alpha-trypsin inhibitor heavy chain H4 [REVIEWED] ENSG00000055955;IPI00896419;Q14624;Q15135;Q9P190;Q9UQ54 
*	20160416_RA_P1_SF_02.13016.13016.2	4.3282	0.3372	100.0	1707.8345	1706.8423	8759.4	1	6.395	64.3	6	R.ANTVQEATFQMELPK.K
*	20160416_RA_P1_SF_03.12110.12110.2	3.7521	0.3982	100.0	1834.9258	1834.9373	9637.2	1	8.334	56.7	3	R.ANTVQEATFQMELPKK.A
*	20160416_RA_P1_SF_05.01915.01915.2	4.605	0.2982	100.0	1497.822	1496.8252	7683.8	1	6.568	86.4	2	K.ITFELVYEELLK.R
*	20160416_RA_P1_SF_03.17678.17678.2	2.8298	0.3575	100.0	1047.6425	1047.6454	3421.4	1	5.548	87.5	3	R.LGVYELLLK.V
*	20160416_RA_P1_SF_02.13775.13775.2	3.9196	0.1139	100.0	1811.9446	1811.9503	8872.2	1	5.551	60.0	1	K.SPEQQETVLDGNLIIR.Y
*	20160416_RA_P1_SF_05.00375.00375.2	2.138	0.2425	100.0	3028.4807	3027.4927	11440.1	4	5.239	22.2	1	R.AISGGSIQIENGYFVHYFAPEGLTTMPK.N
*	20160416_RA_P1_SF_05.00475.00475.3	3.7958	0.2321	100.0	3028.4849	3027.4927	8401.7	1	5.268	29.6	2	R.AISGGSIQIENGYFVHYFAPEGLTTMPK.N
*	20160416_RA_P1_SF_02.10847.10847.1	1.9744	0.1196	96.4	933.5394	933.54095	6154.5	15	5.088	71.4	1	K.NVVFVIDK.S
*	20160416_RA_P1_SF_02.10903.10903.2	1.3961	0.185	99.1	933.53687	933.54095	4362.4	3	4.011	78.6	1	K.NVVFVIDK.S
*	20160416_RA_P1_SF_05.22143.22143.3	4.8912	0.2668	100.0	3263.6597	3261.6543	11095.7	1	5.967	31.2	1	R.DQFNLIVFSTEATQWRPSLVPASAENVNK.A
*	20160416_RA_P1_SF_03.10474.10474.2	2.9635	0.3047	100.0	1656.8815	1656.8921	8183.5	2	5.606	46.7	1	K.LQDRGPDVLTATVSGK.L
*	20160416_RA_P1_SF_05.05970.05970.2	2.0374	0.1575	99.8	1256.5829	1256.5886	4576.3	2	4.531	68.8	8	K.YIFHNFMER.L
*	20160416_RA_P1_SF_05.17655.17655.2	3.1029	0.3487	100.0	1536.8308	1535.8296	6360.7	1	5.838	83.3	6	K.WKETLFSVMPGLK.M
*	20160416_RA_P1_SF_02.17223.17223.2	2.0704	0.2965	100.0	1221.6525	1221.6553	6841.8	2	4.88	65.0	2	K.ETLFSVMPGLK.M
*	20160416_RA_P1_SF_05.21231.21231.3	3.5607	0.3509	100.0	3125.499	3124.4878	4660.0	1	5.767	27.7	2	R.FSSHVGGTLGQFYQEVLWGSPAASDDGRR.T
*	20160416_RA_P1_SF_05.21673.21673.4	2.589	0.0557	96.6	3125.5132	3124.4878	8867.4	4	2.939	21.4	1	R.FSSHVGGTLGQFYQEVLWGSPAASDDGRR.T
*	20160416_RA_P1_SF_04.00468.00468.2	4.6509	0.3732	100.0	2335.1086	2334.1077	10017.6	1	8.273	52.6	7	R.RLDYQEGPPGVEISCWSVEL.-
sp|P00739|HPTR_HUMAN	9	87	21.8%	348	39030	7.1	U	HPR Haptoglobin-related protein [REVIEWED] ENSG00000205103;ENSG00000261701;IPI00607707;P00739;Q7LE20;Q92658;Q92659;Q9ULB0 
	20160416_RA_P1_SF_04.13110.13110.3	4.6269	0.0566	99.7	2378.2034	2378.2468	12338.1	1	5.473	35.5	3	R.LRTEGDGVYTLNDKKQWINK.A
	20160416_RA_P1_SF_03.12061.12061.2	2.7442	0.1727	100.0	922.46484	920.463	2951.2	1	4.733	85.7	3	K.GSFPWQAK.M
	20160416_RA_P1_SF_02.14334.14334.2	2.7117	0.2099	100.0	1290.7268	1290.731	5010.9	1	5.602	81.8	10	K.DIAPTLTLYVGK.K
	20160416_RA_P1_SF_04.13024.13024.2	3.1705	0.1918	100.0	1418.8169	1418.8259	4498.2	1	5.497	79.2	16	K.DIAPTLTLYVGKK.Q
	20160416_RA_P1_SF_04.13530.13530.2	2.4988	0.3208	99.7	1190.7094	1190.7148	8590.6	4	6.257	60.0	1	I.APTLTLYVGKK.Q
	20160416_RA_P1_SF_03.11352.11352.2	1.4839	0.1831	99.3	1044.5547	1044.5586	2490.8	1	3.919	81.2	2	R.VMPICLPSK.N
*	20160416_RA_P1_SF_02.10399.10399.2	2.5975	0.0855	99.8	1543.7157	1543.7181	12599.5	18	3.487	50.0	3	R.VGYVSGWGQSDNFK.L
	20160416_RA_P1_SF_02.09759.09759.1	1.689	0.1476	96.5	1345.6398	1345.6462	10607.7	74	4.328	50.0	3	K.SCAVAEYGVYVK.V
	20160416_RA_P1_SF_02.09388.09388.2	4.6265	0.4611	100.0	1345.6383	1345.6462	6326.1	1	9.271	86.4	46	K.SCAVAEYGVYVK.V
sp|Q7L7L0|H2A3_HUMAN	2	3	21.5%	130	14121	11.1	U	HIST3H2A Histone H2A type 3 [REVIEWED] ENSG00000181218;IPI00031562;Q7L7L0;B2R4S4 
	20160416_RA_P1_SF_03.11791.11791.2	2.6406	0.0804	99.9	944.5277	944.5318	4939.5	3	3.559	87.5	2	R.AGLQFPVGR.V
	20160416_RA_P1_SF_05.00696.00696.2	2.388	0.142	99.8	1931.1589	1931.1693	7778.4	3	4.174	44.4	1	R.VTIAQGGVLPNIQAVLLPK.K
sp|P62805|H4_HUMAN	2	17	21.4%	103	11367	11.4	U	HIST4H4 Histone H4 [REVIEWED] ENSG00000198558;ENSG00000198339;ENSG00000196176;ENSG00000124529;ENSG00000197837;ENSG00000158406;ENSG00000197914;ENSG00000198518;ENSG00000183941;ENSG00000198327;ENSG00000182217;ENSG00000197061;ENSG00000188987;ENSG00000197238;IPI00453473;P62805;A2VCL0;P02304;P02305;Q6DRA9;Q6FGB8;Q6NWP7 
*	20160416_RA_P1_SF_04.09212.09212.2	2.6523	0.0633	99.8	1325.751	1325.7542	6898.7	60	3.251	54.5	3	R.DNIQGITKPAIR.R
*	20160416_RA_P1_SF_02.09156.09156.2	3.1042	0.1792	100.0	1181.6174	1180.6213	6329.7	1	4.339	88.9	14	R.ISGLIYEETR.G
sp|P04433|KV309_HUMAN	3	10	20.9%	115	12575	4.9	U	Ig kappa chain V-III region VG [REVIEWED] ENSG00000163245;IPI00784430;P04433 
	20160416_RA_P1_SF_05.13458.13458.2	2.4659	0.3658	100.0	1792.9095	1792.9135	7163.4	1	6.88	53.6	1	S.SYLAWYQQKPGQAPR.L
	20160416_RA_P1_SF_05.13193.13193.2	4.3523	0.4295	100.0	1706.8807	1705.8815	4672.4	1	6.877	69.2	3	S.YLAWYQQKPGQAPR.L
*	20160416_RA_P1_SF_02.07701.07701.2	2.1682	0.3241	100.0	1064.5701	1064.574	6749.5	1	5.648	75.0	6	R.LLIYDASNR.A
sp|P06312|KV401_HUMAN	4	36	19.8%	121	13380	5.2	U	IGKV4-1 Ig kappa chain V-IV region [REVIEWED] ENSG00000211598;IPI00943265;P06312 
*	20160416_RA_P1_SF_03.12449.12449.2	2.3642	0.1396	99.9	1213.5934	1213.6006	10963.9	90	4.54	62.5	3	K.NYLAWYQQK.P
*	20160416_RA_P1_SF_05.14008.14008.2	4.1158	0.4195	100.0	1818.9332	1817.9338	7599.4	1	7.585	60.7	10	K.NYLAWYQQKPGQPPK.L
*	20160416_RA_P1_SF_05.14209.14209.3	2.6802	0.2154	99.6	1817.9287	1817.9338	5221.0	111	4.453	35.7	2	K.NYLAWYQQKPGQPPK.L
*	20160416_RA_P1_SF_04.14622.14622.2	3.4228	0.3461	100.0	1122.6274	1122.6311	4764.0	1	6.358	93.8	21	K.LLIYWASTR.E
sp|P04207|KV308_HUMAN	2	18	19.4%	129	14275	8.5	U	Ig kappa chain V-III region CLL [REVIEWED] ENSG00000172038;ENSG00000173799;IPI00385253;P04207 
	20160416_RA_P1_SF_03.08925.08925.2	3.0559	0.1141	100.0	993.5695	993.5733	4262.5	1	5.141	81.2	17	R.LLIYGASTR.A
*	20160416_RA_P1_SF_02.12935.12935.2	2.534	0.1971	100.0	1646.7981	1646.8026	3929.4	17	4.601	46.7	1	R.FSGSGSGTEFTLTISR.L
sp|P05109|S10A8_HUMAN	2	3	19.4%	93	10834	7.0	U	S100A8 Protein S100-A8 [REVIEWED] ENSG00000143546;IPI00007047;P05109;A8K5L3;D3DV37;Q5SY70;Q9UC84;Q9UC92;Q9UCJ0;Q9UCM6 
*	20160416_RA_P1_SF_04.12476.12476.2	1.9809	0.15	99.8	1272.6914	1272.6952	6069.2	9	4.321	55.0	1	K.ALNSIIDVYHK.Y
*	20160416_RA_P1_SF_02.10708.10708.1	1.9514	0.0801	96.8	822.4124	822.41504	6472.9	10	4.013	75.0	2	K.GADVWFK.E
sp|P02760|AMBP_HUMAN	6	29	19.3%	352	38999	6.2	U	AMBP Protein AMBP [REVIEWED] ENSG00000106927;IPI00022426;P02760;P00977;P02759;P78491;Q2TU33;Q5TBD7;Q9UC58;Q9UDI8 
*	20160416_RA_P1_SF_04.00234.00234.2	4.7072	0.3574	100.0	1709.8491	1708.8522	6218.1	1	6.933	80.8	1	K.WYNLAIGSTCPWLK.K
*	20160416_RA_P1_SF_05.17595.17595.2	2.0155	0.035	98.4	1837.9443	1836.947	8035.5	10	3.703	42.9	1	K.WYNLAIGSTCPWLKK.I
*	20160416_RA_P1_SF_02.12768.12768.2	1.8053	0.1828	99.8	1021.5273	1021.53186	6934.0	378	4.169	64.3	1	R.ETLLQDFR.V
*	20160416_RA_P1_SF_02.06993.06993.2	2.5051	0.2454	100.0	2005.0096	2005.0065	5198.8	11	5.316	41.7	1	R.VVAQGVGIPEDSIFTMADR.G
*	20160416_RA_P1_SF_03.09820.09820.2	3.65	0.2923	100.0	1213.6685	1213.6727	7804.1	1	6.412	80.0	22	R.TVAACNLPIVR.G
*	20160416_RA_P1_SF_03.12085.12085.2	3.6452	0.2548	100.0	1670.7367	1670.742	3792.1	1	6.075	82.1	3	K.CVLFPYGGCQGNGNK.F
sp|P02753|RET4_HUMAN	3	11	18.9%	201	23010	6.1	U	RBP4 Retinol-binding protein 4 [REVIEWED] ENSG00000138207;IPI00022420;P02753;D3DR38;O43478;O43479;Q5VY24;Q8WWA3;Q9P178 
*	20160416_RA_P1_SF_03.12479.12479.2	2.6399	0.2918	100.0	1161.5336	1161.5403	4970.2	1	4.956	77.8	4	R.FSGTWYAMAK.K
*	20160416_RA_P1_SF_03.17864.17864.2	2.7986	0.1527	100.0	1198.6213	1198.6261	3978.1	1	5.738	88.9	3	K.YWGVASFLQK.G
*	20160416_RA_P1_SF_02.18630.18630.2	4.7059	0.6002	100.0	2064.9624	2064.97	9888.2	1	10.858	64.7	4	R.LLNLDGTCADSYSFVFSR.D
sp|P00734|THRB_HUMAN	10	55	18.3%	622	70037	5.9	U	F2 Prothrombin [REVIEWED] ENSG00000180210;IPI00019568;P00734;B2R7F7;B4E1A7;Q4QZ40;Q53H04;Q53H06;Q7Z7P3;Q9UCA1 
*	20160416_RA_P1_SF_03.11571.11571.2	2.8822	0.1242	99.9	2214.101	2212.0127	10102.7	5	4.2	42.1	2	R.DKLAACLEGNCAEGLGTNYR.G
*	20160416_RA_P1_SF_05.16720.16720.2	4.7225	0.4743	100.0	1995.0378	1995.0486	4657.9	1	8.971	66.7	4	R.LAVTTHGLPCLAWASAQAK.A
*	20160416_RA_P1_SF_05.16712.16712.3	4.3942	0.3869	100.0	1995.0436	1995.0486	5877.0	1	6.553	43.1	2	R.LAVTTHGLPCLAWASAQAK.A
*	20160416_RA_P1_SF_02.13052.13052.2	3.628	0.4552	100.0	1561.7234	1561.7286	8870.9	1	6.989	66.7	4	R.TATSEYQTFFNPR.T
*	20160416_RA_P1_SF_03.14391.14391.2	3.9448	0.2179	100.0	1883.8928	1883.8961	8171.6	1	5.658	53.1	5	R.TFGSGEADCGLRPLFEK.K
*	20160416_RA_P1_SF_03.01684.01684.2	5.4557	0.566	100.0	2266.1055	2265.1047	6050.1	1	10.031	63.2	3	R.IVEGSDAEIGMSPWQVMLFR.K
*	20160416_RA_P1_SF_04.13664.13664.2	4.4079	0.548	100.0	1773.9174	1773.9169	8356.9	1	9.928	76.7	9	R.KSPQELLCGASLISDR.W
*	20160416_RA_P1_SF_04.13429.13429.3	2.7447	0.2384	99.8	1773.9108	1773.9169	6968.0	1	4.849	41.7	3	R.KSPQELLCGASLISDR.W
*	20160416_RA_P1_SF_02.14496.14496.2	4.1884	0.3724	100.0	1646.8165	1645.8219	8638.8	1	7.122	67.9	4	K.SPQELLCGASLISDR.W
*	20160416_RA_P1_SF_05.14208.14208.2	3.5038	0.3784	100.0	1189.5757	1189.5795	6090.9	1	7.186	81.2	19	K.YGFYTHVFR.L
sp|P04264|K2C1_HUMAN	10	56	18.3%	644	66039	8.1	U	KRT1 Keratin, type II cytoskeletal 1 [REVIEWED] ENSG00000167768;IPI00220327;P04264;B2RA01;Q14720;Q6GSJ0;Q9H298 
*	20160416_RA_P1_SF_03.09133.09133.2	5.2735	0.5275	100.0	1765.7307	1765.7352	6738.1	1	9.513	63.2	26	R.FSSCGGGGGSFGAGGGFGSR.S
*	20160416_RA_P1_SF_03.06563.06563.2	3.7687	0.4152	100.0	1383.6874	1383.6908	8125.0	1	7.223	81.8	4	K.SLNNQFASFIDK.V
	20160416_RA_P1_SF_02.08934.08934.2	4.0827	0.2814	100.0	1475.7802	1475.7858	10533.1	1	6.648	81.8	3	R.FLEQQNQVLQTK.W
*	20160416_RA_P1_SF_02.14257.14257.2	3.4725	0.2792	100.0	1475.7467	1475.7494	4470.9	1	6.474	72.7	2	K.WELLQQVDTSTR.T
*	20160416_RA_P1_SF_02.10209.10209.2	2.2119	0.2757	100.0	1300.527	1300.5302	5303.1	5	5.556	66.7	2	K.NMQDMVEDYR.N
*	20160416_RA_P1_SF_03.09268.09268.2	2.433	0.3611	100.0	1393.7292	1393.7327	6535.1	15	6.057	45.5	4	R.TNAENEFVTIKK.D
*	20160416_RA_P1_SF_03.00010.00010.2	4.3309	0.3458	100.0	1302.7104	1302.7157	6961.1	1	7.263	86.4	3	R.SLDLDSIIAEVK.A
*	20160416_RA_P1_SF_04.10092.10092.2	3.1877	0.5126	100.0	1844.9402	1844.9467	9374.4	1	8.178	56.7	4	K.KQISNLQQSISDAEQR.G
*	20160416_RA_P1_SF_04.12171.12171.2	2.8244	0.0793	99.8	1523.7832	1523.7892	6779.6	2	4.901	63.6	7	R.LLRDYQELMNTK.L
*	20160416_RA_P1_SF_04.12356.12356.3	2.9715	0.1374	99.7	1523.7811	1523.7892	10274.3	8	4.123	45.5	1	R.LLRDYQELMNTK.L
sp|P35858|ALS_HUMAN	9	11	18.3%	605	66035	6.8	U	IGFALS Insulin-like growth factor-binding protein complex acid labile subunit [REVIEWED] ENSG00000099769;IPI00020996;P35858 
*	20160416_RA_P1_SF_04.01608.01608.2	4.0773	0.3577	100.0	1761.9824	1761.9904	4128.7	1	6.857	70.0	1	R.LAYLQPALFSGLAELR.E
*	20160416_RA_P1_SF_05.00763.00763.2	3.0927	0.2961	100.0	1454.869	1454.8735	6356.8	1	5.777	60.7	1	R.NLIAAVAPGAFLGLK.A
*	20160416_RA_P1_SF_03.05582.05582.3	2.0564	0.1872	99.3	1796.1145	1795.0958	6974.9	6	4.185	32.4	1	R.NLIAAVAPGAFLGLKALR.W
*	20160416_RA_P1_SF_04.01967.01967.2	4.228	0.5236	100.0	1670.9436	1670.9481	5581.8	1	9.178	73.3	1	R.VAGLLEDTFPGLLGLR.V
*	20160416_RA_P1_SF_02.14081.14081.2	2.3007	0.175	100.0	1006.59247	1006.5937	5815.9	1	4.449	85.7	1	K.LEYLLLSR.N
*	20160416_RA_P1_SF_02.14111.14111.2	3.9533	0.4665	100.0	1463.8185	1463.8221	5566.4	1	8.202	73.1	2	R.LAELPADALGPLQR.A
*	20160416_RA_P1_SF_04.13748.13748.2	3.2791	0.2724	100.0	1245.6151	1244.6177	6124.9	1	5.511	83.3	1	R.AFWLDVSHNR.L
*	20160416_RA_P1_SF_03.17310.17310.2	2.785	0.1522	100.0	1464.8468	1463.8585	6923.1	6	5.322	53.8	1	R.LEALPNSLLAPLGR.L
*	20160416_RA_P1_SF_02.17912.17912.2	3.5287	0.4377	100.0	1844.8447	1844.8464	6047.8	1	7.331	64.3	2	R.LWLEGNPWDCGCPLK.A
sp|P02746|C1QB_HUMAN	5	10	17.8%	253	26722	8.6	U	C1QB Complement C1q subcomponent subunit B [REVIEWED] ENSG00000173369;IPI00477992;P02746;Q5T959;Q96H17 
*	20160416_RA_P1_SF_05.16424.16424.2	3.3927	0.5053	100.0	1661.812	1660.8124	7196.9	1	8.215	69.2	3	K.VPGLYYFTYHASSR.G
*	20160416_RA_P1_SF_05.16433.16433.3	2.8179	0.3596	100.0	1660.8033	1660.8124	3988.1	2	6.271	44.2	1	K.VPGLYYFTYHASSR.G
*	20160416_RA_P1_SF_03.11211.11211.2	2.7832	0.1838	100.0	1076.5312	1076.5345	5684.2	1	5.346	75.0	4	R.GNLCVNLMR.G
*	20160416_RA_P1_SF_05.01358.01358.2	4.524	0.3684	100.0	2515.2014	2514.2048	10616.4	1	8.182	50.0	1	K.VVTFCDYAYNTFQVTTGGMVLK.L
*	20160416_RA_P1_SF_05.01351.01351.3	3.321	0.1027	99.4	2515.1934	2514.2048	8042.1	2	4.494	31.0	1	K.VVTFCDYAYNTFQVTTGGMVLK.L
sp|P00747|PLMN_HUMAN	12	64	17.7%	810	90569	7.2	U	PLG Plasminogen [REVIEWED] ENSG00000122194;IPI00019580;P00747;Q15146;Q5TEH4;Q6PA00 
*	20160416_RA_P1_SF_04.11729.11729.2	2.8269	0.2978	100.0	1136.6106	1136.6138	7222.2	1	5.163	81.2	10	R.MRDVVLFEK.K
*	20160416_RA_P1_SF_02.13351.13351.2	2.4966	0.2209	100.0	1088.516	1088.5199	6087.4	2	4.718	92.9	5	R.WELCDIPR.C
*	20160416_RA_P1_SF_02.09851.09851.2	4.4938	0.4269	100.0	1901.8285	1900.8322	4626.1	1	8.231	66.7	6	K.TPENYPNAGLTMNYCR.N
*	20160416_RA_P1_SF_03.13390.13390.2	3.1169	0.3965	100.0	2062.9243	2062.9292	5980.9	1	6.899	52.9	6	R.NPDADKGPWCFTTDPSVR.W
*	20160416_RA_P1_SF_03.13343.13343.3	2.7913	0.1963	99.6	2063.927	2062.9292	8803.8	2	4.851	36.8	1	R.NPDADKGPWCFTTDPSVR.W
*	20160416_RA_P1_SF_02.10814.10814.2	5.4592	0.4411	100.0	1906.816	1905.819	6642.2	1	8.705	75.0	12	R.NPDGDVGGPWCYTTNPR.K
*	20160416_RA_P1_SF_04.13332.13332.2	5.1302	0.4083	100.0	2497.3179	2496.321	5771.4	1	7.345	50.0	3	K.VILGAHQEVNLEPHVQEIEVSR.L
*	20160416_RA_P1_SF_04.13224.13224.3	5.5544	0.4333	100.0	2497.3135	2496.321	6648.3	1	7.036	44.0	7	K.VILGAHQEVNLEPHVQEIEVSR.L
*	20160416_RA_P1_SF_03.00067.00067.2	5.5797	0.5642	100.0	2274.0823	2273.0913	8441.9	1	10.343	60.0	5	R.TECFITGWGETQGTFGAGLLK.E
*	20160416_RA_P1_SF_02.09346.09346.2	1.7227	0.1462	99.7	898.4371	898.44226	3844.5	7	4.544	75.0	1	R.YEFLNGR.V
	20160416_RA_P1_SF_03.17791.17791.2	3.6908	0.3692	100.0	1680.8534	1680.8531	7436.3	1	7.308	67.9	1	K.YILQGVTSWGLGCAR.P
*	20160416_RA_P1_SF_03.18121.18121.2	3.7176	0.3793	100.0	1237.6353	1237.6404	6384.8	1	6.962	94.4	7	R.FVTWIEGVMR.N
sp|P04003|C4BPA_HUMAN	8	35	17.3%	597	67033	7.3	U	C4BPA C4b-binding protein alpha chain [REVIEWED] ENSG00000123838;IPI00021727;P04003 
*	20160416_RA_P1_SF_03.17909.17909.2	3.8061	0.5066	100.0	2389.1428	2389.153	6102.6	1	8.319	52.4	4	G.NCGPPPTLSFAAPMDITLTETR.F
*	20160416_RA_P1_SF_05.05533.05533.2	3.5704	0.2591	100.0	1707.8647	1706.8688	5057.8	1	5.241	60.7	1	R.GVGWSHPLPQCEIVK.C
*	20160416_RA_P1_SF_05.16732.16732.2	3.5036	0.4356	100.0	2226.0688	2225.07	7505.4	1	8.084	50.0	7	R.KPDVSHGEMVSGFGPIYNYK.D
*	20160416_RA_P1_SF_05.16940.16940.3	3.3723	0.2437	100.0	2226.071	2225.07	9103.6	1	4.778	35.5	8	R.KPDVSHGEMVSGFGPIYNYK.D
*	20160416_RA_P1_SF_02.09681.09681.2	3.6325	0.3975	100.0	1582.7089	1581.712	10278.0	1	7.52	65.4	8	R.FSAICQGDGTWSPR.T
*	20160416_RA_P1_SF_02.10484.10484.2	1.7932	0.1654	99.8	1019.5164	1019.5202	2831.6	2	4.399	71.4	1	R.TWYPEVPK.C
*	20160416_RA_P1_SF_02.10396.10396.2	3.386	0.341	100.0	1443.6912	1443.6976	5102.7	1	6.061	77.3	5	R.LMQCLPNPEDVK.M
*	20160416_RA_P1_SF_02.15799.15799.2	3.8419	0.1882	100.0	1470.813	1470.8168	9817.4	1	5.44	77.3	1	K.LSLEIEQLELQR.D
sp|P05546|HEP2_HUMAN	7	20	17.2%	499	57071	6.9	U	SERPIND1 Heparin cofactor 2 [REVIEWED] ENSG00000099937;IPI00879573;P05546;B2RAI1;D3DX34;Q6IBZ5 
*	20160416_RA_P1_SF_04.15622.15622.2	3.2544	0.4935	100.0	1406.7377	1406.7432	5671.6	1	8.057	80.0	8	K.YEITTIHNLFR.K
*	20160416_RA_P1_SF_03.10365.10365.2	1.9904	0.0284	99.0	870.44415	870.4474	4233.5	41	3.348	83.3	1	R.NFGYTLR.S
*	20160416_RA_P1_SF_04.00600.00600.2	1.5439	0.0705	98.0	1120.636	1120.6406	4381.9	30	3.515	62.5	1	K.QFPILLDFK.T
*	20160416_RA_P1_SF_05.00791.00791.2	4.3744	0.3019	100.0	2314.081	2312.0764	10534.8	1	5.768	52.6	2	R.EYYFAEAQIADFSDPAFISK.T
*	20160416_RA_P1_SF_03.01910.01910.2	5.4803	0.4527	100.0	2501.1875	2500.1926	6878.6	1	9.114	57.5	3	K.DALENIDPATQMMILNCIYFK.G
*	20160416_RA_P1_SF_02.11333.11333.2	2.6122	0.1075	100.0	1079.5702	1079.5737	6272.8	15	4.387	75.0	2	K.NYNLVESLK.L
*	20160416_RA_P1_SF_03.14125.14125.2	3.0243	0.2651	100.0	1084.5244	1084.5283	4648.1	2	6.749	81.2	3	R.TSCLLFMGR.V
sp|P07737|PROF1_HUMAN	2	3	17.1%	140	15054	8.3	U	PFN1 Profilin-1 [REVIEWED] ENSG00000108518;IPI00216691;P07737;Q53Y44 
*	20160416_RA_P1_SF_03.17961.17961.2	3.7519	0.2999	100.0	1644.9379	1643.9373	5796.6	1	6.313	63.3	2	K.TFVNITPAEVGVLVGK.D
*	20160416_RA_P1_SF_03.13945.13945.2	1.7401	0.0936	99.0	874.54016	874.5436	3858.3	2	3.532	85.7	1	K.TLVLLMGK.E
sp|P35527|K1C9_HUMAN	7	31	17.0%	623	62064	5.2	U	KRT9 Keratin, type I cytoskeletal 9 [REVIEWED] ENSG00000171403;IPI00019359;P35527;O00109;Q0IJ47;Q14665 
*	20160416_RA_P1_SF_03.15265.15265.2	4.3194	0.5294	100.0	2706.1538	2705.1616	8583.0	1	10.396	30.6	3	R.GGGGSFGYSYGGGSGGGFSASSLGGGFGGGSR.G
*	20160416_RA_P1_SF_05.01437.01437.2	3.3236	0.3454	100.0	2904.413	2902.4111	8554.2	1	6.719	37.5	1	K.NYSPYYNTIDDLKDQIVDLTVGNNK.T
*	20160416_RA_P1_SF_04.02335.02335.3	4.5276	0.3332	100.0	2903.401	2902.4111	3922.4	1	7.132	33.3	7	K.NYSPYYNTIDDLKDQIVDLTVGNNK.T
*	20160416_RA_P1_SF_02.09843.09843.2	2.979	0.1216	100.0	1060.5592	1060.5638	4408.7	2	4.498	87.5	10	K.TLLDIDNTR.M
*	20160416_RA_P1_SF_04.11178.11178.2	2.656	0.2312	100.0	1307.6721	1307.6782	4788.2	2	4.792	72.2	7	R.IKFEMEQNLR.Q
*	20160416_RA_P1_SF_02.08743.08743.2	2.3851	0.2348	100.0	1157.5872	1157.5914	3508.1	26	5.024	65.0	2	R.QGVDADINGLR.Q
*	20160416_RA_P1_SF_04.00499.00499.3	2.6105	0.1239	99.2	2300.1206	2299.12	5263.4	34	3.499	29.2	1	K.SDLEMQYETLQEELMALKK.N
sp|P02751|FINC_HUMAN	27	95	16.6%	2386	262622	5.7	U	FN1 Fibronectin [REVIEWED] ENSG00000115414;IPI00867588;P02751;O95609;O95610;Q14312;Q14325;Q14326;Q17RV7;Q585T2;Q59EH1;Q60FE4;Q68DP8;Q68DP9;Q68DT4;Q6LDP6;Q6MZS0;Q6MZU5;Q6N025;Q6N0A6;Q86T27;Q8IVI8;Q96KP7;Q96KP8;Q96KP9;Q9H1B8;Q9HAP3;Q9UMK2 
*	20160416_RA_P1_SF_03.06533.06533.2	4.2568	0.4178	100.0	1792.8138	1791.8158	8146.5	1	6.933	56.7	3	R.TYLGNALVCTCYGGSR.G
*	20160416_RA_P1_SF_03.16067.16067.3	3.3525	0.2758	100.0	2905.2139	2903.2253	9189.8	1	4.989	28.3	1	R.GFNCESKPEAEETCFDKYTGNTYR.V
*	20160416_RA_P1_SF_03.12501.12501.2	4.0302	0.2711	100.0	1462.6838	1462.6895	7961.1	1	8.446	79.2	5	R.GNLLQCICTGNGR.G
*	20160416_RA_P1_SF_03.11233.11233.2	3.0016	0.3044	100.0	1727.8132	1726.8223	10263.7	1	5.357	53.8	4	K.YSFCTDHTVLVQTR.G
*	20160416_RA_P1_SF_02.13596.13596.2	3.3057	0.2483	100.0	1483.6918	1483.7003	9834.2	2	5.588	63.6	3	R.GEWTCIAYSQLR.D
*	20160416_RA_P1_SF_05.16146.16146.3	2.284	0.1041	97.7	2800.4753	2799.4792	3736.4	182	3.523	20.8	1	K.GLKPGVVYEGQLISIQQYGHQEVTR.F
*	20160416_RA_P1_SF_04.00295.00295.3	6.211	0.4728	100.0	3776.837	3774.86	9949.8	1	8.238	28.8	1	R.VEYELSEEGDEPQYLDLPSTATSVNIPDLLPGRK.Y
*	20160416_RA_P1_SF_05.12037.12037.2	2.9938	0.3595	100.0	1431.7444	1431.7498	4697.3	1	6.364	68.2	7	R.WSRPQAPITGYR.I
*	20160416_RA_P1_SF_05.11879.11879.3	2.4435	0.2679	99.9	1431.7439	1431.7498	6156.8	17	4.12	43.2	2	R.WSRPQAPITGYR.I
*	20160416_RA_P1_SF_02.15979.15979.2	3.3048	0.4392	100.0	1807.903	1807.9053	4000.8	1	7.45	66.7	3	K.VTIMWTPPESAVTGYR.V
*	20160416_RA_P1_SF_02.18473.18473.2	4.0535	0.4795	100.0	1994.9846	1993.9911	6612.4	1	8.273	64.7	2	R.NTFAEVTGLSPGVTYYFK.V
*	20160416_RA_P1_SF_03.06569.06569.2	3.8222	0.4163	100.0	1733.9481	1732.9485	3917.2	1	7.478	63.3	6	R.NLQPASEYTVSLVAIK.G
*	20160416_RA_P1_SF_05.00168.00168.2	1.7281	0.105	98.7	3043.5977	3042.59	9230.5	35	3.659	20.4	1	K.VVTPLSPPTNLHLEANPDTGVLTVSWER.S
*	20160416_RA_P1_SF_05.00203.00203.3	3.0637	0.2346	99.8	3043.5754	3042.59	7677.3	4	5.185	23.1	1	K.VVTPLSPPTNLHLEANPDTGVLTVSWER.S
*	20160416_RA_P1_SF_04.01742.01742.2	3.7543	0.3417	100.0	1927.0435	1926.049	3863.4	1	6.589	75.0	2	R.VTWAPPPSIDLTNFLVR.Y
*	20160416_RA_P1_SF_02.18599.18599.2	5.7371	0.5458	100.0	2296.069	2295.0781	10299.3	1	9.68	57.1	1	K.TGLDSPTGIDFSDITANSFTVH.W
*	20160416_RA_P1_SF_05.01213.01213.2	3.616	0.5073	100.0	2919.419	2918.4324	6261.0	1	8.765	32.7	1	K.TGLDSPTGIDFSDITANSFTVHWIAPR.A
*	20160416_RA_P1_SF_05.01334.01334.3	4.9536	0.4577	100.0	2919.4268	2918.4324	4981.5	1	8.394	34.6	1	K.TGLDSPTGIDFSDITANSFTVHWIAPR.A
*	20160416_RA_P1_SF_05.01963.01963.2	5.21	0.5171	100.0	2525.3633	2524.3662	7213.3	1	9.951	56.5	2	R.DLEVVAATPTSLLISWDAPAVTVR.Y
*	20160416_RA_P1_SF_03.11030.11030.2	2.1366	0.113	99.7	1349.6793	1349.6854	5172.5	7	4.305	68.2	10	K.WLPSSSPVTGYR.V
*	20160416_RA_P1_SF_03.17693.17693.2	4.9621	0.5409	100.0	2693.3672	2692.3735	4255.7	1	9.037	50.0	3	K.FTQVTPTSLSAQWTPPNVQLTGYR.V
*	20160416_RA_P1_SF_04.17846.17846.2	3.0896	0.2865	100.0	2118.1133	2117.1165	5067.6	1	5.954	42.5	2	K.EINLAPDSSSVVVSGLMVATK.Y
*	20160416_RA_P1_SF_02.11131.11131.2	3.555	0.2935	100.0	1355.6909	1355.6959	8210.0	1	6.266	90.0	10	K.IYLYTLNDNAR.S
*	20160416_RA_P1_SF_04.17799.17799.2	4.2164	0.4853	100.0	1928.0398	1927.0442	6800.3	2	8.333	46.9	6	R.FLATTPNSLLVSWQPPR.A
*	20160416_RA_P1_SF_04.17913.17913.3	4.8727	0.3452	100.0	1929.0415	1927.0442	9208.6	1	6.103	48.4	2	R.FLATTPNSLLVSWQPPR.A
*	20160416_RA_P1_SF_03.14739.14739.2	3.0144	0.3045	100.0	1182.6603	1182.6635	5876.2	1	5.913	94.4	1	N.SLLVSWQPPR.A
*	20160416_RA_P1_SF_03.09710.09710.2	3.6547	0.5356	100.0	1461.7866	1461.7913	7096.2	1	10.052	67.9	14	R.VPGTSTSATLTGLTR.G
sp|Q08380|LG3BP_HUMAN	7	19	16.6%	585	65331	5.3	U	LGALS3BP Galectin-3-binding protein [REVIEWED] ENSG00000108679;IPI00023673;Q08380;Q7M4S0;Q9UCH8;Q9UCH9;Q9UCI0 
*	20160416_RA_P1_SF_03.00526.00526.2	3.9882	0.4782	100.0	2452.1	2452.1025	8884.5	1	8.269	45.0	1	R.GQWGTVCDNLWDLTDASVVCR.A
*	20160416_RA_P1_SF_02.16709.16709.2	3.776	0.4241	100.0	1592.7909	1592.792	7319.2	1	7.805	69.2	2	R.ELSEALGQIFDSQR.G
*	20160416_RA_P1_SF_04.11169.11169.2	1.9681	0.0491	98.8	1131.6688	1131.6737	6924.5	54	4.214	61.1	2	R.RIDITLSSVK.C
*	20160416_RA_P1_SF_05.20043.20043.2	3.6172	0.3267	100.0	1984.1017	1984.102	6641.8	5	6.52	43.8	4	K.TLQALEFHTVPFQLLAR.Y
*	20160416_RA_P1_SF_05.20048.20048.3	2.967	0.0254	97.5	1986.1056	1984.102	6271.4	36	3.333	35.9	3	K.TLQALEFHTVPFQLLAR.Y
*	20160416_RA_P1_SF_04.00155.00155.2	3.7074	0.4261	100.0	2163.0134	2162.0195	9332.6	1	7.763	50.0	3	R.IYTSPTWSAFVTDSSWSAR.K
*	20160416_RA_P1_SF_05.13618.13618.2	1.6654	0.2165	99.7	1768.7771	1768.7865	6032.4	5	4.731	40.0	4	K.STSSFPCPAGHFNGFR.T
sp|P04004|VTNC_HUMAN	9	38	16.3%	478	54306	5.8	U	VTN Vitronectin [REVIEWED] ENSG00000262062;ENSG00000255604;ENSG00000109072;IPI00298971;P04004;B2R7G0;P01141;Q9BSH7 
*	20160416_RA_P1_SF_03.00619.00619.2	4.3102	0.4678	100.0	1646.8138	1646.8179	6775.0	1	8.088	78.6	4	R.DVWGIEGPIDAAFTR.I
*	20160416_RA_P1_SF_02.11324.11324.2	3.9353	0.2035	100.0	1422.6489	1422.6542	6516.7	1	6.239	81.8	7	R.FEDGVLDPDYPR.N
	20160416_RA_P1_SF_03.06767.06767.2	2.2511	0.2146	100.0	1007.5288	1007.5348	8112.8	1	4.7	81.2	1	R.IYISGMAPR.P
	20160416_RA_P1_SF_03.10106.10106.2	2.5743	0.2176	96.9	1192.6182	1191.6196	7952.8	3	4.574	65.0	1	R.IYISGMAPRPS.L
	20160416_RA_P1_SF_03.13283.13283.2	2.5459	0.2318	97.6	1304.6989	1304.7036	8520.3	9	4.815	54.5	1	R.IYISGMAPRPSL.A
	20160416_RA_P1_SF_05.13328.13328.2	3.5823	0.3444	100.0	1503.8319	1503.8357	9956.1	1	7.297	61.5	4	R.IYISGMAPRPSLAK.K
	20160416_RA_P1_SF_04.02377.02377.2	3.5595	0.3627	100.0	2575.194	2574.2048	3846.7	1	6.391	45.2	1	R.MDWLVPATCEPIQSVFFFSGDK.Y
*	20160416_RA_P1_SF_03.15633.15633.2	3.2066	0.3051	100.0	1558.7335	1556.732	8464.8	1	5.406	57.7	1	R.SIAQYWLGCPAPGH.L
*	20160416_RA_P1_SF_04.14967.14967.2	3.9536	0.3667	100.0	1670.8154	1669.816	9173.8	1	7.748	57.1	18	R.SIAQYWLGCPAPGHL.-
sp|P61626|LYSC_HUMAN	2	3	16.2%	148	16537	9.1	U	LYZ Lysozyme C [REVIEWED] ENSG00000090382;IPI00019038;P61626;P00695;Q13170;Q9UCF8 
*	20160416_RA_P1_SF_05.00204.00204.2	3.1902	0.3502	100.0	1364.6844	1363.6866	8387.0	1	5.792	77.3	2	R.GISLANWMCLAK.W
*	20160416_RA_P1_SF_02.06967.06967.2	2.3136	0.0103	98.9	1401.6685	1400.681	4940.7	12	3.523	63.6	1	R.STDYGIFQINSR.Y
sp|P51884|LUM_HUMAN	4	7	16.0%	338	38429	6.6	U	LUM Lumican [REVIEWED] ENSG00000139329;IPI00020986;P51884;B2R6R5;Q96QM7 
*	20160416_RA_P1_SF_03.10260.10260.2	3.7367	0.32	100.0	1297.6707	1297.6752	10622.1	1	6.025	80.0	3	K.SLEDLQLTHNK.I
*	20160416_RA_P1_SF_02.18536.18536.2	4.2434	0.3743	100.0	1668.8547	1668.8597	7420.1	1	6.874	69.2	1	K.SLEYLDLSFNQIAR.L
*	20160416_RA_P1_SF_03.15239.15239.2	2.6663	0.2849	100.0	1024.5524	1024.558	6364.5	2	4.97	85.7	2	R.FNALQYLR.L
*	20160416_RA_P1_SF_02.18640.18640.2	2.8355	0.3873	100.0	2536.2527	2536.257	3781.6	1	6.094	45.0	1	K.NIPTVNENLENYYLEVNQLEK.F
sp|P01871|IGHM_HUMAN	7	35	15.9%	452	49307	6.8	U	IGHM Ig mu chain C region [REVIEWED] ENSG00000130076;IPI00896380;P01871;P20769 
*	20160416_RA_P1_SF_04.16145.16145.2	2.5695	0.2021	100.0	1386.831	1386.836	3660.8	8	4.874	62.5	5	K.NVPLPVIAELPPK.V
*	20160416_RA_P1_SF_03.10180.10180.2	2.6175	0.2663	100.0	900.5264	900.5307	4003.1	2	5.343	78.6	5	K.VSVFVPPR.D
*	20160416_RA_P1_SF_05.12078.12078.2	2.4951	0.288	100.0	1464.7609	1464.7633	8096.5	1	6.357	62.5	2	K.SKLICQATGFSPR.Q
*	20160416_RA_P1_SF_03.09604.09604.2	2.8561	0.2033	100.0	1249.631	1249.6364	6965.4	1	5.276	80.0	3	K.LICQATGFSPR.Q
*	20160416_RA_P1_SF_03.13869.13869.2	1.8356	0.0606	98.9	1029.5806	1029.5846	2977.8	2	4.168	71.4	1	R.QIQVSWLR.E
*	20160416_RA_P1_SF_05.22739.22739.2	2.3817	0.3297	100.0	1637.9279	1637.9307	3058.5	4	5.756	57.1	1	R.VFAIPPSFASIFLTK.S
*	20160416_RA_P1_SF_04.11152.11152.2	4.6402	0.4419	100.0	1716.8578	1716.863	7397.0	1	8.592	71.4	18	R.FTCTVTHTDLPSPLK.Q
sp|P02750|A2GL_HUMAN	4	7	15.9%	347	38178	7.0	U	LRG1 Leucine-rich alpha-2-glycoprotein [REVIEWED] ENSG00000171236;IPI00022417;P02750;Q8N4F5;Q96QZ4 
*	20160416_RA_P1_SF_05.01206.01206.2	4.4257	0.3756	100.0	1895.005	1894.0074	10712.7	1	6.896	66.7	2	K.ENQLEVLEVSWLHGLK.A
*	20160416_RA_P1_SF_03.12119.12119.1	2.1291	0.0484	97.2	968.5147	968.52057	4782.4	1	4.286	71.4	1	R.YLFLNGNK.L
*	20160416_RA_P1_SF_03.09868.09868.2	3.4203	0.2684	100.0	989.5499	989.5532	7345.9	1	6.22	94.4	3	R.VAAGAFQGLR.Q
*	20160416_RA_P1_SF_03.00603.00603.2	4.9513	0.5076	100.0	2486.1052	2485.1094	7635.1	1	8.827	57.5	1	R.DGFDISGNPWICDQNLSDLYR.W
sp|P05160|F13B_HUMAN	7	15	15.7%	661	75511	6.4	U	F13B Coagulation factor XIII B chain [REVIEWED] ENSG00000143278;IPI00007240;P05160;A8K3E5;Q5VYL5 
*	20160416_RA_P1_SF_04.15106.15106.2	2.1612	0.0437	99.0	1362.6721	1362.6768	8677.7	91	3.697	50.0	1	K.SFYFPMSIDKK.L
*	20160416_RA_P1_SF_04.00070.00070.2	3.7498	0.4237	100.0	1708.7963	1708.8004	8543.2	1	8.03	64.3	1	K.LSFFCLAGYTTESGR.Q
*	20160416_RA_P1_SF_03.09770.09770.2	2.3641	0.1943	100.0	1697.8208	1696.8217	6379.6	42	4.503	46.4	1	K.CTKPDLSNGYISDVK.L
*	20160416_RA_P1_SF_04.09369.09369.2	3.5586	0.4657	100.0	1720.8026	1720.8077	8232.2	1	8.532	57.1	5	K.SGYLLHGSNEITCNR.G
*	20160416_RA_P1_SF_04.14608.14608.2	2.6554	0.4164	100.0	1415.7296	1415.7357	7042.0	1	6.949	81.8	5	K.VLHGDLIDFVCK.Q
*	20160416_RA_P1_SF_02.18274.18274.2	2.0176	0.0859	99.0	2278.1184	2277.1184	7648.0	48	3.954	28.9	1	K.QGYDLSPLTPLSELSVQCNR.G
*	20160416_RA_P1_SF_02.18547.18547.2	3.7087	0.3749	100.0	1768.9075	1768.9121	6876.4	1	7.493	56.7	1	R.GDTYPAELYITGSILR.M
sp|P04196|HRG_HUMAN	6	25	14.7%	525	59578	7.5	U	HRG Histidine-rich glycoprotein [REVIEWED] ENSG00000113905;IPI00022371;P04196;B9EK35;D3DNU7 
*	20160416_RA_P1_SF_04.09714.09714.2	1.9886	0.0478	99.0	942.5696	942.57367	5775.1	8	3.459	78.6	1	K.ALDLINKR.R
*	20160416_RA_P1_SF_03.00264.00264.2	2.9696	0.1338	100.0	1125.6091	1124.6105	5890.6	1	5.138	87.5	2	R.DGYLFQLLR.I
*	20160416_RA_P1_SF_03.01032.01032.2	4.6857	0.4964	100.0	1682.7881	1682.7914	6051.4	1	8.655	76.9	7	K.DSPVLIDFFEDTER.Y
*	20160416_RA_P1_SF_02.15254.15254.2	3.687	0.4038	100.0	1490.6849	1490.6915	6499.7	1	7.479	69.2	11	R.GGEGTGYFVDFSVR.N
*	20160416_RA_P1_SF_03.00299.00299.2	4.5666	0.4356	100.0	1825.8882	1824.8907	6179.3	1	7.6	76.7	3	R.ADLFYDVEALDLESPK.N
*	20160416_RA_P1_SF_05.20857.20857.2	2.4417	0.2725	100.0	1857.8922	1857.8998	7223.3	4	5.53	40.0	1	K.SGFPQVSMFFTHTFPK.-
sp|P29622|KAIN_HUMAN	5	10	14.5%	427	48542	7.8	U	SERPINA4 Kallistatin [REVIEWED] ENSG00000100665;IPI00328609;P29622;Q53XB5;Q86TR9;Q96BZ5 
*	20160416_RA_P1_SF_02.13303.13303.2	3.0413	0.2717	100.0	1388.7046	1388.7102	4990.2	1	5.911	72.7	1	R.FYYLIASETPGK.N
*	20160416_RA_P1_SF_05.13704.13704.2	3.3516	0.2448	100.0	1285.7228	1285.7268	6098.1	1	5.423	68.2	5	R.VGSALFLSHNLK.F
*	20160416_RA_P1_SF_02.16983.16983.2	2.6598	0.2045	100.0	1506.7921	1506.7957	6838.2	1	5.235	57.7	1	K.GDATVFFILPNQGK.M
*	20160416_RA_P1_SF_05.01067.01067.2	2.9367	0.2154	100.0	1694.9049	1694.9117	9595.2	3	4.461	57.1	1	K.FSISGSYVLDQILPR.L
*	20160416_RA_P1_SF_02.17723.17723.2	2.8239	0.2413	100.0	1028.5481	1027.5464	5515.6	1	4.59	93.8	2	R.LGFTDLFSK.W
sp|P00736|C1R_HUMAN	5	6	14.2%	705	80119	6.2	U	C1R Complement C1r subcomponent [REVIEWED] ENSG00000159403;IPI00296165;P00736;A6NJQ8;Q68D77;Q8J012 
*	20160416_RA_P1_SF_05.00588.00588.3	2.5386	0.0275	95.1	3487.7915	3485.7996	9161.7	1	3.221	21.7	1	K.LFGEVTSPLFPKPYPNNFETTTVITVPTGYR.V
*	20160416_RA_P1_SF_03.00438.00438.2	4.1703	0.3339	100.0	2485.143	2484.1433	4809.8	1	6.588	52.6	1	K.LVFQQFDLEPSEGCFYDYVK.I
*	20160416_RA_P1_SF_03.00463.00463.2	2.5669	0.2842	100.0	2255.1504	2254.151	5797.4	5	5.078	38.2	1	K.TLDEFTIIQNLQPQYQFR.D
*	20160416_RA_P1_SF_03.13587.13587.2	3.3667	0.2889	100.0	1667.8303	1667.8328	5853.5	1	6.032	61.5	2	R.LPVANPQACENWLR.G
*	20160416_RA_P1_SF_04.15705.15705.2	2.3248	0.3286	100.0	1969.8701	1968.8771	9541.6	1	5.309	43.8	1	R.MDVFSQNMFCAGHPSLK.Q
sp|P00915|CAH1_HUMAN	3	4	14.2%	261	28870	7.1	U	CA1 Carbonic anhydrase 1 [REVIEWED] ENSG00000133742;IPI00215983;P00915 
*	20160416_RA_P1_SF_02.10200.10200.2	2.6196	0.2694	100.0	1742.9022	1742.9077	7144.4	1	5.874	56.7	1	K.LYPIANGNNQSPVDIK.T
*	20160416_RA_P1_SF_04.00150.00150.2	2.8421	0.2828	100.0	1186.681	1186.6869	8814.6	1	5.368	68.2	1	K.ADGLAVIGVLMK.V
*	20160416_RA_P1_SF_02.11453.11453.2	2.2974	0.1507	100.0	970.5906	970.5937	4512.1	1	3.714	87.5	2	K.VLDALQAIK.T
sp|P10909|CLUS_HUMAN	5	12	13.6%	449	52495	6.3	U	CLU Clusterin [REVIEWED] ENSG00000120885;IPI00978715;P10909;B2R9Q1;B3KSE6;P11380;P11381;Q2TU75;Q5HYC1;Q7Z5B9 
*	20160416_RA_P1_SF_04.09693.09693.2	1.4988	0.0166	96.8	1576.8479	1575.8495	7567.8	50	3.327	50.0	1	K.YVNKEIQNAVNGVK.Q
*	20160416_RA_P1_SF_04.11168.11168.2	3.0364	0.2302	100.0	1245.7003	1245.7054	7075.0	2	6.051	75.0	7	R.KTLLSNLEEAK.K
*	20160416_RA_P1_SF_05.06012.06012.2	2.5509	0.3398	100.0	1373.7971	1373.8004	7867.6	31	5.711	54.5	1	R.KTLLSNLEEAKK.K
*	20160416_RA_P1_SF_03.00180.00180.2	3.8617	0.3506	100.0	1393.6908	1393.6963	6696.5	1	7.459	81.8	2	R.ASSIIDELFQDR.F
*	20160416_RA_P1_SF_03.06320.06320.2	4.4301	0.4221	100.0	2314.1643	2314.1777	7637.2	1	7.681	47.7	1	R.VTTVASHTSDSDVPSGVTEVVVK.L
sp|P01042|KNG1_HUMAN	8	25	13.5%	644	71957	6.8	U	KNG1 Kininogen-1 [REVIEWED] ENSG00000113889;IPI00215894;P01042;A8K474;B2RCR2;P01043;Q53EQ0;Q6PAU9;Q7M4P1 
*	20160416_RA_P1_SF_03.11345.11345.2	2.336	0.1746	100.0	1003.5649	1003.5689	2932.4	7	4.296	68.8	2	R.QVVAGLNFR.I
*	20160416_RA_P1_SF_02.16028.16028.2	3.9126	0.3487	100.0	1384.6611	1383.6619	6933.3	1	5.886	80.0	6	K.ENFLFLTPDCK.S
*	20160416_RA_P1_SF_02.08721.08721.2	1.952	0.1273	99.4	1600.7424	1599.7477	5654.3	79	3.49	38.5	1	R.IASFSQNCDIYPGK.D
*	20160416_RA_P1_SF_03.13424.13424.2	3.4366	0.3448	100.0	2513.2102	2512.2183	5726.5	1	6.995	38.1	4	R.IASFSQNCDIYPGKDFVQPPTK.I
*	20160416_RA_P1_SF_03.13333.13333.3	3.9803	0.261	100.0	2513.2073	2512.2183	7831.1	1	6.381	34.5	6	R.IASFSQNCDIYPGKDFVQPPTK.I
*	20160416_RA_P1_SF_03.15355.15355.2	2.49	0.2037	100.0	2139.078	2139.082	5578.1	1	4.141	41.7	1	R.DIPTNSPELEETLTHTITK.L
*	20160416_RA_P1_SF_02.15508.15508.2	2.6983	0.1908	100.0	1030.5315	1030.5361	3179.5	1	5.121	92.9	4	K.YFIDFVAR.E
*	20160416_RA_P1_SF_02.12608.12608.2	2.114	0.0582	98.9	2107.0117	2107.017	7555.5	1	3.554	38.2	1	K.LGQSLDCNAEVYVVPWEK.K
sp|P08571|CD14_HUMAN	3	4	13.3%	375	40076	6.2	U	CD14 Monocyte differentiation antigen CD14 [REVIEWED] ENSG00000170458;IPI00029260;P08571;Q53XT5;Q96FR6;Q96L99;Q9UNS3 
*	20160416_RA_P1_SF_05.01810.01810.2	3.9055	0.4364	100.0	2139.1975	2138.1895	4651.3	1	7.34	50.0	1	K.ITGTMPPLPLEATGLALSSLR.L
*	20160416_RA_P1_SF_02.17209.17209.2	3.3578	0.331	100.0	1973.9783	1972.998	8480.9	1	6.303	52.8	1	R.AFPALTSLDLSDNPGLGER.G
*	20160416_RA_P1_SF_04.14946.14946.2	2.7706	0.2528	100.0	1142.6635	1142.6686	7060.1	2	5.907	88.9	2	K.FPAIQNLALR.N
sp|P07358|CO8B_HUMAN	5	11	13.0%	591	67047	8.1	U	C8B Complement component C8 beta chain [REVIEWED] ENSG00000021852;IPI00294395;P07358;A1L4K7 
*	20160416_RA_P1_SF_04.12420.12420.2	2.5387	0.3441	100.0	1545.7653	1545.7701	6307.0	1	5.986	54.5	3	K.RLPLEYSYGEYR.D
*	20160416_RA_P1_SF_02.10125.10125.2	2.1856	0.2981	100.0	1390.6681	1389.6691	5862.4	1	5.757	60.0	4	R.LPLEYSYGEYR.D
*	20160416_RA_P1_SF_04.10555.10555.2	1.6283	0.0141	97.3	1057.5986	1057.6006	5940.4	81	2.736	50.0	1	R.GILNEIKDR.N
*	20160416_RA_P1_SF_05.01703.01703.3	5.244	0.4772	100.0	3931.9153	3930.9224	9351.9	1	8.144	25.0	2	R.GGASEHITTLAYQELPTADLMQEWGDAVQYNPAIIK.V
*	20160416_RA_P1_SF_04.02260.02260.2	2.894	0.3531	100.0	2263.132	2261.134	7412.8	1	5.824	44.7	1	K.VEPLYELVTATDFAYSSTVR.Q
sp|Q96PD5|PGRP2_HUMAN	4	15	13.0%	576	62217	7.5	U	PGLYRP2 N-acetylmuramoyl-L-alanine amidase [REVIEWED] ENSG00000161031;IPI00394992;Q96PD5;A8K8C7;B2RMZ2;Q68CK1;Q96N74;Q9UC60 
*	20160416_RA_P1_SF_04.02618.02618.2	4.3466	0.4778	100.0	2882.5376	2881.531	6047.0	1	9.125	41.1	2	K.EYGVVLAPDGSTVAVEPLLAGLEAGLQGR.R
*	20160416_RA_P1_SF_04.01841.01841.2	4.7603	0.5078	100.0	1894.0005	1894.0074	7809.6	1	8.742	61.8	3	M.AFLNGALDGVILGDYLSR.T
*	20160416_RA_P1_SF_04.14000.14000.2	3.5115	0.3466	100.0	1744.8403	1744.8481	7280.9	1	7.549	50.0	8	K.EFTEAFLGCPAIHPR.C
*	20160416_RA_P1_SF_03.00878.00878.2	4.0946	0.4033	100.0	1492.7065	1492.7106	4810.0	1	7.433	75.0	2	R.TDCPGDALFDLLR.T
sp|P13796|PLSL_HUMAN	7	11	12.9%	627	70289	5.4	U	LCP1 Plastin-2 [REVIEWED] ENSG00000136167;IPI00010471;P13796;B2R613;Q5TBN4 
*	20160416_RA_P1_SF_03.01095.01095.2	2.8586	0.2496	100.0	2161.005	2161.009	5212.6	4	5.192	38.9	2	K.VDTDGNGYISFNELNDLFK.A
	20160416_RA_P1_SF_03.15635.15635.2	2.2337	0.154	99.9	1154.5936	1154.5999	7114.8	1	4.848	81.2	1	K.YAFVNWINK.A
*	20160416_RA_P1_SF_04.12939.12939.2	3.95	0.3731	100.0	1431.7573	1431.7637	6432.6	1	6.614	72.7	3	K.AYYHLLEQVAPK.G
*	20160416_RA_P1_SF_04.12838.12838.3	2.1976	0.1375	99.2	1432.7594	1431.7637	4836.3	15	4.112	43.2	1	K.AYYHLLEQVAPK.G
*	20160416_RA_P1_SF_05.22921.22921.2	2.3627	0.1749	100.0	1405.7919	1405.7955	8386.6	1	5.352	63.6	1	K.LNLAFIANLFNR.Y
*	20160416_RA_P1_SF_02.18313.18313.2	4.4533	0.4052	100.0	1534.8042	1534.8116	7203.2	1	7.949	73.1	2	R.YTLNILEEIGGGQK.V
*	20160416_RA_P1_SF_03.01663.01663.2	4.6907	0.4509	100.0	1800.925	1799.9292	6690.2	1	8.312	71.4	1	K.VNDDIIVNWVNETLR.E
sp|P01031|CO5_HUMAN	17	33	12.5%	1676	188304	6.5	U	C5 Complement C5 [REVIEWED] ENSG00000106804;IPI00032291;P01031;Q14CJ0;Q27I61 
*	20160416_RA_P1_SF_03.11623.11623.2	3.7647	0.2972	100.0	1360.7621	1359.7637	10329.9	1	5.58	77.3	3	K.FQNSAILTIQPK.Q
*	20160416_RA_P1_SF_03.12671.12671.2	2.3143	0.202	100.0	898.4465	898.4497	5378.4	1	4.837	91.7	2	R.YGMWTIK.A
*	20160416_RA_P1_SF_05.00509.00509.2	3.1892	0.3502	100.0	2532.251	2531.2498	8229.2	2	6.218	40.0	1	K.EYVLPHFSVSIEPEYNFIGYK.N
*	20160416_RA_P1_SF_05.00436.00436.3	3.3745	0.2116	99.8	2532.251	2531.2498	7164.0	10	4.56	31.2	1	K.EYVLPHFSVSIEPEYNFIGYK.N
*	20160416_RA_P1_SF_05.13792.13792.2	2.5221	0.2692	100.0	1364.7551	1364.7578	5106.5	1	5.84	75.0	7	K.ITHYNYLILSK.G
*	20160416_RA_P1_SF_05.21475.21475.2	3.3169	0.2751	100.0	2046.0387	2045.0284	8438.8	1	5.878	50.0	3	R.SYFPESWLWEVHLVPR.R
*	20160416_RA_P1_SF_03.00341.00341.2	3.4658	0.3836	100.0	1681.861	1681.8623	5481.6	1	7.276	65.4	1	K.DVFLEMNIPYSVVR.G
*	20160416_RA_P1_SF_05.00608.00608.2	4.0042	0.4395	100.0	1437.7427	1437.749	8243.2	1	7.236	73.1	2	K.GGSASTWLTAFALR.V
*	20160416_RA_P1_SF_02.12929.12929.2	2.0671	0.038	99.0	1062.5596	1062.5658	6957.4	34	3.653	68.8	1	K.AFDICPLVK.I
*	20160416_RA_P1_SF_04.01476.01476.2	3.7741	0.2393	100.0	1768.9579	1767.9567	7333.7	1	6.192	56.7	1	R.MVETTAYALLTSLNLK.D
*	20160416_RA_P1_SF_05.01389.01389.3	2.9213	0.1219	99.5	1767.9504	1767.9567	6419.1	2	4.419	40.0	1	R.MVETTAYALLTSLNLK.D
*	20160416_RA_P1_SF_03.00078.00078.2	4.7993	0.4141	100.0	1839.9523	1838.954	9359.8	1	7.369	66.7	1	K.ALVEGVDQLFTDYQIK.D
*	20160416_RA_P1_SF_05.00101.00101.2	2.8955	0.1867	100.0	2270.154	2270.1604	6116.1	2	5.746	39.5	1	K.DGHVILQLNSIPSSDFLCVR.F
*	20160416_RA_P1_SF_04.17721.17721.2	3.0085	0.4224	100.0	1535.8619	1535.8685	12055.5	1	7.427	57.7	3	K.VSITSITVENVFVK.Y
*	20160416_RA_P1_SF_02.12380.12380.2	1.8924	0.165	99.8	936.53674	936.5406	4548.7	8	3.4	71.4	3	K.ATLLDIYK.T
*	20160416_RA_P1_SF_03.11438.11438.2	1.2995	0.0318	96.8	833.3927	833.3946	4620.7	338	2.607	70.0	1	K.YNFSFR.Y
*	20160416_RA_P1_SF_03.04350.04350.2	1.7932	0.22	99.8	3000.2656	2998.2544	10002.5	9	4.75	24.0	1	R.DTTCSSCQAFLANLDEFAEDIFLNGC.-
sp|P00748|FA12_HUMAN	5	9	12.4%	615	67792	7.7	U	F12 Coagulation factor XII [REVIEWED] ENSG00000131187;IPI00019581;P00748;P78339 
*	20160416_RA_P1_SF_05.13380.13380.3	2.7505	0.1906	99.7	2329.048	2328.0579	10042.3	4	3.98	30.3	1	K.GRPGPQPWCATTPNFDQDQR.W
*	20160416_RA_P1_SF_02.10933.10933.2	3.1491	0.2797	100.0	1995.9049	1995.9235	5665.8	1	6.057	50.0	3	R.TTLSGAPCQPWASEATYR.N
*	20160416_RA_P1_SF_05.14154.14154.2	1.8552	0.1207	99.4	1274.5824	1274.5853	6863.9	1	4.053	70.0	1	R.NWGLGGHAFCR.N
*	20160416_RA_P1_SF_03.11328.11328.2	2.9535	0.2067	100.0	883.5685	883.57294	3462.2	1	5.084	87.5	2	R.VVGGLVALR.G
*	20160416_RA_P1_SF_05.17190.17190.2	2.8588	0.3682	100.0	2097.0872	2096.0928	9032.1	1	7.12	50.0	2	R.LHEAFSPVSYQHDLALLR.L
sp|P05155|IC1_HUMAN	6	18	12.4%	500	55154	6.5	U	SERPING1 Plasma protease C1 inhibitor [REVIEWED] ENSG00000149131;IPI00291866;P05155;A6NMU0;A8KAI9;B2R6L5;Q16304;Q547W3;Q59EI5;Q7Z455;Q96FE0;Q9UC49;Q9UCF9 
*	20160416_RA_P1_SF_02.15340.15340.2	3.7641	0.2649	100.0	1264.6731	1264.6788	9160.2	1	6.804	85.0	3	K.TNLESILSYPK.D
*	20160416_RA_P1_SF_04.16271.16271.2	4.4196	0.3603	100.0	1826.9691	1826.9764	6060.2	1	7.245	56.2	3	K.GVTSVSQIFHSPDLAIR.D
*	20160416_RA_P1_SF_04.16175.16175.3	3.2363	0.3395	100.0	1827.9745	1826.9764	5833.8	1	6.975	43.8	3	K.GVTSVSQIFHSPDLAIR.D
*	20160416_RA_P1_SF_05.00298.00298.2	4.3712	0.4375	100.0	1317.8116	1317.8146	7832.8	1	7.552	86.4	3	R.LVLLNAIYLSAK.W
*	20160416_RA_P1_SF_05.12899.12899.2	2.2072	0.0959	99.6	1348.712	1347.7129	6288.5	28	4.102	54.5	3	K.NSVIKVPMMNSK.K
*	20160416_RA_P1_SF_04.14448.14448.2	2.0811	0.1216	99.7	1186.6991	1185.6996	4019.6	2	3.73	72.2	3	K.FQPTLLTLPR.I
sp|P08254|MMP3_HUMAN	5	6	11.5%	477	53977	6.2	U	MMP3 Stromelysin-1 [REVIEWED] ENSG00000263313;ENSG00000149968;IPI00027782;P08254;B2R8B8;Q3B7S0;Q6GRF8 
	20160416_RA_P1_SF_03.12683.12683.2	2.6115	0.2044	100.0	964.5496	963.5515	4144.7	1	4.678	93.8	2	K.FLGLEVTGK.L
*	20160416_RA_P1_SF_03.06344.06344.2	2.5305	0.1361	99.8	2075.0627	2074.0708	4891.0	3	5.037	41.7	1	R.IVNYTPDLPKDAVDSAVEK.A
	20160416_RA_P1_SF_02.15177.15177.2	2.8194	0.0215	99.7	1465.7528	1463.7534	6526.7	11	3.27	63.6	1	K.VWEEVTPLTFSR.L
*	20160416_RA_P1_SF_02.17890.17890.1	1.8571	0.1244	96.3	881.50793	881.5137	7215.3	3	4.396	75.0	1	K.DLVFIFK.G
*	20160416_RA_P1_SF_03.13361.13361.2	2.3505	0.1277	99.9	991.5069	991.51135	6848.4	1	3.712	85.7	1	K.GNQFWAIR.G
sp|P02748|CO9_HUMAN	6	9	11.4%	559	63173	5.6	U	C9 Complement component C9 [REVIEWED] ENSG00000113600;IPI00022395;P02748 
*	20160416_RA_P1_SF_04.02370.02370.2	3.5535	0.3994	100.0	3251.4868	3249.4985	8911.7	1	6.733	32.1	1	R.TAGYGINILGMDPLSTPFDNEFYNGLCNR.D
*	20160416_RA_P1_SF_04.02351.02351.3	2.4482	0.2328	99.6	3250.4963	3249.4985	11522.9	1	4.717	22.3	1	R.TAGYGINILGMDPLSTPFDNEFYNGLCNR.D
*	20160416_RA_P1_SF_04.10748.10748.2	1.9488	0.0329	98.4	1523.7025	1523.7018	8717.9	1	4.262	68.2	1	R.TEHYEEQIEAFK.S
*	20160416_RA_P1_SF_03.15661.15661.2	2.5079	0.3923	100.0	1242.739	1242.7462	3027.3	1	5.96	85.0	1	K.LSPIYNLVPVK.M
*	20160416_RA_P1_SF_03.15608.15608.2	2.6026	0.1833	95.4	1042.6244	1042.6301	4992.6	3	5.295	75.0	1	S.PIYNLVPVK.M
*	20160416_RA_P1_SF_02.16723.16723.2	4.2513	0.433	100.0	1455.7081	1455.712	7933.7	1	8.624	81.8	4	R.AIEDYINEFSVR.K
sp|P01019|ANGT_HUMAN	6	11	11.3%	485	53154	6.3	U	AGT Angiotensinogen [REVIEWED] ENSG00000135744;IPI00032220;P01019;Q16358;Q16359;Q96F91 
*	20160416_RA_P1_SF_02.11641.11641.2	1.9204	0.0733	98.9	1297.6926	1297.7156	5527.9	1	2.957	68.2	1	K.DPTFIPAPIQAK.T
*	20160416_RA_P1_SF_05.01444.01444.3	2.5803	0.1538	99.5	1724.0201	1723.0231	8085.3	17	3.956	34.4	1	K.VLSALQAVQGLLVAQGR.A
*	20160416_RA_P1_SF_05.00626.00626.2	4.287	0.4715	100.0	1899.0854	1898.0903	5921.6	1	7.982	62.5	2	K.QPFVQGLALYTPVVLPR.S
*	20160416_RA_P1_SF_05.00651.00651.3	4.9205	0.4081	100.0	1899.086	1898.0903	5404.4	1	6.9	45.3	2	K.QPFVQGLALYTPVVLPR.S
*	20160416_RA_P1_SF_03.11873.11873.1	1.8527	0.1767	95.2	1067.5299	1067.5348	6552.3	1	4.365	68.8	2	R.FMQAVTGWK.T
*	20160416_RA_P1_SF_03.11966.11966.2	2.6917	0.2404	100.0	1067.528	1067.5348	5071.5	1	5.62	87.5	3	R.FMQAVTGWK.T
sp|P54819|KAD2_HUMAN	2	2	11.3%	239	26478	7.8	U	AK2 Adenylate kinase 2, mitochondrial [REVIEWED] ENSG00000004455;IPI00922165;P54819;A8K6L1;B4DHH7;B4DL64;Q16856;Q5EB54;Q5TIF7;Q8TCY2;Q8TCY3 
*	20160416_RA_P1_SF_03.16522.16522.2	2.6697	0.2694	100.0	1135.5864	1135.59	6348.0	1	5.815	77.8	1	K.NGFLLDGFPR.T
*	20160416_RA_P1_SF_03.05858.05858.4	1.8282	0.0882	95.3	1974.1913	1973.1072	9667.9	322	3.126	29.2	1	K.LDSVIEFSIPDSLLIRR.I
sp|P19827|ITIH1_HUMAN	6	17	11.2%	911	101389	6.8	U	ITIH1 Inter-alpha-trypsin inhibitor heavy chain H1 [REVIEWED] ENSG00000055957;IPI00292530;P19827;A8K9N5;B2RAH9;P78455;Q01746;Q562G1 
*	20160416_RA_P1_SF_05.05332.05332.2	4.8787	0.4828	100.0	2007.0089	2006.0095	8872.5	1	8.249	70.6	2	R.FAHYVVTSQVVNTANEAR.E
*	20160416_RA_P1_SF_04.02651.02651.2	3.3167	0.297	100.0	2159.0857	2157.069	3895.5	1	6.198	55.6	2	K.ILGDMQPGDYFDLVLFGTR.V
*	20160416_RA_P1_SF_02.17621.17621.2	5.9524	0.4362	100.0	2003.9994	2004.015	11364.9	1	9.66	63.9	3	K.GSLVQASEANLQAAQDFVR.G
*	20160416_RA_P1_SF_02.15573.15573.2	4.9722	0.4637	100.0	1676.8549	1676.8607	7760.0	1	8.377	70.0	6	R.GFSLDEATNLNGGLLR.G
*	20160416_RA_P1_SF_05.22710.22710.2	4.4178	0.4591	100.0	1561.9128	1561.8994	8865.5	1	9.11	83.3	1	R.LWAYLTIQELLAK.R
*	20160416_RA_P1_SF_03.00776.00776.2	3.9997	0.2735	100.0	1920.9409	1917.9454	5311.4	1	5.379	59.4	3	Q.MSLDYGFVTPLTSMSIR.G
Reverse_sp|Q9UNK0|STX8_HUMAN	2	2	11.0%	236	26907	5.0	U	STX8 Syntaxin-8 [REVIEWED] ENSG00000170310;IPI00009225;Q9UNK0;O60712;Q53XT8 
*	20160416_RA_P1_SF_02.12345.12345.3	2.4694	0.0756	98.6	1477.8606	1471.7869	5549.2	98	3.751	36.4	1	R.ERTVLDDLLNQR.R
*	20160416_RA_P1_SF_02.15325.15325.2	1.6762	0.0545	97.7	1625.9789	1623.0321	2475.2	183	2.942	30.8	1	K.LLAIKEKLNQLLAR.I
sp|P02743|SAMP_HUMAN	2	18	10.3%	223	25387	6.5	U	APCS Serum amyloid P-component [REVIEWED] ENSG00000132703;IPI00022391;P02743 
*	20160416_RA_P1_SF_03.11816.11816.2	3.8653	0.396	100.0	1407.6656	1406.6704	8485.6	1	7.215	81.8	16	R.AYSLFSYNTQGR.D
*	20160416_RA_P1_SF_05.01030.01030.2	3.0433	0.2707	100.0	1287.7863	1286.7876	4899.9	2	5.085	70.0	2	R.GYVIIKPLVWV.-
sp|P04114|APOB_HUMAN	32	75	10.0%	4563	515611	7.0	U	APOB Apolipoprotein B-100 [REVIEWED] ENSG00000084674;IPI00022229;P04114;O00502;P78479;P78480;P78481;Q13779;Q13785;Q13786;Q13787;Q13788;Q4ZG63;Q53QC8;Q7Z600;Q9UMN0 
*	20160416_RA_P1_SF_03.00677.00677.2	3.2371	0.1229	100.0	1676.9159	1674.9141	3257.2	1	3.851	80.8	3	K.VELEVPQLCSFILK.T
*	20160416_RA_P1_SF_02.17843.17843.2	2.7551	0.3115	100.0	1666.9238	1666.9268	4380.9	10	5.143	43.3	3	R.GIISALLVPPETEEAK.Q
*	20160416_RA_P1_SF_03.15893.15893.2	3.1803	0.3284	100.0	1012.63605	1012.6406	3310.3	1	5.856	94.4	2	R.TGISPLALIK.G
*	20160416_RA_P1_SF_02.15891.15891.2	3.6419	0.2167	100.0	1889.9489	1888.9513	7238.4	1	4.752	62.5	1	R.VIGNMGQTMEQLTPELK.S
*	20160416_RA_P1_SF_04.16070.16070.2	3.0423	0.1918	100.0	1081.5858	1081.5902	5738.8	1	6.064	93.8	6	R.LAAYLMLMR.S
*	20160416_RA_P1_SF_03.15174.15174.2	2.9673	0.1155	100.0	1724.9293	1723.9382	3934.3	1	3.822	65.4	6	K.IVQILPWEQNEQVK.N
*	20160416_RA_P1_SF_05.05560.05560.3	5.6259	0.4185	100.0	2612.3726	2611.373	9681.2	1	7.675	36.4	1	K.NFVASHIANILNSEELDIQDLKK.L
*	20160416_RA_P1_SF_02.18870.18870.2	3.8466	0.179	100.0	1748.9081	1746.9066	5843.3	1	4.7	64.3	3	K.IEGNLIFDPNNYLPK.E
*	20160416_RA_P1_SF_03.00453.00453.2	3.4568	0.2574	100.0	1308.6785	1308.684	4263.0	1	6.649	77.3	2	K.GFEPTLEALFGK.Q
*	20160416_RA_P1_SF_02.09573.09573.2	2.0552	0.1707	99.8	1139.559	1138.5533	3317.4	1	3.849	77.8	3	K.QGFFPDSVNK.A
*	20160416_RA_P1_SF_04.09856.09856.2	2.6739	0.2155	100.0	1178.6158	1178.621	6293.5	2	4.829	72.2	5	K.VLVDHFGYTK.D
*	20160416_RA_P1_SF_05.01314.01314.2	4.7839	0.3958	100.0	2053.125	2053.1333	9716.2	1	7.778	55.6	2	R.ILGEELGFASLHDLQLLGK.L
*	20160416_RA_P1_SF_05.01333.01333.3	2.6609	0.2702	99.9	2053.126	2053.1333	2797.0	2	4.781	38.9	2	R.ILGEELGFASLHDLQLLGK.L
*	20160416_RA_P1_SF_04.10960.10960.2	3.7189	0.3237	100.0	1238.6483	1238.6533	7873.5	1	7.084	85.0	6	R.SEILAHWSPAK.L
*	20160416_RA_P1_SF_05.12774.12774.2	3.0255	0.2766	100.0	999.53564	999.5376	5459.4	1	5.324	87.5	5	K.SVGFHLPSR.E
*	20160416_RA_P1_SF_02.16660.16660.2	2.3867	0.2503	100.0	1306.7019	1306.7047	3768.0	9	4.939	70.0	2	R.EFQVPTFTIPK.L
*	20160416_RA_P1_SF_04.00929.00929.2	3.6235	0.3916	100.0	2376.2769	2375.2822	4743.8	1	6.68	47.5	1	K.QTVNLQLQPYSLVTTLNSDLK.Y
*	20160416_RA_P1_SF_05.13781.13781.2	1.7011	0.1133	98.8	1582.828	1581.8276	6714.5	4	3.84	42.9	1	K.HIYAISSAALSASYK.A
*	20160416_RA_P1_SF_04.13317.13317.2	3.0643	0.1557	100.0	1603.8335	1602.828	9641.9	1	4.583	61.5	1	K.LALWGEHTGQLYSK.F
*	20160416_RA_P1_SF_02.11632.11632.2	2.9897	0.2143	100.0	1453.8031	1452.8062	9047.8	10	4.36	54.2	3	R.LNGEIQALELPQK.A
*	20160416_RA_P1_SF_02.18355.18355.2	5.6861	0.504	100.0	1929.8988	1928.9031	10609.9	1	8.917	80.0	1	K.NLTDFAEQYSIQDWAK.R
*	20160416_RA_P1_SF_03.00690.00690.2	4.0285	0.3966	100.0	1834.9739	1833.9751	5321.7	1	6.245	73.3	2	K.ATFQTPDFIVPLTDLR.I
*	20160416_RA_P1_SF_02.10287.10287.2	3.2391	0.1924	100.0	1286.7268	1286.7319	6693.8	1	4.292	81.8	2	K.NTLELSNGVIVK.I
*	20160416_RA_P1_SF_03.18444.18444.2	3.284	0.3494	100.0	2530.2212	2529.226	5748.7	1	7.032	34.1	1	K.NSLFFSAQPFEITASTNNEGNLK.V
*	20160416_RA_P1_SF_05.22416.22416.3	4.9462	0.4114	100.0	2244.332	2243.3167	9270.5	1	7.246	39.5	1	R.VPSYTLILPSLELPVLHVPR.N
*	20160416_RA_P1_SF_04.12098.12098.2	2.2162	0.0898	99.7	1263.6305	1263.6373	7591.1	10	3.898	61.1	3	R.IYSLWEHSTK.N
*	20160416_RA_P1_SF_03.17914.17914.2	3.2864	0.2675	100.0	1616.884	1616.8899	5845.7	1	6.134	64.3	2	R.TSSFALNLPTLPEVK.F
*	20160416_RA_P1_SF_02.11873.11873.2	2.187	0.1643	99.9	1047.5667	1047.5726	6865.4	37	4.156	75.0	1	K.FPEVDVLTK.Y
*	20160416_RA_P1_SF_03.01498.01498.2	4.2054	0.4217	100.0	2467.3704	2466.3748	6550.0	1	7.124	57.1	1	K.IADFELPTIIVPEQTIEIPSIK.F
*	20160416_RA_P1_SF_05.01386.01386.2	2.9897	0.3765	100.0	1874.0502	1874.054	5279.4	1	6.315	50.0	1	K.FSVPAGIVIPSFQALTAR.F
*	20160416_RA_P1_SF_03.00487.00487.2	3.8743	0.3436	100.0	1746.8893	1746.8914	8109.9	1	7.383	66.7	1	K.VNWEEEAASGLLTSLK.D
*	20160416_RA_P1_SF_04.00897.00897.2	4.1133	0.2856	100.0	1706.864	1705.8649	7422.4	1	6.416	67.9	1	R.NIQEYLSILTDPDGK.G
sp|P05156|CFAI_HUMAN	4	8	9.9%	583	65750	7.5	U	CFI Complement factor I [REVIEWED] ENSG00000205403;IPI00291867;P05156;O60442 
*	20160416_RA_P1_SF_02.17068.17068.2	4.2673	0.5716	100.0	1730.71	1730.7155	5984.7	1	9.533	67.9	1	K.ADSPMDDFFQCVNGK.Y
*	20160416_RA_P1_SF_02.17526.17526.2	1.7942	0.1461	99.4	1438.8037	1438.8058	8918.6	12	4.0	50.0	1	R.AQLGDLPWQVAIK.D
*	20160416_RA_P1_SF_03.15111.15111.2	3.2717	0.1401	100.0	1192.6322	1192.6366	5451.3	1	5.437	88.9	5	R.VFSLQWGEVK.L
*	20160416_RA_P1_SF_05.22022.22022.2	3.5678	0.4076	100.0	2463.1921	2462.1934	7802.9	1	7.247	42.1	1	K.VANYFDWISYHVGRPFISQY.N
sp|P02741|CRP_HUMAN	2	7	9.8%	224	25039	5.6	U	CRP C-reactive protein [REVIEWED] ENSG00000132693;IPI00218876;P02741;A8K078;D3DVD9;D3DVE0;Q08AK3;Q8WW75 
*	20160416_RA_P1_SF_05.12141.12141.2	2.3065	0.2609	100.0	836.50085	836.5034	3032.2	1	5.025	100.0	6	R.KAFVFPK.E
*	20160416_RA_P1_SF_02.17701.17701.2	2.043	0.0197	98.2	1820.9149	1820.9224	7523.4	18	3.27	39.3	1	K.YEVQGEVFTKPQLWP.-
sp|P02788|TRFL_HUMAN	5	9	9.7%	710	78182	8.1	U	LTF Lactotransferrin [REVIEWED] ENSG00000012223;IPI00298860;P02788;B7Z4X2;E7EQH5;O00756;Q16780;Q16785;Q16786;Q16789;Q8IU92;Q8IZH6;Q8TCD2;Q96KZ4;Q96KZ5;Q9H1Z3;Q9UCY5 
*	20160416_RA_P1_SF_02.08681.08681.2	2.7905	0.2976	100.0	1590.7559	1590.7587	9679.7	1	6.101	73.1	2	R.SVQWCAVSQPEATK.C
*	20160416_RA_P1_SF_03.13329.13329.2	2.3033	0.0412	99.3	1195.6062	1195.6111	6206.8	2	3.67	75.0	2	K.FQLFGSPSGQK.D
*	20160416_RA_P1_SF_04.00916.00916.2	3.4654	0.3243	100.0	2089.0728	2088.0767	9770.7	1	7.149	55.6	1	R.IDSGLYLGSGYFTAIQNLR.K
*	20160416_RA_P1_SF_02.11949.11949.2	3.23	0.3172	100.0	1445.7112	1445.7211	6269.3	1	5.597	77.3	1	R.VVWCAVGEQELR.K
*	20160416_RA_P1_SF_02.12361.12361.2	2.896	0.3054	100.0	1579.7473	1579.7539	8209.3	2	6.234	62.5	3	K.NLLFNDNTECLAR.L
sp|O75636|FCN3_HUMAN	2	6	9.7%	299	32903	6.7	U	FCN3 Ficolin-3 [REVIEWED] ENSG00000142748;IPI00419744;O75636;Q6IBJ5;Q8WW86 
*	20160416_RA_P1_SF_05.01384.01384.2	2.1087	0.0095	98.2	2300.0618	2298.0688	8553.8	104	3.389	28.9	1	R.ALPVFCDMDTEGGGWLVFQR.R
*	20160416_RA_P1_SF_05.11965.11965.2	1.442	0.0095	96.8	1113.5447	1113.5481	7033.9	1	3.896	62.5	5	R.TFAHYATFR.L
sp|P13671|CO6_HUMAN	7	11	9.4%	934	104786	6.8	U	C6 Complement component C6 [REVIEWED] ENSG00000039537;IPI00879709;P13671 
*	20160416_RA_P1_SF_04.01188.01188.2	4.2503	0.488	100.0	2654.1116	2653.1196	7949.1	1	8.731	52.4	1	R.CPINCLLGDFGPWSDCDPCIEK.Q
*	20160416_RA_P1_SF_04.01227.01227.3	2.9823	0.0632	98.5	2655.1252	2653.1196	9082.8	25	4.143	25.0	1	R.CPINCLLGDFGPWSDCDPCIEK.Q
*	20160416_RA_P1_SF_04.16066.16066.2	2.2734	0.0772	99.7	1186.6431	1186.6472	7045.2	5	3.891	77.8	2	K.DLHLSDVFLK.A
*	20160416_RA_P1_SF_03.16664.16664.2	3.0328	0.1813	100.0	1225.6067	1225.6105	5124.0	1	5.617	83.3	1	K.TFSEWLESVK.E
*	20160416_RA_P1_SF_03.02236.02236.2	5.1588	0.4792	100.0	2011.0999	2010.0912	5940.3	1	8.016	64.7	2	K.ENPAVIDFELAPIVDLVR.N
*	20160416_RA_P1_SF_02.12230.12230.2	2.6556	0.319	100.0	2344.0364	2343.0386	5132.6	1	6.196	39.5	2	R.YTCQGNSWTPPISNSLTCEK.D
*	20160416_RA_P1_SF_02.11942.11942.2	1.8577	0.1077	99.5	1030.5282	1030.5322	3019.9	11	3.461	71.4	2	R.QLEWGLER.T
sp|P05164|PERM_HUMAN	5	15	9.3%	745	83869	9.0	U	MPO Myeloperoxidase [REVIEWED] ENSG00000005381;IPI00236556;P05164;A1L4B8;Q14862;Q4PJH5;Q9UCL7 
*	20160416_RA_P1_SF_03.15022.15022.2	3.3344	0.3645	100.0	1152.6111	1152.6166	5171.7	1	6.566	94.4	2	R.IANVFTNAFR.Y
*	20160416_RA_P1_SF_03.16691.16691.2	3.1174	0.371	100.0	1973.0314	1972.0326	5702.0	1	6.415	52.9	1	R.FCGLPQPETVGQLGTVLR.N
*	20160416_RA_P1_SF_05.18562.18562.2	3.2903	0.3042	100.0	1545.8613	1544.8623	9727.6	1	5.593	61.5	9	R.VGPLLACIIGTQFR.K
*	20160416_RA_P1_SF_03.11799.11799.2	2.6076	0.2278	100.0	1096.6425	1096.6478	3853.4	1	5.548	83.3	2	R.QALAQISLPR.I
*	20160416_RA_P1_SF_03.00766.00766.2	1.5744	0.0542	97.3	1964.9727	1963.97	7781.9	128	3.622	40.6	1	R.DFVNCSTLPALNLASWR.E
sp|P19823|ITIH2_HUMAN	6	10	9.0%	946	106463	6.9	U	ITIH2 Inter-alpha-trypsin inhibitor heavy chain H2 [REVIEWED] ENSG00000151655;IPI00305461;P19823;Q14659;Q15484;Q5T986 
*	20160416_RA_P1_SF_05.05499.05499.2	2.8208	0.2241	100.0	2242.1345	2241.1345	9336.0	2	4.864	39.5	1	R.FLHVPDTFEGHFDGVPVISK.G
*	20160416_RA_P1_SF_04.17186.17186.2	2.1255	0.2042	99.9	1649.8552	1649.8638	11404.6	72	4.706	42.9	1	R.ETAVDGELVVLYDVK.R
*	20160416_RA_P1_SF_05.22914.22914.2	4.1499	0.3799	100.0	2838.4011	2836.3987	7169.9	1	6.315	35.4	1	K.AGELEVFNGYFVHFFAPDNLDPIPK.N
*	20160416_RA_P1_SF_05.22878.22878.3	5.1968	0.3988	100.0	2837.396	2836.3987	7301.2	1	6.688	36.5	2	K.AGELEVFNGYFVHFFAPDNLDPIPK.N
*	20160416_RA_P1_SF_03.12565.12565.2	3.6265	0.3628	100.0	1337.7144	1337.7218	5774.5	1	6.77	80.0	4	K.FYNQVSTPLLR.N
*	20160416_RA_P1_SF_05.01783.01783.2	5.218	0.4242	100.0	1704.9532	1703.9485	9899.3	1	7.48	84.6	1	K.LWAYLTINQLLAER.S
sp|P03952|KLKB1_HUMAN	4	4	8.5%	638	71370	8.2	U	KLKB1 Plasma kallikrein [REVIEWED] ENSG00000164344;IPI00654888;P03952;A6NH96;B2R8H9;Q17RE8;Q17RE9;Q4W5C3 
*	20160416_RA_P1_SF_04.00204.00204.2	4.4406	0.4182	100.0	1619.7665	1618.7688	8487.0	1	7.502	79.2	1	C.GCLTQLYENAFFR.G
*	20160416_RA_P1_SF_03.16059.16059.2	2.3078	0.2177	100.0	2193.9773	2193.9836	7502.2	1	5.138	34.4	1	R.CQFFTYSLLPEDCKEEK.C
*	20160416_RA_P1_SF_02.10761.10761.2	1.5895	0.0223	97.1	1545.7749	1543.779	7409.0	53	3.056	45.8	1	K.VNIPLVTNEECQK.R
*	20160416_RA_P1_SF_02.18330.18330.2	3.5938	0.4415	100.0	1396.6708	1396.6823	7134.8	1	7.603	85.0	1	K.VAEYMDWILEK.T
sp|Q96IY4|CBPB2_HUMAN	3	11	8.0%	423	48424	7.7	U	CPB2 Carboxypeptidase B2 [REVIEWED] ENSG00000080618;IPI00329775;Q96IY4;A8K464;Q15114;Q5T9K1;Q5T9K2;Q9P2Y6 
*	20160416_RA_P1_SF_04.12378.12378.2	1.6823	0.0277	97.4	1425.7003	1425.7062	8389.0	342	3.176	45.5	1	K.NAIWIDCGIHAR.E
*	20160416_RA_P1_SF_04.09720.09720.2	3.9833	0.443	100.0	1781.798	1781.803	10043.9	1	8.603	64.3	7	R.SFYANNHCIGTDLNR.N
*	20160416_RA_P1_SF_05.13163.13163.2	1.5368	0.0062	97.2	894.529	894.5314	2179.7	16	4.929	75.0	3	K.IAWHVIR.N
sp|Q16610|ECM1_HUMAN	2	2	7.8%	540	60674	6.7	U	ECM1 Extracellular matrix protein 1 [REVIEWED] ENSG00000143369;IPI00909747;Q16610;A8K8S0;B4DW49;B4DY60;O43266;Q5T5G4;Q5T5G5;Q5T5G6;Q8IZ60 
*	20160416_RA_P1_SF_05.00398.00398.3	3.2217	0.0777	99.0	2986.4966	2986.4985	8796.9	46	3.142	25.0	1	R.ACPSHQPDISSGLELPFPPGVPTLDNIK.N
*	20160416_RA_P1_SF_05.12790.12790.2	2.2192	0.3426	100.0	1596.7715	1596.7739	5411.5	1	6.146	57.7	1	R.VTPNLMGHLCGNQR.V
tr|B4E1Z4|B4E1Z4_HUMAN	8	29	7.7%	1266	140942	7.2	U	CFB cDNA FLJ55673, highly similar to Complement factor B (EC 3.4.21.47) [NOT_REVIEWED] ENSG00000243570;ENSG00000244255;ENSG00000239754;ENSG00000242335;ENSG00000243649;ENSG00000241534;IPI00019591;B4E1Z4 
	20160416_RA_P1_SF_02.15720.15720.2	2.3503	0.2802	100.0	1250.6749	1250.6785	7909.1	1	5.235	63.6	1	K.AVISPGFDVFAK.K
	20160416_RA_P1_SF_03.16602.16602.2	3.5002	0.2959	100.0	1759.864	1758.8705	4349.8	1	6.072	60.7	1	R.PICLPCTMEANLALR.R
	20160416_RA_P1_SF_02.18045.18045.2	4.368	0.5264	100.0	2816.3699	2815.3765	6044.7	1	8.66	43.5	7	R.LLQEGQALEYVCPSGFYPYPVQTR.T
	20160416_RA_P1_SF_02.18005.18005.3	4.2067	0.3432	100.0	2816.3757	2815.3765	6755.2	1	6.564	31.5	2	R.LLQEGQALEYVCPSGFYPYPVQTR.T
	20160416_RA_P1_SF_03.11983.11983.2	2.7061	0.0495	99.9	988.5448	988.5501	4972.1	23	4.117	85.7	4	K.CLVNLIEK.V
	20160416_RA_P1_SF_02.11189.11189.2	4.0992	0.4754	100.0	1275.657	1275.6625	5201.2	1	7.955	90.0	8	R.YGLVTYATYPK.I
	20160416_RA_P1_SF_02.18693.18693.2	4.2277	0.4517	100.0	1843.9152	1842.9165	3002.2	1	8.089	73.3	4	K.EAGIPEFYDYDVALIK.L
	20160416_RA_P1_SF_02.15660.15660.2	3.3787	0.3182	100.0	1306.6482	1306.6531	8665.3	1	5.98	85.0	2	K.EKLQDEDLGFL.-
sp|P10643|CO7_HUMAN	4	8	7.7%	843	93518	6.5	U	C7 Complement component C7 [REVIEWED] ENSG00000112936;IPI00296608;P10643;Q6P3T5;Q92489 
*	20160416_RA_P1_SF_03.15541.15541.2	3.9717	0.4183	100.0	1455.7766	1455.7848	7368.7	1	7.485	66.7	2	R.LSGNVLSYTFQVK.I
*	20160416_RA_P1_SF_05.13586.13586.2	1.8403	0.1697	99.8	1047.5426	1046.5424	7454.7	7	4.484	75.0	3	K.SSGWHFVVK.F
*	20160416_RA_P1_SF_05.21253.21253.3	2.7197	0.0442	96.6	2750.4082	2749.4097	4064.9	8	3.263	27.2	1	R.LLEPHCFPLSLVPTEFCPSPPALK.D
*	20160416_RA_P1_SF_02.13467.13467.2	4.8782	0.3922	100.0	2127.0305	2126.0342	7701.2	1	8.47	63.9	2	K.NVVYTCNEGYSLIGNPVAR.C
sp|P35908|K22E_HUMAN	5	9	7.4%	639	65433	8.0	U	KRT2 Keratin, type II cytoskeletal 2 epidermal [REVIEWED] ENSG00000172867;IPI00021304;P35908;Q4VAQ2 
	20160416_RA_P1_SF_02.08934.08934.2	4.0827	0.2814	100.0	1475.7802	1475.7858	10533.1	1	6.648	81.8	3	R.FLEQQNQVLQTK.W
*	20160416_RA_P1_SF_02.18789.18789.2	3.9189	0.1937	100.0	1460.7969	1460.8	5547.8	1	6.239	81.8	2	K.VDLLNQEIEFLK.V
	20160416_RA_P1_SF_03.00094.00094.1	1.833	0.1536	96.1	1329.723	1329.7266	6234.9	19	3.88	50.0	1	R.NLDLDSIIAEVK.A
	20160416_RA_P1_SF_03.00030.00030.2	3.9921	0.2398	100.0	1329.7228	1329.7266	5926.6	1	6.33	81.8	2	R.NLDLDSIIAEVK.A
	20160416_RA_P1_SF_04.15289.15289.2	1.8949	0.1763	99.8	1263.7185	1263.6948	5389.7	1	3.903	60.0	1	K.LALDVEIATYR.K
sp|O95445|APOM_HUMAN	2	2	7.4%	188	21253	6.0	U	APOM Apolipoprotein M [REVIEWED] ENSG00000204444;ENSG00000227567;ENSG00000206409;ENSG00000224290;ENSG00000235754;ENSG00000231974;ENSG00000226215;IPI00030739;O95445;B0UX98;Q9P046;Q9UMP6 
*	20160416_RA_P1_SF_05.16918.16918.2	1.5321	0.0325	97.1	1718.8857	1718.8866	7382.2	4	3.063	50.0	1	R.KWIYHLTEGSTDLR.T
*	20160416_RA_P1_SF_04.12810.12810.2	2.9438	0.2726	100.0	1591.786	1590.7916	7343.2	1	5.905	58.3	1	K.WIYHLTEGSTDLR.T
sp|P08697|A2AP_HUMAN	3	8	7.3%	491	54566	6.3	U	SERPINF2 Alpha-2-antiplasmin [REVIEWED] ENSG00000167711;IPI00879231;P08697;B4E1B7;Q8N5U7;Q9UCG2;Q9UCG3 
*	20160416_RA_P1_SF_03.17733.17733.2	2.0688	0.1138	99.5	2282.074	2280.043	5987.1	1	4.46	41.7	4	R.DSFHLDEQFTVPVEMMQAR.T
*	20160416_RA_P1_SF_05.21582.21582.2	4.6326	0.4353	100.0	2130.1196	2129.1223	6204.0	1	7.547	65.6	2	R.WFLLEQPEIQVAHFPFK.N
*	20160416_RA_P1_SF_05.21636.21636.3	3.2667	0.1603	99.6	2129.1128	2129.1223	4516.9	158	5.053	31.2	2	R.WFLLEQPEIQVAHFPFK.N
sp|Q15582|BGH3_HUMAN	4	5	7.2%	683	74681	7.7	U	TGFBI Transforming growth factor-beta-induced protein ig-h3 [REVIEWED] ENSG00000120708;IPI00018219;Q15582;D3DQB1;O14471;O14472;O14476;O43216;O43217;O43218;O43219;Q53XM1 
*	20160416_RA_P1_SF_05.00917.00917.2	2.5661	0.0772	99.8	1315.7941	1315.799	5994.6	22	4.127	54.5	1	R.LTLLAPLNSVFK.D
*	20160416_RA_P1_SF_04.11597.11597.2	2.0737	0.2185	99.9	1579.8077	1579.812	7399.9	5	4.13	53.8	2	K.YLYHGQTLETLGGK.K
*	20160416_RA_P1_SF_02.12160.12160.2	1.6164	0.0876	98.6	1103.5156	1103.5195	4566.7	3	3.792	68.8	1	R.YGTLFTMDR.V
*	20160416_RA_P1_SF_03.18355.18355.2	1.9015	0.0984	98.9	1501.8154	1500.817	4008.8	91	3.973	46.2	1	R.VLTPPMGTVMDVLK.G
sp|P80108|PHLD_HUMAN	4	6	7.0%	840	92336	6.4	U	GPLD1 Phosphatidylinositol-glycan-specific phospholipase D [REVIEWED] ENSG00000112293;IPI00376358;P80108;Q15127;Q15128;Q2M2F2;Q5T3Y0;Q7Z6T8;Q8TCV0;Q8WW82;Q96ID6;Q9H167;Q9H4M1;Q9UJC9 
*	20160416_RA_P1_SF_04.00436.00436.3	3.0064	0.0094	95.8	3114.4668	3113.4753	9156.3	14	3.087	23.0	1	R.ELLLEHQDAYQAGIVFPDCFYPSICK.G
*	20160416_RA_P1_SF_05.12622.12622.2	1.894	0.0483	99.0	947.54376	947.5467	4539.3	2	3.649	83.3	1	R.RWYVPVK.D
*	20160416_RA_P1_SF_03.15683.15683.2	3.032	0.2837	100.0	1214.7083	1214.7148	5303.2	1	5.023	75.0	2	R.TLLLVGSPTWK.N
*	20160416_RA_P1_SF_05.15058.15058.2	1.8152	0.0081	97.3	1572.8712	1570.8706	7790.6	2	3.209	50.0	2	K.VAFLTVTLHQGGATR.M
sp|Q562R1|ACTBL_HUMAN	2	6	6.9%	376	42003	5.6	U	ACTBL2 Beta-actin-like protein 2 [REVIEWED] ENSG00000169067;IPI00003269;Q562R1;B2RPJ1;Q562R2;Q562S9;Q562X8 
*	20160416_RA_P1_SF_03.12720.12720.3	2.8703	0.0592	98.5	1954.0532	1954.065	6696.9	3	5.524	36.8	3	R.VAPDEHPILLTEAPLNPK.I
	20160416_RA_P1_SF_02.09886.09886.1	1.832	0.1693	95.3	998.4814	998.4869	6622.6	1	4.624	64.3	3	R.DLTDYLMK.I
sp|P02538|K2C6A_HUMAN	5	6	6.7%	564	60045	8.0	U	KRT6A Keratin, type II cytoskeletal 6A [REVIEWED] ENSG00000205420;IPI00300725;P02538;A4QPC1;P48667;Q08AR4;Q6NT67;Q96CL4 
sp|P13647|K2C5_HUMAN	5	6	6.4%	590	62378	7.8	U	KRT5 Keratin, type II cytoskeletal 5 [REVIEWED] ENSG00000186081;IPI00009867;P13647;Q6PI71;Q6UBJ0;Q8TA91 
	20160416_RA_P1_SF_04.01399.01399.2	4.1234	0.4917	100.0	1890.9669	1890.9714	5143.4	1	8.015	78.6	1	R.QNLEPLFEQYINNLR.R
	20160416_RA_P1_SF_04.01408.01408.3	2.7532	0.027	97.0	1892.9617	1890.9714	9870.6	7	3.391	44.6	1	R.QNLEPLFEQYINNLR.R
	20160416_RA_P1_SF_03.00094.00094.1	1.833	0.1536	96.1	1329.723	1329.7266	6234.9	19	3.88	50.0	1	R.NLDLDSIIAEVK.A
	20160416_RA_P1_SF_03.00030.00030.2	3.9921	0.2398	100.0	1329.7228	1329.7266	5926.6	1	6.33	81.8	2	R.NLDLDSIIAEVK.A
	20160416_RA_P1_SF_04.15289.15289.2	1.8949	0.1763	99.8	1263.7185	1263.6948	5389.7	1	3.903	60.0	1	K.LALDVEIATYR.K
sp|P43652|AFAM_HUMAN	5	7	6.5%	599	69069	5.9	U	AFM Afamin [REVIEWED] ENSG00000079557;IPI00019943;P43652;A8K3E1;Q32MR3;Q4W5C5 
*	20160416_RA_P1_SF_03.13088.13088.2	2.0578	0.0161	99.0	992.4727	991.4711	4301.6	17	3.341	91.7	1	R.LCFFYNK.K
*	20160416_RA_P1_SF_05.13086.13086.2	1.3311	0.046	97.0	1119.5629	1119.5662	5194.7	3	3.924	50.0	1	R.LCFFYNKK.S
*	20160416_RA_P1_SF_03.00182.00182.2	3.3392	0.2993	100.0	1888.9362	1887.938	3941.0	1	5.59	53.1	1	K.SDVGFLPPFPTLDPEEK.C
*	20160416_RA_P1_SF_02.10007.10007.2	1.7071	0.1129	99.3	949.4382	949.44196	4641.6	2	3.773	91.7	3	K.FTFEYSR.R
*	20160416_RA_P1_SF_03.13674.13674.2	1.8059	0.0068	98.2	832.52545	832.52966	3563.6	7	2.224	100.0	1	R.FLVNLVK.L
sp|P06727|APOA4_HUMAN	2	3	6.3%	396	45399	5.4	U	APOA4 Apolipoprotein A-IV [REVIEWED] ENSG00000110244;IPI00304273;P06727;A8MSL6;Q14CW8;Q6Q787 
*	20160416_RA_P1_SF_03.00034.00034.2	4.8709	0.3544	100.0	1634.833	1634.839	9177.9	1	7.852	80.8	2	K.SELTQQLNALFQDK.L
*	20160416_RA_P1_SF_04.12465.12465.2	2.223	0.2135	100.0	1311.7014	1311.706	3863.3	1	3.897	70.0	1	K.LVPFATELHER.L
sp|P18428|LBP_HUMAN	2	2	6.2%	481	53384	6.7	U	LBP Lipopolysaccharide-binding protein [REVIEWED] ENSG00000129988;IPI00032311;P18428;B2R938;O43438;Q92672;Q9H403;Q9UD66 
*	20160416_RA_P1_SF_04.02282.02282.2	3.3781	0.1961	100.0	2073.1282	2073.1345	11085.1	1	6.248	50.0	1	K.GLQYAAQEGLLALQSELLR.I
*	20160416_RA_P1_SF_03.16443.16443.2	3.5334	0.392	100.0	1268.6354	1268.6383	7332.8	1	7.725	70.0	1	R.ATAQMLEVMFK.G
sp|P05154|IPSP_HUMAN	2	2	6.2%	406	45675	9.3	U	SERPINA5 Plasma serine protease inhibitor [REVIEWED] ENSG00000188488;IPI00007221;P05154;Q07616;Q9UG30 
*	20160416_RA_P1_SF_03.17944.17944.2	4.2489	0.2514	100.0	1456.8152	1456.8197	8995.3	1	5.242	87.5	1	K.MQILEGLGLNLQK.S
*	20160416_RA_P1_SF_03.13779.13779.2	2.2908	0.1674	99.9	1226.644	1226.6533	6754.5	14	4.428	59.1	1	R.AAAATGTIFTFR.S
sp|P08185|CBG_HUMAN	2	6	5.7%	405	45141	6.0	U	SERPINA6 Corticosteroid-binding globulin [REVIEWED] ENSG00000170099;IPI00027482;P08185;A8K456;Q7Z2Q9 
*	20160416_RA_P1_SF_02.14472.14472.2	2.6716	0.0852	99.8	1479.7161	1479.7233	6138.9	8	4.274	58.3	3	K.GTWTQPFDLASTR.E
*	20160416_RA_P1_SF_03.12582.12582.2	3.3238	0.2276	100.0	1075.5878	1075.5934	3971.7	1	5.818	94.4	3	K.MNTVIAALSR.D
sp|P43251|BTD_HUMAN	2	3	5.5%	543	61133	6.3	U	BTD Biotinidase [REVIEWED] ENSG00000169814;IPI00218413;P43251;B2R865;Q96EM9 
*	20160416_RA_P1_SF_04.01857.01857.2	2.6995	0.274	100.0	1998.0193	1997.0206	7808.2	1	5.75	53.1	1	R.TSIYPFLDFMPSPQVVR.W
*	20160416_RA_P1_SF_03.14329.14329.2	2.5943	0.3076	100.0	1307.726	1307.7323	8641.4	4	6.047	54.2	2	R.LSSGLVTAALYGR.L
sp|P09871|C1S_HUMAN	2	3	5.4%	688	76685	5.0	U	C1S Complement C1s subcomponent [REVIEWED] ENSG00000182326;IPI00017696;P09871;D3DUT4;Q9UCU7;Q9UCU8;Q9UCU9;Q9UCV0;Q9UCV1;Q9UCV2;Q9UCV3;Q9UCV4;Q9UCV5;Q9UM14 
*	20160416_RA_P1_SF_03.00239.00239.2	4.8324	0.328	100.0	1763.9133	1763.918	9259.8	1	8.708	70.0	2	K.SNALDIIFQTDLTGQK.K
*	20160416_RA_P1_SF_05.00155.00155.2	2.2014	0.2451	100.0	2368.1213	2367.1233	6253.5	1	5.123	32.5	1	K.FYAAGLVSWGPQCGTYGLYTR.V
sp|P07357|CO8A_HUMAN	2	5	5.3%	584	65163	6.5	U	C8A Complement component C8 alpha chain [REVIEWED] ENSG00000157131;IPI00011252;P07357;A2RUI4;A2RUI5;Q13668;Q9H130 
*	20160416_RA_P1_SF_02.16488.16488.2	4.5675	0.414	100.0	1631.7375	1630.7357	8261.0	1	7.348	70.8	3	R.ALDQYLMEFNACR.C
*	20160416_RA_P1_SF_03.13991.13991.2	3.8241	0.5094	100.0	2037.8882	2037.8944	6023.0	1	8.47	55.9	2	R.CGPCFNNGVPILEGTSCR.C
sp|Q7Z4T9|AAT1_HUMAN	2	2	4.8%	603	70999	7.8	U	AAT1 AMY-1-associating protein expressed in testis 1 [REVIEWED] ENSG00000183833;IPI00969208;Q7Z4T9;A0AVK2;A8K1J9;B3KP23;B4DG52;B4DZ14;C9JUG4;Q68DX2;Q8TD41;Q96A45;Q96JE8 
*	20160416_RA_P1_SF_03.14227.14227.2	2.6176	0.0585	99.7	1886.8923	1885.8876	8147.0	132	3.341	42.3	1	R.KMMNEMERKEWAFR.E
*	20160416_RA_P1_SF_02.08420.08420.2	1.2429	0.0076	95.8	1882.115	1882.071	5602.0	489	2.863	28.6	1	R.IHAFVMLAERQRRVR.E
sp|P06276|CHLE_HUMAN	2	2	4.8%	602	68418	7.4	U	BCHE Cholinesterase [REVIEWED] ENSG00000114200;IPI00025864;P06276;A8K7P8 
*	20160416_RA_P1_SF_04.00597.00597.2	4.9264	0.524	100.0	2282.1646	2281.1616	6226.4	1	9.87	60.0	1	R.AILQSGSFNAPWAVTSLYEAR.N
*	20160416_RA_P1_SF_04.17948.17948.2	1.9299	0.0317	98.8	1059.5258	1059.5304	5226.5	1	3.373	78.6	1	R.FWTSFFPK.V
sp|P07225|PROS_HUMAN	3	9	4.7%	676	75123	5.7	U	PROS1 Vitamin K-dependent protein S [REVIEWED] ENSG00000184500;IPI00294004;P07225;A8KAC9;D3DN28;Q15518;Q7Z715;Q9UCZ8 
*	20160416_RA_P1_SF_03.13146.13146.2	2.7798	0.2169	100.0	1198.6158	1198.6221	9679.1	1	4.996	75.0	1	R.SFQTGLFTAAR.Q
*	20160416_RA_P1_SF_03.13421.13421.2	2.4316	0.176	100.0	956.4951	956.4994	3668.4	28	4.205	78.6	1	K.VYFAGFPR.K
*	20160416_RA_P1_SF_05.11411.11411.2	2.2495	0.2794	100.0	1523.8966	1522.8958	6089.9	4	5.069	50.0	7	R.KVESELIKPINPR.L
sp|Q92954|PRG4_HUMAN	4	8	4.3%	1404	151076	9.5	U	PRG4 Proteoglycan 4 [REVIEWED] ENSG00000116690;IPI00656111;Q92954;Q6DNC4;Q6DNC5;Q6ZMZ5;Q9BX49 
*	20160416_RA_P1_SF_03.01207.01207.2	3.6185	0.3643	100.0	1931.0178	1931.0278	3945.1	1	7.384	56.2	2	R.ITEVWGIPSPIDTVFTR.C
*	20160416_RA_P1_SF_04.10089.10089.2	2.0883	0.0734	99.4	1135.6106	1135.6151	4289.7	1	4.25	83.3	3	K.DAGYPKPIFK.G
*	20160416_RA_P1_SF_05.01243.01243.2	4.6847	0.4699	100.0	1590.8784	1590.8855	8885.5	1	8.147	78.1	1	K.GFGGLTGQIVAALSTAK.Y
*	20160416_RA_P1_SF_04.06556.06556.2	2.988	0.2823	100.0	1650.9528	1650.9542	6734.5	1	5.025	53.3	2	R.GLPNVVTSAISLPNIR.K
sp|P02671|FIBA_HUMAN	4	10	4.2%	866	94973	6.0	U	FGA Fibrinogen alpha chain [REVIEWED] ENSG00000171560;IPI00029717;P02671;D3DP14;D3DP15;Q4QQH7;Q9BX62;Q9UCH2 
*	20160416_RA_P1_SF_05.00274.00274.2	4.1425	0.4126	100.0	1629.8224	1629.827	7207.4	1	8.605	76.9	3	K.DSHSLTTNIMEILR.G
*	20160416_RA_P1_SF_05.00264.00264.3	3.4497	0.1794	99.8	1629.8214	1629.827	6613.9	15	4.197	48.1	1	K.DSHSLTTNIMEILR.G
*	20160416_RA_P1_SF_05.11905.11905.2	3.1537	0.1579	100.0	1106.6659	1106.6686	6026.3	1	5.39	87.5	5	K.VQHIQLLQK.N
*	20160416_RA_P1_SF_05.14451.14451.2	1.8489	0.0915	98.9	1442.7869	1441.7877	7392.4	25	4.003	50.0	1	K.MKPVPDLVPGNFK.S
sp|Q9NVC6|MED17_HUMAN	2	2	4.0%	651	72890	7.4	U	MED17 Mediator of RNA polymerase II transcription subunit 17 [REVIEWED] ENSG00000042429;IPI00855753;Q9NVC6;B3KN07;Q9HA81;Q9UNP7;Q9Y2W0;Q9Y660 
*	20160416_RA_P1_SF_04.16626.16626.2	1.5177	0.0027	96.5	1843.1785	1840.102	8400.0	34	2.813	32.4	1	K.SLAGAAQILLKGAERLTK.S
*	20160416_RA_P1_SF_04.09010.09010.2	1.5015	0.1206	98.7	1012.5747	1012.6056	6131.7	265	3.677	57.1	1	K.QAKHIFLR.S
sp|P26927|HGFL_HUMAN	2	2	3.4%	711	80320	7.7	U	MST1 Hepatocyte growth factor-like protein [REVIEWED] ENSG00000173531;IPI00925540;P26927;A6NLA3;A8MSX3;Q13350;Q14870;Q6GTN4 
*	20160416_RA_P1_SF_03.13394.13394.2	3.6648	0.2946	100.0	1489.786	1488.7919	6294.1	5	5.843	57.7	1	K.MVCGPSGSQLVLLK.L
	20160416_RA_P1_SF_04.16492.16492.2	1.4687	0.0964	98.0	1229.6617	1229.6682	10006.4	136	3.328	50.0	1	R.VSVFVDWIHK.V
Reverse_sp|Q8N8V2|GBP7_HUMAN	2	2	3.4%	638	72513	6.0	U	GBP7 Guanylate-binding protein 7 [REVIEWED] ENSG00000213512;IPI00298353;Q8N8V2 
*	20160416_RA_P1_SF_05.16488.16488.2	1.6997	0.0497	98.0	1277.7094	1277.6993	7736.3	110	2.955	55.0	1	K.FGETLLEELVK.M
*	20160416_RA_P1_SF_03.10421.10421.2	1.4444	7.0E-4	96.4	1220.6025	1220.6461	5569.0	6	3.282	70.0	1	K.VTCGLPFGKNK.G
Reverse_sp|P25100|ADA1D_HUMAN	2	3	2.8%	572	60463	9.2	U	ADRA1D Alpha-1D adrenergic receptor [REVIEWED] ENSG00000171873;IPI00012725;P25100;Q9NPY0 
*	20160416_RA_P1_SF_05.12751.12751.2	1.7845	0.0139	98.0	801.5163	800.47424	3314.5	19	1.744	71.4	1	R.QAGGARIK.H
*	20160416_RA_P1_SF_02.16436.16436.2	1.3163	0.0433	96.8	960.5914	958.55865	7737.5	1	3.089	71.4	2	R.FASPPKRR.S
sp|P12821|ACE_HUMAN	2	29	2.1%	1306	149714	6.4	U	ACE Angiotensin-converting enzyme [REVIEWED] ENSG00000159640;IPI00909226;P12821;B0LPF0;B4DXI3;E7EU16;P22966;Q53YX9;Q59GY8;Q7M4L4 
*	20160416_RA_P1_SF_04.17630.17630.2	3.9625	0.084	100.0	2037.0277	2034.9773	9341.6	37	3.994	41.2	28	R.QEEAALLSQEFAEAWGQK.A
*	20160416_RA_P1_SF_03.13011.13011.2	1.6814	0.0109	97.3	1089.5406	1089.4965	3910.5	358	3.032	55.6	1	R.NETHFDAGAK.F
Reverse_sp|O95197|RTN3_HUMAN	2	2	1.9%	1032	112611	5.0	U	RTN3 Reticulon-3 [REVIEWED] ENSG00000133318;IPI00743293;O95197;B3KQS2;B7Z308;Q147U9;Q496K2;Q53GN3;Q59EP0;Q5UEP2;Q6T930;Q7RTM7;Q7RTM8;Q7RTN3 
*	20160416_RA_P1_SF_03.09176.09176.2	2.0042	0.0022	98.5	935.52094	933.50055	3273.6	43	2.477	62.5	1	K.SLSSVADVR.T
*	20160416_RA_P1_SF_02.12489.12489.2	2.7465	0.193	96.5	1164.5848	1164.557	3725.4	2	4.126	70.0	1	P.TSGDISCVPTK.Q
sp|O75882|ATRN_HUMAN	2	3	1.5%	1429	158536	7.3	U	ATRN Attractin [REVIEWED] ENSG00000088812;IPI00939169;O75882;A8KAE5;O60295;O95414;Q3MIT3;Q5TDA2;Q5TDA4;Q5VYW3;Q9NTQ3;Q9NTQ4;Q9NU01;Q9NZ57;Q9NZ58;Q9UC75;Q9UDF5 
*	20160416_RA_P1_SF_02.18235.18235.2	2.0749	0.0085	98.4	1513.6987	1512.7408	5879.1	140	2.951	54.5	1	R.YDVDTQMWTILK.D
*	20160416_RA_P1_SF_04.17042.17042.2	2.285	0.203	100.0	1155.684	1155.689	4934.1	1	4.719	66.7	2	K.LTLTPWVGLR.K
sp|Q13535|ATR_HUMAN	2	2	1.2%	2644	301365	7.4	U	ATR Serine/threonine-protein kinase ATR [REVIEWED] ENSG00000175054;IPI00926461;Q13535;Q59HB2;Q7KYL3;Q93051;Q9BXK4 
*	20160416_RA_P1_SF_03.17838.17838.2	2.0858	0.0916	99.3	1697.9504	1696.9386	7809.6	29	3.464	42.3	1	K.RDITAFYDSLKLVR.A
*	20160416_RA_P1_SF_04.02523.02523.2	1.6761	0.1372	98.9	2167.9998	2168.103	11590.6	12	3.874	35.3	1	K.EKGVYMTGKELRQCMLPK.S
sp|Q5TCS8|AKD1_HUMAN	2	2	1.2%	1911	221411	5.0	U	AKD1 Adenylate kinase domain-containing protein 1 [REVIEWED] ENSG00000155085;IPI00930224;Q5TCS8;A6NL75;B2RDJ0;B6ZDM7;Q3MIS4;Q5I0W8;Q6ZNF1;Q6ZVR7;Q8N7C6;Q8WW00;Q96NF4 
*	20160416_RA_P1_SF_03.04234.04234.2	1.3821	0.0128	96.4	1292.7993	1288.7993	5422.8	77	2.826	55.6	1	K.EIFKRLLLEK.E
*	20160416_RA_P1_SF_03.04884.04884.2	1.57	0.0325	97.2	1418.8861	1418.8372	6507.8	126	3.479	40.9	1	R.LTLSELKSRFPK.C
Reverse_sp|Q96L91|EP400_HUMAN	2	2	0.8%	3159	343489	9.2	U	EP400 E1A-binding protein p400 [REVIEWED] ENSG00000183495;IPI00878154;Q96L91;O15411;Q6P2F5;Q8N8Q7;Q8NE05;Q96JK7;Q9P230 
*	20160416_RA_P1_SF_02.06207.06207.3	1.8148	0.1505	98.2	1738.945	1736.0156	5862.8	59	3.278	35.7	1	K.KKRGAASPDTKHRKR.E
*	20160416_RA_P1_SF_04.09333.09333.2	1.0164	0.0413	95.7	1012.57495	1010.52057	4317.1	3	3.0	43.8	1	R.GHSPLACIR.L
Reverse_sp|Q8WZ42|TITIN_HUMAN	2	2	0.1%	34350	3815965	6.3	U	TTN Titin [REVIEWED] ENSG00000155657;IPI00939967;Q8WZ42;A6NKB1;E7EQE6;E7ET18;Q10465;Q10466;Q15598;Q2XUS3;Q32Q60;Q4U1Z6;Q4ZG20;Q6NSG0;Q6PDB1;Q6PJP0;Q7KYM2;Q7KYN4;Q7KYN5;Q7LDM3;Q7Z2X3;Q8TCG8;Q8WZ51;Q8WZ52;Q8WZ53;Q8WZB3;Q92761;Q92762;Q9UD97;Q9UP84;Q9Y6L9 
*	20160416_RA_P1_SF_05.16966.16966.2	1.2223	0.0787	96.7	1735.0737	1732.0597	5264.1	223	3.174	32.1	1	K.RPVPVKEEAVVRKPK.M
*	20160416_RA_P1_SF_05.03212.03212.2	1.5153	0.0541	97.2	1680.0201	1677.9387	7815.3	66	3.328	36.7	1	K.VSKTIKQASSTASLEK.Q
sp|Q8WZ42|TITIN_HUMAN	2	8	0.1%	34350	3815922	6.3	U	TTN Titin [REVIEWED] ENSG00000155657;IPI00939967;Q8WZ42;A6NKB1;E7EQE6;E7ET18;Q10465;Q10466;Q15598;Q2XUS3;Q32Q60;Q4U1Z6;Q4ZG20;Q6NSG0;Q6PDB1;Q6PJP0;Q7KYM2;Q7KYN4;Q7KYN5;Q7LDM3;Q7Z2X3;Q8TCG8;Q8WZ51;Q8WZ52;Q8WZ53;Q8WZB3;Q92761;Q92762;Q9UD97;Q9UP84;Q9Y6L9 
*	20160416_RA_P1_SF_03.12389.12389.2	2.4926	0.081	99.8	1313.6211	1313.6411	5825.5	327	3.79	50.0	7	K.ELVSGGSCYITK.E
*	20160416_RA_P1_SF_03.02275.02275.2	1.1379	0.0324	95.8	1063.6587	1061.6359	6677.4	90	2.921	50.0	1	K.VEAPPPKVPK.K
	Proteins	Peptide IDs	Spectra
Unfiltered	26672	84982	86551
Filtered	135	1246	8365
Forward matches	129	1234	8352
Decoy matches	6	12	13
Forward FP rate	4.65	0.97	0.16

Classification	Nonredundant Proteins	Redundant Proteins
Unclassified	0	0
